≡ Risteys
R14

Documentation Changelog GitHub Contact & Feedback

Cholangitis (primary sclerosing, PSC)

DOID EFO Endpoint Browser PheWeb

K11_CHOLANGI

sclerosing cholangitis: A chronic, autoimmune inflammatory liver disorder characterized by narrowing and scarring of the lumen of the bile ducts. It is often seen in patients with ulcerative colitis. Signs and symptoms include jaundice, fatigue, and malabsorption. It may lead to cirrhosis and liver failure.

Suggest a new description

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps

FinnGen

Phenotype data

519870

1. Apply sex-specific rule

None

519870

2. Check conditions

None

519870

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — K83.0
  • Hospital discharge: ICD-9 — 5761
  • Hospital discharge: ICD-8 — 5750[4-5]
  • Cause of death: ICD-10 — K83.0
  • Cause of death: ICD-9 — 5761
  • Cause of death: ICD-8 — 5750[4-5]

2 out of 7 registries used, show all original rules.

2745

4. Check minimum number of events

None

2745

5. Include endpoints

None

2745

6. Filter based on genotype QC (FinnGen only)

2665

Control definitions (FinnGen only)

Control exclude
K11_GALLBILPANC

Extra metadata

Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF2
Parent code in ICD-10
K83
Name in latin
Cholangitis

Similar endpoints

↥

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 17623 8929 8513
Only index persons 14119 7308 6811
Unadjusted period prevalence (%)
Whole population 0.25 0.26 0.24
Only index persons 0.26 0.27 0.26
Median age at first event (years)
Whole population 69.88 71.11 68.55
Only index persons 69.40 70.72 67.98

-FinnGen-

Key figures

All Female Male
Number of individuals 2665 1279 1386
Unadjusted period prevalence (%) 0.55 0.45 0.64
Median age at first event (years) 64.82 61.56 67.83

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
2745
Matched controls
27450
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
L04AX01
ATC
azathioprine; systemic
10.0
315.7
386
442
R10.1
ICD-10 Finland
Pain localized to upper abdomen
5.0
311.8
881
2369
R17
ICD-10 Finland
Hyperbilirubinaemia, with or without jaundice, not elsewhere classified
38.7
307.7
307
89
JJ2AT
NOMESCO Finland
Biopsy of liver with ultrasound guidance
26.4
307.7
443
199
A09AA02
ATC
multienzymes (lipase, protease etc.); oral
38.8
307.7
323
94
JKE98
NOMESCO Finland
Other transduodenal endoscopic operation on bile duct or ampulla of Vater
1067.4
307.7
922
13
JN3BD
NOMESCO Finland
Extensive abdominal CT
6.6
307.7
621
1158
JN1DG
NOMESCO Finland
Very extensive MRI examination of upper part of abdomen with high intensity magnet
41.4
307.7
443
127
A07EC02
ATC
mesalazine; oral, rectal
10.5
307.7
553
645
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
7.0
307.7
951
1921
JL5AG
NOMESCO Finland
Simple MRI examinaiton of bile and pancreas ducts with high intesity magnet
90.4
307.7
262
32
JN1CG
NOMESCO Finland
Extensive MRI examination of upper part of abdomen with high intensity magnet
35.4
307.7
494
169
C25.0
ICD-10 Finland
Malignant neoplasm: Head of pancreas
42.3
307.7
247
64
JL5SB
NOMESCO Finland
Endoscopic retrograd cholangiopancreaticography
641.8
307.7
713
15
JN3AD
NOMESCO Finland
Abdominal CT examination
8.0
307.7
967
1742
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
15.8
307.7
1014
983
JKA20
NOMESCO Finland
Cholecystectomy
49.2
307.7
226
50
K83.1
ICD-10 Finland
Obstruction of bile duct
2573.1
307.7
640
*
K51.5
ICD-10 Finland
Left sided colitis
17.4
307.7
417
280
JKE18
NOMESCO Finland
Endoscopic internal drainage of bile duct
298.5
307.7
407
16
JKE02
NOMESCO Finland
Transduodenal endoscopic incision of common bile duct orifice
510.2
307.7
567
14
J01MA12
ATC
levofloxacin; systemic
5.1
307.7
1060
3035
D37.7
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Other digestive organs
17.4
307.7
286
182
A05AA02
ATC
ursodeoxycholic acid; oral
130.0
307.7
835
92
JKE12
NOMESCO Finland
Endoscopic extraction of calculus from bile duct
2302.8
307.7
417
*
Z94.4
ICD-10 Finland
Liver transplant status
129.4
307.7
170
14
K83.0
ICD-10 Finland
Cholangitis
4503599627370496.0
307.7
2665
*
UJK02
NOMESCO Finland
ERCP
526.3
307.7
1024
31
K80.5
ICD-10 Finland
Calculus of bile duct without cholangitis or cholecystitis
1533.2
307.7
502
*
K80.0
ICD-10 Finland
Calculus of gallbladder with acute cholecystitis
961.1
307.7
410
5
208
Kela drug reimbursment
Ulcerative colitis and Crohn's disease
13.6
307.7
551
496
K80.2
ICD-10 Finland
Calculus of gallbladder without cholecystitis
239.6
307.7
643
35
JKA21
NOMESCO Finland
Laparoscopic cholecystectomy
449.7
307.7
652
19
202
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
5.8
307.7
738
1634
JL5CG
NOMESCO Finland
Extensive MRI examinaiton of bile and pancreas ducts with high intesity magnet
189.4
307.7
226
13
K80.3
ICD-10 Finland
Calculus of bile duct with cholangitis
+∞
307.7
331
*
JL5BG
NOMESCO Finland
MRI examinaiton of bile and pancreas ducts with high intesity magnet
100.7
307.7
648
84
K51.9
ICD-10 Finland
Ulcerative colitis, unspecified
13.7
307.7
390
328
JN1BG
NOMESCO Finland
MRI examination of upper part of abodmen with high intensity magnet
38.6
307.7
204
57
JLC30
NOMESCO Finland
Pancreatoduodenectomy
105.7
291.3
150
15
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
4.1
289.8
1338
5152
133
Kela drug reimbursment
Severe chronic pancreatic insufficiency
+∞
283.3
267
*
A41.5
ICD-10 Finland
Sepsis due to other Gram-negative organisms
9.3
276.2
354
429
JKE22
NOMESCO Finland
Endoscopic extraction of foreign body from bile duct
2693.6
269.1
256
*
WX402
NOMESCO Finland
General anaesthesia
4.1
263.0
1029
3486
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
3.8
260.2
1406
5924
UJF30
NOMESCO Finland
Ileoscopy through colon
5.2
258.8
646
1547
R50.9
ICD-10 Finland
Fever, unspecified
4.2
236.4
814
2492
127
Kela drug reimbursment
Transplant complication
17.5
235.3
196
120
A07EA06
ATC
budesonide; oral, local oral
8.8
232.5
309
390
K51.8
ICD-10 Finland
Other ulcerative colitis
16.4
231.1
199
130
JN3DE
NOMESCO Finland
Abdominal extensive ultrasoudn examination with blood flow measurements after transplantation
46.1
230.6
136
31
JKE32
NOMESCO Finland
Endoscopic dilatation of bile duct
601.1
227.0
222
*
JJ1LE
NOMESCO Finland
Ultrasound elastography of liver
22.9
225.8
166
77
K51.1
ICD-10 Finland
Ulcerative (chronic) ileocolitis
22.7
223.9
165
77
JKE25
NOMESCO Finland
Endoscopic external drainage of bile duct
108.1
221.8
114
11
601
Kela drug reimbursment
Severe malabsorption of nutrients, mainly fats
24.4
219.4
157
68
K81.0
ICD-10 Finland
Acute cholecystitis
262.9
215.3
218
9
K83.9
ICD-10 Finland
Disease of biliary tract, unspecified
1117.6
214.5
207
*
K80.8
ICD-10 Finland
Other cholelithiasis
49.9
214.1
124
26
TPH04
NOMESCO Finland
Cathetrisation of vein
3.6
213.0
999
3745
A49.9
ICD-10 Finland
Bacterial infection, unspecified
4.3
206.3
656
1877
K85.9
ICD-10 Finland
Acute pancreatitis, unspecified
+∞
205.9
195
*
UJK12
NOMESCO Finland
Peroral cholangioscopy
1958.0
201.5
193
*
JN3CD
NOMESCO Finland
Abdominal CT examination both without and with contrast
9.1
200.3
255
304
J01MA02
ATC
ciprofloxacin; systemic
3.2
196.6
1510
7548
K74.3
ICD-10 Finland
Primary biliary cirrhosis
34.4
196.5
125
38
K76.9
ICD-10 Finland
Liver disease, unspecified
17.5
192.7
160
97
UJF32
NOMESCO Finland
Coloscopy
3.3
190.9
1101
4638
JK3BT
NOMESCO Finland
Catherisation of bile duct with X-ray guidance
384.0
181.8
181
5
WX302
NOMESCO Finland
Thoracal epidural anesthesy
6.1
181.5
342
627
C25.9
ICD-10 Finland
Malignant neoplasm: Pancreas, unspecified
18.9
180.7
144
80
K83.8
ICD-10 Finland
Other specified diseases of biliary tract
1922.9
179.1
172
*
JN4AD
NOMESCO Finland
Body CT examination
4.0
173.6
593
1770
L04AD02
ATC
tacrolimus; systemic
18.9
172.0
137
76
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
5.3
170.3
377
800
WX404
NOMESCO Finland
Intravenous generell anesthesy
3.4
169.0
833
3157
L04AA06
ATC
mycophenolic acid; systemic
11.1
162.2
176
168
D37.6
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Liver, gallbladder and bile ducts
13.4
159.9
153
120
JJ1CE
NOMESCO Finland
Liver, bile duct and pancreas endoscopic ultrasound examination
64.9
159.7
88
14
130
Kela drug reimbursment
Malignant tumour
4.1
159.3
500
1399
K50.8
ICD-10 Finland
Other Crohn disease
13.5
159.0
152
119
K80.1
ICD-10 Finland
Calculus of gallbladder with other cholecystitis
1636.4
156.8
151
*
N02AA05
ATC
oxycodone; systemic
3.1
152.5
849
3431
C22.1
ICD-10 Finland
Malignant neoplasm: Intrahepatic bile duct carcinoma
39.2
148.5
91
24
L04AD01
ATC
ciclosporin; systemic
11.6
148.3
156
142
K51.0
ICD-10 Finland
Ulcerative (chronic) pancolitis
19.5
145.3
114
61
TJJ00
NOMESCO Finland
Percutaneous needle biopsy of liver
42.8
145.1
87
21
JA3AT
NOMESCO Finland
Cathetrisation of abdominal cavity with ultrasound guidance
10.8
139.8
154
150
K73.2
ICD-10 Finland
Chronic active hepatitis, not elsewhere classified
51.5
139.0
80
16
WX004
NOMESCO Finland
Patient-controlled sedation
48.4
137.3
80
17
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.7
136.1
1660
9940
JJC00
NOMESCO Finland
Allogenic transplantation of liver
185.7
135.9
141
8
K50.1
ICD-10 Finland
Crohn disease of large intestine
14.7
133.6
121
86
R74.0
ICD-10 Finland
Elevation of levels of transaminase and lactic acid dehydrogenase [LDH]
9.4
133.1
162
181
K85
ICD-10 Finland
Acute pancreatitis
204.3
131.9
136
7
K75.9
ICD-10 Finland
Inflammatory liver disease, unspecified
15.8
131.3
114
75
JK3NB
NOMESCO Finland
Percutaneous transhepatic cholangiography
444.7
129.0
128
*
K85.8
ICD-10 Finland
Other acute pancreatitis
+∞
128.1
122
*
A41.8
ICD-10 Finland
Other specified sepsis
8.6
127.0
166
203
UJF14
NOMESCO Finland
Enteroscopy of ileoanal anastomosis
27.7
126.5
86
32
Z51.5
ICD-10 Finland
Palliative care
3.6
125.9
473
1485
I85.9
ICD-10 Finland
Oesophageal varices without bleeding
17.4
125.9
104
62
XJD02
NOMESCO Finland
Peroral endoscopic ultrasonography
21.4
123.7
93
45
P01AB01
ATC
metronidazole; oral, rectal
2.6
123.0
1270
6915
K50.9
ICD-10 Finland
Crohn disease, unspecified
11.0
120.3
130
123
D98
ICPC
Cholecystitis/cholelithiasis
47.9
119.8
70
15
C24.9
ICD-10 Finland
Malignant neoplasm: Biliary tract, unspecified
49.8
117.3
68
14
WX002
NOMESCO Finland
Sedation and analgesia
2.8
114.7
750
3244
JJ9AE
NOMESCO Finland
Ultrasound examination of liver transplant
301.7
114.0
115
*
JN4CD
NOMESCO Finland
Very extensive body CT
5.6
113.8
226
431
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
5.1
112.0
252
537
WVA20
NOMESCO Finland
Medicine administration
6.6
111.5
185
296
K86.1
ICD-10 Finland
Other chronic pancreatitis
1122.7
111.3
108
*
TPH07
NOMESCO Finland
Cathetrisation of artery
3.3
110.6
499
1750
K80.4
ICD-10 Finland
Calculus of bile duct with cholecystitis
1101.0
109.2
106
*
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.8
107.5
707
3054
K81.9
ICD-10 Finland
Cholecystitis, unspecified
+∞
107.0
102
*
K85.1
ICD-10 Finland
Biliary acute pancreatitis
+∞
105.9
101
*
WX408
NOMESCO Finland
General anesthesy, balanced
2.6
104.5
877
4264
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
5.1
104.5
231
484
JDW98
NOMESCO Finland
Other transluminal endoscopic operation on stomach or duodenum
10.3
103.4
117
118
E13.9
ICD-10 Finland
Other specified diabetes mellitus, without complications
15.2
101.8
90
61
A41.9
ICD-10 Finland
Sepsis, unspecified
5.2
100.0
218
451
C10AC01
ATC
colestyramine; oral
7.0
98.1
154
232
A02BC02
ATC
pantoprazole; systemic
2.5
95.8
2034
14637
N02AX02
ATC
tramadol; systemic, rectal
2.3
93.4
1346
8197
UJF12
NOMESCO Finland
Enteroscopy through intestinal stoma
33.5
92.1
59
18
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
4.1
92.0
272
717
A03FA01
ATC
metoclopramide; systemic, rectal
2.5
91.9
761
3645
JAH00
NOMESCO Finland
Laparotomy
6.0
90.6
165
289
JK3NT
NOMESCO Finland
Percutaneous transhepatic dilatation of bileducts
907.5
90.3
88
*
K50.0
ICD-10 Finland
Crohn disease of small intestine
9.6
89.4
106
114
JK4ZT
NOMESCO Finland
Percutaneous transhepatic implantation of bile duct prothesis
160.4
88.7
93
6
ZXE00
NOMESCO Finland
One hour or less
2.2
88.6
1220
7249
L01BB02
ATC
mercaptopurine; oral
10.7
86.3
95
92
JK3FT
NOMESCO Finland
Exchange of bile duct catheter with radiological guidance
301.3
86.2
87
*
K75.0
ICD-10 Finland
Abscess of liver
40.8
85.6
52
13
A04AA02
ATC
granisetron; systemic, transdermal
3.7
85.2
288
833
326
Kela drug reimbursment
Adalimumab, golimumab, infliximab and ustekinumab (intestinal diseases)
11.2
82.7
88
81
NK6QA
NOMESCO Finland
Measurement of bone density from two or more locations with X-ray
3.6
78.7
287
872
L01BC06
ATC
capecitabine; oral
4.5
77.9
198
464
R4190
NOMESCO Finland
Nutritional therapy
4.4
77.6
205
495
5562A
ICD-9 Finland
Idiopathic proctocolitis, Ulcerative (chronic) proctitis
27.0
77.3
53
20
K74.6
ICD-10 Finland
Other and unspecified cirrhosis of liver
8.0
75.9
104
134
JAH01
NOMESCO Finland
Laparoscopy
4.9
75.6
173
372
ZXD05
NOMESCO Finland
Urgent procedure
2.2
75.0
945
5336
K85.0
ICD-10 Finland
Idiopathic acute pancreatitis
748.2
74.6
73
*
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
2.4
74.0
609
2874
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
3.2
71.7
321
1106
K56.6
ICD-10 Finland
Other and unspecified intestinal obstruction
5.0
71.1
159
335
JKD20
NOMESCO Finland
Anastomosis of bile duct to jejunum
361.4
71.0
71
*
K90.3
ICD-10 Finland
Pancreatic steatorrhoea
29.9
70.8
47
16
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
2.1
70.5
1082
6553
56310
ICD-8 Finland
Chronic enteritis and ulcerative colitis, Ulcerative colitis
22.6
69.5
51
23
K51.3
ICD-10 Finland
Ulcerative (chronic) rectosigmoiditis
6.5
68.6
114
182
8140/3-C25.9
ICD-O-3
Adenocarcinoma, NOS, of pancreas, NOS
15.3
68.3
60
40
ZX120
NOMESCO Finland
Intravenous
2.9
67.9
364
1386
JF1AB
NOMESCO Finland
Passage examination of small bowell with X-ray
7.2
67.9
102
146
C78.7
ICD-10 Finland
Secondary malignant neoplasm of liver and intrahepatic bile duct
5.3
67.1
139
274
K73.9
ICD-10 Finland
Chronic hepatitis, unspecified
25.2
66.8
47
19
JA2AT
NOMESCO Finland
Abdominal puncture with ultrasound guidance
10.7
66.7
73
70
JK3SB
NOMESCO Finland
Endoscopic retrorade cholangiography
232.3
66.5
68
*
H02AB06
ATC
prednisolone; systemic
2.0
65.0
1407
9540
I81
ICD-10 Finland
Portal vein thrombosis
16.9
63.5
53
32
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
2.6
63.0
431
1855
K51
ICD-10 Finland
Ulcerative colitis
9.0
62.8
78
89
L04AA01
ATC
[U] ciclosporin
8.3
62.5
83
103
8000/3-C25.9
ICD-O-3
Neoplasm, malignant of pancreas, NOS
14.2
62.2
57
41
D76
ICPC
Malignant neoplasm pancreas
24.8
62.2
44
18
A10AB05
ATC
insulin aspart; parenteral
3.0
61.7
306
1114
A07AA11
ATC
rifaximin; oral
25.7
61.5
43
17
R11
ICD-10 Finland
Nausea and vomiting
2.9
61.4
323
1215
JCA22
NOMESCO Finland
Endoscopic ligature of oesophageal varices
21.8
60.5
45
21
JJ5AT, ,
NOMESCO Finland
211.3
60.3
62
*
JFH30
NOMESCO Finland
Total colectomy, mucosal proctectomy and ileoanal anastomosis without ileostomy
27.7
60.3
41
15
WZC00
NOMESCO Finland
Treatment plan or consultation
2.0
59.7
1086
6883
WX419
NOMESCO Finland
Other general anesthesy
9.9
59.1
68
70
K86.00
ICD-10 Finland
Acute pancreatitis caused by alcohol
590.5
58.9
58
*
TK800
NOMESCO Finland
Hemodialysis
5.6
58.7
113
208
J01DB01
ATC
cefalexin; oral
2.3
58.7
2268
18541
L04AC05
ATC
ustekinumab; parenteral
17.7
57.6
47
27
JN1CD
NOMESCO Finland
Very extensive CT examination of upper part of abdomen
13.0
57.2
55
43
D13.6
ICD-10 Finland
Benign neoplasm: Pancreas
14.3
57.1
52
37
C03CA01
ATC
furosemide; systemic
1.9
56.9
1042
6592
B01AB05
ATC
enoxaparin; parenteral
1.9
54.9
929
5710
D37.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Digestive organ, unspecified
15.9
54.7
47
30
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
4.7
54.4
129
285
UJF02
NOMESCO Finland
Peroral enteroscopy
12.5
53.9
53
43
ZXD10
NOMESCO Finland
Scheduled procedure
1.9
53.5
1095
7148
57505
ICD-8 Finland
Cholecystitis and cholangitis, without mention of calculus, Cholangitis alia sive NUD
+∞
53.3
51
*
O99.6
ICD-10 Finland
Diseases of the digestive system complicating pregnancy, childbirth and the puerperium
17.2
53.2
44
26
C22.0
ICD-10 Finland
Malignant neoplasm: Liver cell carcinoma
9.7
53.1
62
65
K86.3
ICD-10 Finland
Pseudocyst of pancreas
527.9
52.7
52
*
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.8
52.4
1440
10287
JF1CG
NOMESCO Finland
Extensive MRI of small bowel
12.3
52.3
52
43
TPX10
NOMESCO Finland
Implantation of vascular injection port
4.4
51.7
135
322
JN4BD
NOMESCO Finland
Extensive body CT
2.5
51.5
366
1595
K72.0
ICD-10 Finland
Acute and subacute hepatic failure
16.8
51.4
43
26
R94.5
ICD-10 Finland
Abnormal results of liver function studies
7.0
50.9
78
114
T81.8
ICD-10 Finland
Other complications of procedures, not elsewhere classified
5.6
50.6
97
178
A07EA02
ATC
hydrocortisone; rectal
4.9
50.5
112
234
K86.08
ICD-10 Finland
Alcohol-induced chronic pancreatitis
+∞
50.2
48
*
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
2.0
50.1
649
3614
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
3.7
49.9
166
472
K92.1
ICD-10 Finland
Melaena
3.0
49.8
230
802
TJK01
NOMESCO Finland
Laparoscopic cholangiography
496.7
49.5
49
*
5761C
ICD-9 Finland
Other disorders of biliary tract, Cholangitis[CHOLANGITIS SCLEROSIVA]
+∞
49.1
47
*
R18
ICD-10 Finland
Ascites
5.1
49.0
105
213
WX610
NOMESCO Finland
Patient controlled analgesia
13.8
48.5
45
33
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
3.3
48.2
196
634
UJF92
NOMESCO Finland
Capsular endoscopy
5.0
48.2
106
220
A07AA09
ATC
vancomycin; oral
6.4
48.0
80
128
B01AB10
ATC
tinzaparin; parenteral
2.4
47.8
362
1621
K52.9
ICD-10 Finland
Noninfective gastroenteritis and colitis, unspecified
3.7
47.5
155
435
ZXE30
NOMESCO Finland
More than five and less than seven hours
3.3
47.3
187
594
ZXE40
NOMESCO Finland
More than seven and less than nine hours
4.8
47.3
110
239
JN1BD
NOMESCO Finland
Extensive CT examination of upper part of abdomen
11.9
47.2
48
41
H02AB02
ATC
dexamethasone; systemic
2.4
47.1
382
1763
SPAT1255
SPAT
Intravenous administration of medicine
2.9
47.0
244
907
K86.2
ICD-10 Finland
Cyst of pancreas
166.2
47.0
49
*
JJA20
NOMESCO Finland
Open biopsy of liver
16.2
47.0
40
25
WX000
NOMESCO Finland
Monitoring vital functions without anesthesy
3.5
46.3
167
501
A10AE04
ATC
insulin glargine; parenteral
2.5
46.0
328
1428
K86.9
ICD-10 Finland
Disease of pancreas, unspecified
101.9
45.9
50
5
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
2.3
45.7
411
1981
ZXE20
NOMESCO Finland
More than three and less than five hours
2.2
45.7
434
2140
H02AB04
ATC
methylprednisolone; systemic
2.2
45.2
440
2191
D02
ICPC
Abdominal pain epigastric
3.1
45.0
199
676
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
2.1
44.4
505
2669
A06AH03
ATC
naloxegol; oral
5.7
44.3
83
149
WW500
NOMESCO Finland
Blood transfusion
3.4
44.1
165
506
R93.2
ICD-10 Finland
Abnormal findings on diagnostic imaging of liver and biliary tract
8.9
44.1
55
63
A04AA01
ATC
ondansetron; systemic, rectal
2.6
43.6
280
1159
UJF45
NOMESCO Finland
Flexible sigmoidoscopy with biopsy
2.6
43.1
282
1178
A02BC05
ATC
esomeprazole; systemic
1.8
42.7
1071
7304
I85.0
ICD-10 Finland
Oesophageal varices with bleeding
16.6
42.7
36
22
H02AB07
ATC
prednisone; oral
2.2
42.5
427
2149
WZC30
NOMESCO Finland
Teaching
2.1
41.7
499
2682
D97
ICPC
Liver disease NOS
13.6
41.7
39
29
K43.9
ICD-10 Finland
Other and unspecified ventral hernia without obstruction or gangrene
3.4
41.5
152
460
K72.9
ICD-10 Finland
Hepatic failure, unspecified
10.4
41.4
46
45
R10.0
ICD-10 Finland
Acute abdomen
4.1
40.9
115
290
K86.8
ICD-10 Finland
Other specified diseases of pancreas
111.8
40.8
44
*
N17.9
ICD-10 Finland
Acute renal failure, unspecified
3.1
40.7
173
574
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
2.3
40.3
328
1512
TPH30
NOMESCO Finland
Insertion of central venous catheter through periferal vein
5.1
40.2
86
174
JLB28
NOMESCO Finland
Endoscopic internal drainage of pancreatic duct
403.3
40.2
40
*
Z2221
NOMESCO Finland
Medical doctor
1.8
40.2
774
4867
WX892
NOMESCO Finland
Monitored bed care
2.5
39.9
271
1151
JLW98
NOMESCO Finland
Other transluminal endoscopic operation on pancreas
142.1
39.8
42
*
5742A
ICD-9 Finland
Cholelithiasis, Calculus of gallbladder without mention of cholecystitis[CHOLECYSTOLITHIASIS SINE CHOLECYSTITIDE,SINE OBSTR]
+∞
39.7
38
*
Z94.0
ICD-10 Finland
Kidney transplant status
6.9
39.5
61
90
H02AB09
ATC
hydrocortisone; systemic
4.2
39.5
108
267
A06AD11
ATC
lactulose; oral
2.0
39.3
498
2728
K56.5
ICD-10 Finland
Intestinal adhesions [bands] with obstruction
5.2
38.8
80
157
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
3.4
38.7
147
455
K83.3
ICD-10 Finland
Fistula of bile duct
+∞
38.6
37
*
PG1DE
NOMESCO Finland
Other extensive ultrasound examination of artery
3.0
38.5
174
598
B99
ICD-10 Finland
Other and unspecified infectious diseases
4.8
38.2
86
182
6663
FHL
Cholecystectomy and cholangiography
197.7
37.9
39
*
SPAT1262
SPAT
Handing over of treatment supplies
2.0
37.6
516
2900
C03DA01
ATC
spironolactone; oral
2.1
36.6
412
2157
WX882
NOMESCO Finland
High dependency care
3.6
35.9
124
361
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
2.8
35.9
194
735
J18.9
ICD-10 Finland
Pneumonia, unspecified
1.7
35.6
820
5399
D94
ICPC
Chronic enteritis/ulcerative colitis
8.8
34.9
44
51
C24.00
ICD-10 Finland
Hepatic duct
125.0
34.8
37
*
JKB20
NOMESCO Finland
Intraoperative cholangioscopy
+∞
34.4
33
*
TJK00
NOMESCO Finland
Intraoperative cholangiography
177.2
33.8
35
*
IAZ97
NOMESCO Finland
Psychiatric consultation in another specialty
5.0
33.1
72
148
JKB00
NOMESCO Finland
Incision of bile duct
331.0
33.0
33
*
C24.0
ICD-10 Finland
Malignant neoplasm: Extrahepatic bile duct
118.2
32.7
35
*
WB121
NOMESCO Finland
Demanding neoadjuvant cytostatic therapy
6.2
32.7
56
92
A04.7
ICD-10 Finland
Enterocolitis due to Clostridium difficile
3.6
32.2
107
304
C23
ICD-10 Finland
Malignant neoplasm of gallbladder
62.5
32.1
37
6
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
2.0
32.1
421
2321
3AC01, ,
NOMESCO Finland
6.1
32.0
56
94
ZXE10
NOMESCO Finland
More than one and less than three hours
1.6
31.4
944
6623
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
2.1
31.4
342
1764
K81.1
ICD-10 Finland
Chronic cholecystitis
+∞
31.3
30
*
JKE15
NOMESCO Finland
Endoscopic lithotripsy in bile duct
+∞
31.3
30
*
K75.4
ICD-10 Finland
Autoimmune hepatitis
32.0
31.3
41
13
JFG00
NOMESCO Finland
Closure of loop enterostomy without resection
8.0
31.1
42
53
JFA15
NOMESCO Finland
Endoscopic polypectomy in colon
2.5
31.0
204
852
XX2RW, ,
NOMESCO Finland
5.1
30.8
65
130
UJD02
NOMESCO Finland
Gastroscopy
2.8
30.8
165
622
WX704
NOMESCO Finland
Intubation
2.4
30.8
229
1011
K80
ICD-10 Finland
Cholelithiasis
9.8
30.3
35
36
JK3MB
NOMESCO Finland
Postoperative cholangiography
+∞
30.3
29
*
B01AB04
ATC
dalteparin; parenteral
2.7
30.0
167
642
KA1MN
NOMESCO Finland
Glomerular filtration rate (GFR) Isotope mesurement
12.1
29.9
30
25
A02BC01
ATC
omeprazole; systemic
1.7
29.8
721
4770
K52.88
ICD-10 Finland
Other specified noninfective gastroenteritis and colitis
3.8
29.7
90
240
L04AB04
ATC
adalimumab; parenteral
4.2
29.6
80
196
8170/3-C22.0
ICD-O-3
Hepatocellular carcinoma, NOS, of liver
8.7
29.3
37
43
JFA98
NOMESCO Finland
Other transluminal endoscopic local operation on intestine
4.0
29.2
83
211
JAD30
NOMESCO Finland
Repair of incisional hernia using prosthetic material
4.7
28.8
67
146
A07EA01
ATC
prednisolone; oral, rectal
9.1
28.6
35
39
8140/3-C25.0
ICD-O-3
Adenocarcinoma, NOS, of head of pancreas
49.1
28.4
34
7
XX4AT
NOMESCO Finland
Other canalization with ultrasound guidance
10.1
28.3
32
32
UJK52
NOMESCO Finland
Endoscopy of biliary tract in connection with endoscopic retrograde cholangiopancreatography
+∞
28.2
27
*
57409
ICD-8 Finland
Cholelithiasis, Unspecified
+∞
28.2
27
*
6662
FHL
Cholecystectomy
64.7
28.0
32
5
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
2.4
27.8
204
894
1370
FHL
Colonoscopy, whole colon
8.1
27.8
37
46
JJ3AT
NOMESCO Finland
Cytology of liver with ultrasound guidance
43.0
27.7
34
8
R4110
NOMESCO Finland
Physiotherapy
1.6
27.3
760
5195
JN1AD
NOMESCO Finland
CT examination of upper part of abdomen
8.0
27.3
37
47
C25.1
ICD-10 Finland
Malignant neoplasm: Body of pancreas
8.8
27.2
34
39
C22.9
ICD-10 Finland
Malignant neoplasm: Liver, unspecified
8.4
27.0
35
42
D64.9
ICD-10 Finland
Anaemia, unspecified
1.9
26.9
356
1961
Z93.2
ICD-10 Finland
Ileostomy status
10.8
26.9
29
27
K57.3
ICD-10 Finland
Diverticular disease of large intestine without perforation or abscess
1.8
26.9
514
3175
K83
ICD-10 Finland
Other diseases of biliary tract
75.9
26.8
30
*
C24.02
ICD-10 Finland
Common bile duct
273.7
26.8
27
*
ZXE50
NOMESCO Finland
More than nine and less than 12 hours
4.5
26.7
66
151
1280
FHL
Endoscopic retrograde cholangiography and pancreaticography
141.4
26.7
28
*
E14.9
ICD-10 Finland
Unspecified diabetes mellitus, without complications
4.2
26.5
71
173
A03
ICPC
Fever
1.8
26.4
438
2592
C78.6
ICD-10 Finland
Secondary malignant neoplasm of retroperitoneum and peritoneum
5.2
25.7
53
104
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
1.8
25.7
417
2451
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
2.9
25.5
126
455
WX872
NOMESCO Finland
Intensive care
2.5
25.2
163
674
D50.9
ICD-10 Finland
Iron deficiency anaemia, unspecified
2.1
25.2
253
1261
3042, ,
Kela drug reimbursment
22.8
25.2
36
16
253, ,
Kela drug reimbursment
22.8
25.2
36
16
5761X
ICD-9 Finland
Other disorders of biliary tract, Cholangitis[CHOLANGITIS ALIA]
+∞
25.0
24
*
SPAT1148
SPAT
Treatment of chronic ulcer or burn
1.8
24.6
380
2197
ZJX00
NOMESCO Finland
Double balloon technique in gastroenterological endoscopy
48.8
24.3
29
6
K92.0
ICD-10 Finland
Haematemesis
3.3
24.2
94
295
JFB00
NOMESCO Finland
Partial resection of small intestine
4.3
24.0
62
147
B03BA03
ATC
hydroxocobalamin; parenteral
2.3
23.9
181
804
215
Kela drug reimbursment
Diabetes, non-insulin-treated
1.6
23.9
636
4277
JN3CG
NOMESCO Finland
Extensive MRI examination of abdomen with high intensity magnet
8.1
23.9
32
40
Z2446
NOMESCO Finland
Social worker
2.2
23.7
203
950
TBW99
NOMESCO Finland
Other minor procedure in endocrine surgery
8.7
23.7
30
35
Y83.9
ICD-10 Finland
Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
3.1
23.6
100
331
R53
ICD-10 Finland
Malaise and fatigue
1.6
23.6
675
4620
Z01.8
ICD-10 Finland
Other specified special examinations
1.6
23.5
599
3981
D01
ICPC
Abdominal pain/cramps general
1.9
23.3
309
1699
SPAT1263
SPAT
Sampling
1.5
23.3
1036
7827
JN1CM
NOMESCO Finland
Upper part of abdomen extensive MRI examination with 3 Tesla magnet
22.3
23.0
33
15
57401
ICD-8 Finland
Cholelithiasis, Cum cholecystitide chronica
+∞
22.9
22
*
L03AA02
ATC
filgrastim; parenteral
3.0
22.9
100
337
A07EC01
ATC
sulfasalazine; oral, rectal
2.1
22.7
219
1074
K56.7
ICD-10 Finland
Ileus, unspecified
3.8
22.7
68
180
ZX108
NOMESCO Finland
Inhalation
6.5
22.6
37
58
JDE00
NOMESCO Finland
Gastrojejunostomy
26.1
22.6
31
12
PHN73
NOMESCO Finland
Reconstruction of superior mesenteric or portal vein
121.0
22.6
24
*
A06AC01
ATC
ispaghula (psylla seeds); oral
1.6
22.2
674
4669
C24.1
ICD-10 Finland
Malignant neoplasm: Ampulla of Vater
52.5
22.1
26
5
K51.2
ICD-10 Finland
Ulcerative (chronic) proctitis
4.2
22.0
59
144
5561A
ICD-9 Finland
Idiopathic proctocolitis, Ulcerative (chronic) ileocolitis
17.2
21.8
34
20
XF400
NOMESCO Finland
ECG with 12 standard connections
1.7
21.8
448
2811
C24.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of biliary tract
80.8
21.7
24
*
C24.09
ICD-10 Finland
Biliary duct or passage NOS
116.0
21.6
23
*
K21.0
ICD-10 Finland
Gastro-oesophageal reflux disease with oesophagitis
2.0
21.6
263
1405
XX1AT
NOMESCO Finland
Other puncture with ultrasound guidance
4.6
21.5
51
113
D99
ICPC
Disease digestive system other
5.1
21.4
45
90
JMA10
NOMESCO Finland
Transabdominal total splenectomy
8.3
21.4
28
34
256, ,
Kela drug reimbursment
26.6
21.3
29
11
K70.3
ICD-10 Finland
Alcoholic cirrhosis of liver
4.6
21.3
50
110
K76.0
ICD-10 Finland
Fatty (change of) liver, not elsewhere classified
3.3
21.1
78
238
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
3.6
20.9
70
200
8000/3-C25.0
ICD-O-3
Neoplasm, malignant of head of pancreas
60.5
20.9
24
*
JKD50
NOMESCO Finland
Hepatoportoenterostomy
+∞
20.9
20
*
K86.01
ICD-10 Finland
Late effects of pancreatitis caused by alcohol
+∞
20.9
20
*
K85.2
ICD-10 Finland
Alcohol-induced acute pancreatitis
+∞
20.9
20
*
K81.8
ICD-10 Finland
Other cholecystitis
+∞
20.9
20
*
Z3226
NOMESCO Finland
Physiotherapist
1.7
20.9
483
3124
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
1.7
20.8
427
2675
JA3BT
NOMESCO Finland
Cathetrisation of abdominal cavity with X-ray guidance
15.9
20.6
33
21
103
Kela drug reimbursment
Diabetes, insulin-treated
1.5
20.5
713
5079
A11CC03
ATC
alfacalcidol; systemic
3.1
20.5
84
273
8160/3-C22.1
ICD-O-3
Cholangiocarcinoma of intrahepatic bile duct
25.7
20.4
28
11
WGA11
NOMESCO Finland
Planning of pain management
7.5
20.4
29
39
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
2.1
20.3
210
1058
A49.8
ICD-10 Finland
Other bacterial infections of unspecified site
5.3
19.9
40
77
5761A
ICD-9 Finland
Other disorders of biliary tract, Cholangitis[CHOLANGITIS SUPPURATIVA]
+∞
19.8
19
*
Q44.21
ICD-10 Finland
Atresia of extrahepatic bile ducts
+∞
19.8
19
*
JLB12
NOMESCO Finland
Transduodenal endoscopic incision of pancreatic duct orifice
+∞
19.8
19
*
WX110
NOMESCO Finland
Infiltration anesthesia
1.5
19.7
1761
15076
WX725
NOMESCO Finland
Noninvasive ventilation
2.3
19.7
154
694
K65.0
ICD-10 Finland
Acute peritonitis
4.5
19.6
48
109
H26.3
ICD-10 Finland
Drug-induced cataract
6.7
19.6
31
47
Z3231
NOMESCO Finland
Registered nurse
1.5
19.5
705
5054
E11.8
ICD-10 Finland
Type 2 diabetes mellitus, with unspecified complications
1.8
19.5
310
1803
K31.5
ICD-10 Finland
Obstruction of duodenum
40.4
19.5
24
6
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
2.1
19.5
205
1039
JAP00
NOMESCO Finland
Freeing of adhesions in the peritoneal cavity
4.9
19.5
42
86
E0000UV, ,
ATC
1.5
19.4
1038
8058
XX3DW
NOMESCO Finland
Time consuming IT work
1.8
19.4
294
1685
N03AX16
ATC
[U] pregabalin
1.6
19.3
552
3755
A41.4
ICD-10 Finland
Sepsis due to anaerobes
8.4
19.3
25
30
XF603
NOMESCO Finland
Direct intraarterial blood pressure measurement
2.6
19.2
114
453
D77
ICPC
Malignant digestive neopl other/NOS
7.9
19.2
26
33
OAB74
NOMESCO Finland
Nutritional guidance related to treatment and rehabilitation for medical condition
4.7
19.2
44
95
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
1.5
18.8
624
4385
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
4.1
18.8
52
130
57408
ICD-8 Finland
Cholelithiasis, Alia definita
+∞
18.8
18
*
K82.2
ICD-10 Finland
Perforation of gallbladder
+∞
18.8
18
*
K83.2
ICD-10 Finland
Perforation of bile duct
+∞
18.8
18
*
8160/3-C24.0
ICD-O-3
Cholangiocarcinoma of extrahepatic bile duct
+∞
18.8
18
*
Z53.8
ICD-10 Finland
Procedure not carried out for other reasons
8.1
18.8
25
31
A02BA02
ATC
ranitidine; systemic
1.6
18.7
481
3185
E13.8
ICD-10 Finland
Other specified diabetes mellitus, with unspecified complications
28.0
18.7
25
9
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
1.9
18.6
260
1451
5568X
ICD-9 Finland
Idiopathic proctocolitis, Other ulcerative colitis
14.2
18.6
31
22
PC2DE
NOMESCO Finland
Ultrasound examination of liver vasculature with Doppler method
191.3
18.5
19
*
JX1XE
NOMESCO Finland
Other ultrasound examinaton of alimentary organs
38.7
18.5
23
6
XX1XW
NOMESCO Finland
Extensive written report from radiologist
3.2
18.4
73
233
K73.0
ICD-10 Finland
Chronic persistent hepatitis, not elsewhere classified
44.3
18.2
22
5
T90
ICPC
Diabetes non-insulin dependent
1.5
18.1
614
4331
T89
ICPC
Diabetes insulin dependent
2.5
18.1
115
472
K44.9
ICD-10 Finland
Diaphragmatic hernia without obstruction or gangrene
2.0
18.0
213
1125
GD1AD
NOMESCO Finland
Thorax CT examination
2.1
17.8
180
899
123
Kela drug reimbursment
Chronic disorders of vitamin D metabolism
3.0
17.7
77
259
L04AA10
ATC
[U] sirolimus
67.0
17.7
20
*
JL5AM
NOMESCO Finland
Bile and pancreas ducts simple MRI examination with 3 Tesla magnet
67.0
17.7
20
*
JL5CM
NOMESCO Finland
Bile and pancreas ducts extensive MRI examination with 3 Tesla magnet
+∞
17.7
17
*
8500/3-C25.0
ICD-O-3
Infiltrating duct carcinoma, NOS, of head of pancreas
+∞
17.7
17
*
JJC60
NOMESCO Finland
Total excision of transplanted liver
+∞
17.7
17
*
JK1AT
NOMESCO Finland
Cathetrisation of bile cyst with radiological guidance
+∞
17.7
17
*
SPAT1083
SPAT
Initiation and monitoring of IV fluid therapy
2.4
17.7
129
564
KA2AE
NOMESCO Finland
Ultrasound examination transplanted kidney
6.4
17.6
29
46
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
1.6
17.5
469
3132
8140/3-C23.9
ICD-O-3
Adenocarcinoma, NOS, of gallbladder
181.1
17.5
18
*
JN5DR
NOMESCO Finland
PET-CT of upper body metabolism
3.8
17.4
53
142
A10AC01
ATC
insulin (human); parenteral
1.9
17.4
214
1145
Z94.9
ICD-10 Finland
Transplanted organ and tissue status, unspecified
29.0
17.4
23
8
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
2.4
17.4
121
518
TPH40
NOMESCO Finland
Insertion of a long peripheral venous catheter
5.0
17.4
37
75
K29.7
ICD-10 Finland
Gastritis, unspecified
2.6
17.3
99
386
D50.0
ICD-10 Finland
Iron deficiency anaemia secondary to blood loss (chronic)
2.5
17.3
112
464
138
Kela drug reimbursment
Severe anaemia associated with chronic renal failure
3.0
17.1
75
254
TJF80
NOMESCO Finland
Ostomy education
4.4
17.1
42
96
XX9TE
NOMESCO Finland
Compementary ultrasound examination
6.6
17.0
27
41
C25.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of pancreas
16.0
17.0
27
17
XX9BW
NOMESCO Finland
Submitting image material and/or investigation material to authority or other institution
3.7
16.8
53
146
JKB21
NOMESCO Finland
Laparoscopic cholangioscopy
+∞
16.7
16
*
JK3PB
NOMESCO Finland
Peroperative cholangiography
+∞
16.7
16
*
5741A
ICD-9 Finland
Cholelithiasis, Calculus of gallbladder with other cholecystitis[CHOLECYSTOLITHIASIS CUM CHOLECYSTITIDE CHR,SINE OBS]
+∞
16.7
16
*
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
2.0
16.6
184
949
SPAT1254
SPAT
Administration of medicine
1.6
16.6
395
2560
ZXM00
NOMESCO Finland
Intraoperative use of ultrasonographic imaging
4.9
16.6
36
74
N02BE01
ATC
paracetamol; systemic, rectal
1.6
16.5
2293
20972
Q44.29
ICD-10 Finland
Atresia of bile ducts
171.0
16.5
17
*
JCA32
NOMESCO Finland
Endoscopic injection in oesophagus
23.2
16.4
23
10
KAS10
NOMESCO Finland
Allogenic transplantation of kidney from cadaver donor
5.4
16.4
32
60
K30
ICD-10 Finland
Functional dyspepsia
1.8
16.2
257
1492
JAD10
NOMESCO Finland
Repair of incisional hernia
5.9
16.2
29
50
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.4
16.1
974
7663
A28
ICPC
Limited function/disability NOS
1.5
16.1
517
3596
WZC10
NOMESCO Finland
Written specialist consultation based on a referral from a dentist or a physician
2.3
16.0
122
544
K72.1
ICD-10 Finland
Chronic hepatic failure
24.6
16.0
22
9
J01FF01
ATC
clindamycin; systemic
1.5
15.9
644
4701
ZXD30
NOMESCO Finland
Difficulties in perfomrming procedure
2.3
15.7
118
523
K83.5
ICD-10 Finland
Biliary cyst
+∞
15.6
15
*
JK3RT
NOMESCO Finland
Percutaneous transhepatic removal of stones from bile ducts
+∞
15.6
15
*
JL5BM
NOMESCO Finland
Bile and pancreas ducts MRI examination with 3 Tesla magnet
85.6
15.6
17
*
JLD12
NOMESCO Finland
Endoscopic drainage of pancreatic pseudocyst
85.6
15.6
17
*
C25
ICD-10 Finland
Malignant neoplasm of pancreas
85.6
15.6
17
*
D13.2
ICD-10 Finland
Benign neoplasm: Duodenum
5.6
15.5
29
52
JFH33
NOMESCO Finland
Total colectomy, mucosal proctectomy, ileoanal anastomosis and ileostomy
38.3
15.4
19
5
L04AA05
ATC
[U] tacrolimus
38.3
15.4
19
5
E87.6
ICD-10 Finland
Hypokalaemia
2.4
15.2
106
455
166
Kela drug reimbursment
Dalteparin and tinzaparin (treatment for more than 6 months)
4.5
15.2
36
80
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
2.1
15.1
144
703
WX720
NOMESCO Finland
Own respiration
2.2
15.1
128
597
D12.6
ICD-10 Finland
Benign neoplasm: Colon, unspecified
2.1
15.1
153
765
6611
FHL
Needle biopsy in the operating room
45.2
15.1
18
*
SPAT1144
SPAT
Treatment of reopened or infected surgical wound
2.0
15.1
177
933
OAB50, ,
SPAT
1.9
15.0
202
1113
K56.0
ICD-10 Finland
Paralytic ileus
4.3
15.0
38
89
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
2.6
15.0
86
337
T81.0
ICD-10 Finland
Haemorrhage and haematoma complicating a procedure, not elsewhere classified
2.0
14.9
154
776
SPAT1250
SPAT
Comprehensive monitoring of chronic illness
1.5
14.7
645
4769
RS220, ,
NOMESCO Finland
3.7
14.6
45
122
K83.4
ICD-10 Finland
Spasm of sphincter of Oddi
+∞
14.6
14
*
J01XX08
ATC
linezolid; systemic
5.1
14.6
30
59
M07.5*K51.9
ICD-10 Finland
Arthropathy in ulcerative colitis
11.9
14.6
26
22
TPH04, ,
SPAT
4.0
14.5
40
100
JF1AD
NOMESCO Finland
Small bowel CT
5.4
14.5
28
52
ZXH04
NOMESCO Finland
Procedure performed in other inpatient unit
5.8
14.5
26
45
JN1DM
NOMESCO Finland
Upper part of abdomen very extensive MRI examination with 3 Tesla magnet
36.2
14.4
18
5
E11.9
ICD-10 Finland
Type 2 diabetes mellitus, without complications
1.5
14.4
618
4551
Y83.8
ICD-10 Finland
Other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
2.8
14.3
73
269
N18.8
ICD-10 Finland
Other chronic renal failure
2.7
14.3
77
292
A10AE05
ATC
insulin detemir; parenteral
2.1
14.3
146
732
B81
ICPC
Anaemia vit B12/folate deficiency
2.3
14.3
109
487
WZB00
NOMESCO Finland
Telephone prescription or other care instructions
1.4
14.3
654
4874
S18
ICPC
Laceration/cut
1.4
14.0
1160
9559
RD210, ,
NOMESCO Finland
3.3
14.0
52
160
L28
ICPC
Limited function/disability (L)
1.5
13.8
507
3617
1300
FHL
Esophagogastroduodenoscopy (also includes staining)
4.1
13.7
37
91
A02BC03
ATC
lansoprazole; oral
1.4
13.7
675
5091
PH1AE
NOMESCO Finland
Ultrasound examination of upper extremity veins
3.2
13.7
53
167
K92.2
ICD-10 Finland
Gastrointestinal haemorrhage, unspecified
2.4
13.6
89
371
D06
ICPC
Abdominal pain localized other
1.8
13.6
202
1149
JLB35
NOMESCO Finland
Transduodenal endoscopic extraction of foreign body from pancreatic duct
+∞
13.5
13
*
5770A
ICD-9 Finland
Diseases of pancreas, Acute pancreatitis[PANCREATITIS ACUTA NONALCOHOLICA NONHAEMORRHAGICA]
+∞
13.5
13
*
5740A
ICD-9 Finland
Cholelithiasis, Calculus of gallbladder with acute cholecystitis[CHOLECYSTOLITHIASIS CUM CHOLECYSTITIDE AC,SINE OBST]
+∞
13.5
13
*
8000/3-C24.9
ICD-O-3
Neoplasm, malignant of billiary tract, NOS
34.2
13.5
17
5
8000/3-C22.1
ICD-O-3
Neoplasm, malignant of intrahepatic bile duct
140.7
13.5
14
*
M80.4
ICD-10 Finland
Drug-induced osteoporosis with pathological fracture
5.2
13.4
27
52
E86
ICD-10 Finland
Volume depletion
2.5
13.4
80
320
8160/3-C24.9
ICD-O-3
Cholangiocarcinoma of billiary tract, NOS
25.9
13.4
18
7
ZXE60
NOMESCO Finland
More than 12 and less than 15 hours
4.5
13.3
32
72
SPAT1125
SPAT
Stoma care and guidance
3.0
13.2
58
197
SPAT1256
SPAT
Intramuscular and subcutaneous injection
1.4
13.2
983
7943
JFF10
NOMESCO Finland
Loop enterostomy
5.1
13.2
27
53
JN3KE
NOMESCO Finland
Abdominal ultrasound with added contrast
5.1
13.2
27
53
XF612
NOMESCO Finland
Measurement of central venous pressure
12.2
13.1
23
19
T81.9
ICD-10 Finland
Unspecified complication of procedure
3.1
13.1
53
172
ZY010
NOMESCO Finland
Hospital outpatient
2.1
13.0
121
587
K76.6
ICD-10 Finland
Portal hypertension
50.2
12.8
15
*
NK6MA
NOMESCO Finland
Measurement of bone age from hand and elbow using X-ray
4.6
12.8
30
66
GA4YT
NOMESCO Finland
Puncture of pleura with ultrasound guidance
2.3
12.8
98
439
N30.0
ICD-10 Finland
Acute cystitis
1.5
12.8
402
2773
K43.0
ICD-10 Finland
Incisional hernia with obstruction, without gangrene
4.6
12.6
29
63
NF1AA
NOMESCO Finland
Hip X-ray examination
1.7
12.5
244
1499
WX006
NOMESCO Finland
Intravenous sedation or analgesia without general anesthesia
1.9
12.5
172
955
5770D
ICD-9 Finland
Diseases of pancreas, Acute pancreatitis[PANCREATITIS ACUTA ALCOHOLICA NONHAEMORHAGICA]
+∞
12.5
12
*
JK2AT
NOMESCO Finland
Puncture of bile cyst with ultrasound guidance
+∞
12.5
12
*
JJ9AT
NOMESCO Finland
Sampling of liver transplant under radiological guidance
+∞
12.5
12
*
JKC30
NOMESCO Finland
Partial excision of bile duct and anastomosis to jejunum
+∞
12.5
12
*
T86.4
ICD-10 Finland
Liver transplant failure and rejection
+∞
12.5
12
*
XX4BW, ,
NOMESCO Finland
17.4
12.5
19
11
PD5AD
NOMESCO Finland
CT of aorta
2.6
12.4
70
272
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
1.6
12.4
333
2216
ZXK00
NOMESCO Finland
Conversion from percutaneous endoscopic to open procedure
4.9
12.4
27
56
SPAT1222
SPAT
Counselling/guidance promoting independent living
1.5
12.4
383
2631
S97
ICPC
Chronic ulcer skin
1.8
12.4
172
959
ZXE90
NOMESCO Finland
More than 22 hours
4.3
12.2
31
73
J01MA14
ATC
moxifloxacin; systemic
1.7
12.2
219
1317
A12AA04
ATC
calcium carbonate; oral
3.1
12.2
51
169
L04AG05
ATC
vedolizumab; parenteral
12.4
12.1
21
17
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
1.5
12.1
403
2811
V03AE01
ATC
polystyrene sulfonate; oral
3.3
12.0
45
139
JFH10
NOMESCO Finland
Total colectomy and ileostomy
13.4
11.9
20
15
R07.4
ICD-10 Finland
Chest pain, unspecified
1.4
11.9
672
5174
JDE01
NOMESCO Finland
Laparoscopic gastroenterostomy
46.9
11.9
14
*
B34.9
ICD-10 Finland
Viral infection, unspecified
2.5
11.8
74
303
K74.0
ICD-10 Finland
Hepatic fibrosis
11.7
11.8
21
18
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
1.5
11.8
465
3354
K70.4
ICD-10 Finland
Alcoholic hepatic failure
10.6
11.7
22
21
A41.0
ICD-10 Finland
Sepsis due to Staphylococcus aureus
2.7
11.7
60
222
C07AA05
ATC
propranolol; systemic
1.5
11.7
435
3100
N02BF02
ATC
pregabalin; oral
1.9
11.7
158
873
N05CF01
ATC
zopiclone; oral
1.4
11.7
776
6132
A06AC51
ATC
ispaghula, combinations; oral
2.1
11.7
113
556
UKC02
NOMESCO Finland
Cystoscopy
1.5
11.7
415
2932
XF600
NOMESCO Finland
Bloodpressure measurement
1.8
11.7
161
895
JLC10
NOMESCO Finland
Distal pancreatectomy
16.5
11.7
18
11
N17.8
ICD-10 Finland
Other acute renal failure
3.3
11.6
43
132
A04
ICPC
Weakness/tiredness general
1.5
11.6
396
2774
JF1DG
NOMESCO Finland
Small bowel very extensive MRI with with high intensity magnet
12.6
11.6
20
16
B01AA03
ATC
warfarin; systemic
1.4
11.6
523
3869
L04AA33
ATC
[U] vedolizumab
19.0
11.6
17
9
JL1AT
NOMESCO Finland
Biopsy of pancreas with ultrasound guidance
19.0
11.6
17
9
J02AC01
ATC
fluconazole; systemic
1.4
11.5
791
6279
SPAT1153
SPAT
Removal of sutures
1.4
11.5
732
5741
AA1AD
NOMESCO Finland
CT of head and brain
1.4
11.5
731
5734
C77.2
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Intra-abdominal lymph nodes
5.0
11.5
24
48
JK5ZT
NOMESCO Finland
Implantation of bile duct prosthesis with combined percutaneous transhepatic and endoscopic retrograde technic
+∞
11.5
11
*
K86.0
ICD-10 Finland
Alcohol-induced chronic pancreatitis
+∞
11.5
11
*
5714X
ICD-9 Finland
Chronic liver disease and cirrhosis, Chronic hepatitis[HEPATITIS CHRONICA ALIA SEU NUD]
+∞
11.5
11
*
8000/3-C24.0
ICD-O-3
Neoplasm, malignant of extrahepatic bile duct
+∞
11.5
11
*
57709
ICD-8 Finland
Diseases of pancreas, Pancreatitis NUD
+∞
11.5
11
*
K82.9
ICD-10 Finland
Disease of gallbladder, unspecified
+∞
11.5
11
*
57403
ICD-8 Finland
Cholelithiasis, Choledocholithiasis
+∞
11.5
11
*
OAB73
NOMESCO Finland
Prevention and treatment of malnutrition
3.8
11.5
34
90
8140/3-C24.1
ICD-O-3
Adenocarcinoma, NOS, of ampulla of Vater
120.5
11.4
12
*
6664
FHL
Cholecystectomy and choledocotomy
120.5
11.4
12
*
JKD30
NOMESCO Finland
Extrahepatic anastomosis of right or left hepatic duct to jejunum
120.5
11.4
12
*
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
1.7
11.4
231
1435
D69.6
ICD-10 Finland
Thrombocytopenia, unspecified
2.9
11.3
53
187
JN3DG
NOMESCO Finland
Very extensive MRI examination with high intensity magnet
8.3
11.3
24
29
A04AA55
ATC
palonosetron, combinations; systemic
2.3
11.3
86
385
E10.9
ICD-10 Finland
Type 1 diabetes mellitus, Without complications
2.2
11.3
96
450
FB1AD
NOMESCO Finland
CT examination of arteria pulmonalis
2.5
11.2
71
292
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
1.7
11.2
194
1155
8500/3-C25.9
ICD-O-3
Infiltrating duct carcinoma, NOS, of pancreas, NOS
25.1
11.1
15
6
JJ1AT
NOMESCO Finland
Puncture of lesion of liver with ultrasound guidance
25.1
11.1
15
6
KH1AD
NOMESCO Finland
CT of urinary organs
2.3
11.1
83
368
A10AE06
ATC
insulin degludec; parenteral
2.3
11.1
85
381
ZXE03
NOMESCO Finland
Procedure duration 20 to 29 minutes
1.9
11.1
135
721
XW000
NOMESCO Finland
Bone marrow biopsy
2.0
10.9
109
543
D70.82
ICD-10 Finland
Drug-induced neutropenia
3.1
10.9
45
148
JFC00
NOMESCO Finland
Entero-enterostomy
15.5
10.8
17
11
WPA13
NOMESCO Finland
Palliative consultation
5.1
10.8
22
43
Z49.1
ICD-10 Finland
Extracorporeal dialysis
3.3
10.7
40
124
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
1.7
10.6
202
1233
SPAT1301
SPAT
No procedures
1.4
10.6
731
5793
A07DA03
ATC
loperamide; oral
2.2
10.6
85
389
C08CA01
ATC
amlodipine; oral
1.3
10.5
972
8048
JDA12
NOMESCO Finland
Endoscopic insertion of gastric stent
110.4
10.4
11
*
Q44.20
ICD-10 Finland
Atresia of intrahepatic bile ducts
110.4
10.4
11
*
Q44.3
ICD-10 Finland
Congenital stenosis and stricture of bile ducts
+∞
10.4
10
*
JFG73
NOMESCO Finland
Excision of ileal pelvic pouch
+∞
10.4
10
*
Q44.4
ICD-10 Finland
Choledochal cyst
+∞
10.4
10
*
JJA21
NOMESCO Finland
Laparoscopic biopsy of liver
32.6
10.3
13
*
L29.9
ICD-10 Finland
Pruritus, unspecified
2.4
10.3
72
311
K76.89
ICD-10 Finland
Other specified diseases of liver
9.6
10.2
20
21
R50.8
ICD-10 Finland
Other specified fever
4.6
10.2
24
53
QX2XE
NOMESCO Finland
Ultrsound examination of soft tissue not elsewhere classified
2.2
10.2
79
357
R74.8
ICD-10 Finland
Abnormal levels of other serum enzymes
1.8
10.2
151
860
SPAT1149
SPAT
Suture or treatment of traumatic wound
1.5
10.1
286
1922
SPAT1253
SPAT
Initiation, adjustment, discontinuation or repetition of medication
1.4
10.1
684
5398
N05BA04
ATC
oxazepam; oral
1.4
10.1
607
4705
Y69
ICD-10 Finland
Unspecified misadventure during surgical and medical care
3.1
10.0
40
129
K29.1
ICD-10 Finland
Other acute gastritis
3.5
10.0
34
99
TJD00
NOMESCO Finland
Insertion of nasogastric or naso-gastroduodenal tube
3.2
10.0
39
124
4AA12, ,
NOMESCO Finland
9.1
10.0
20
22
R60.0
ICD-10 Finland
Localized oedema
1.5
10.0
308
2110
7890A
ICD-9 Finland
Other symptoms involving abdomen and pelvis, Abdominal pain
2.0
10.0
105
534
JFA65
NOMESCO Finland
Endoscopic insertion of ileum stent
40.2
10.0
12
*
Z03.80
ICD-10 Finland
Observation for other suspected diseases and conditions
2.2
9.9
78
355
TPW99
NOMESCO Finland
Other minor surgical procedure on peripheral vessel or lymphatic system
3.3
9.8
36
110
R19.8
ICD-10 Finland
Other specified symptoms and signs involving the digestive system and abdomen
3.0
9.8
42
141
5739X
ICD-9 Finland
Other disorders of liver, Unspecified disorder of liver
26.1
9.8
13
5
I26.9
ICD-10 Finland
Pulmonary embolism without mention of acute cor pulmonale
1.8
9.8
138
773
E78.0
ICD-10 Finland
Pure hypercholesterolaemia
0.7
9.8
288
4128
57309
ICD-8 Finland
Other diseases of liver, Unspecified
10.6
9.8
18
17
N30.9
ICD-10 Finland
Cystitis, unspecified
1.8
9.8
154
893
107
Kela drug reimbursment
Pernicious anaemia
2.6
9.7
54
209
A10BH05
ATC
linagliptin; oral
1.8
9.7
132
731
N06AX11
ATC
mirtazapine; oral
1.3
9.7
779
6301
ZX120, ,
SPAT
3.0
9.7
42
142
E13
ICD-10 Finland
Other specified diabetes mellitus
13.4
9.7
16
12
4AA33, ,
NOMESCO Finland
55.2
9.6
11
*
M13.9
ICD-10 Finland
Arthritis, unspecified
1.7
9.5
168
1007
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
1.7
9.5
171
1030
JK3AN
NOMESCO Finland
Biliary tract isotope imaging
100.4
9.4
10
*
JK3AT
NOMESCO Finland
Catherisation of bile duct with ultrasound guidance
100.4
9.4
10
*
C24.01
ICD-10 Finland
Cystic duct
+∞
9.4
9
*
57400
ICD-8 Finland
Cholelithiasis, Cum cholecystitide acuta
+∞
9.4
9
*
K82.0
ICD-10 Finland
Obstruction of gallbladder
+∞
9.4
9
*
57500
ICD-8 Finland
Cholecystitis and cholangitis, without mention of calculus, Cholecystitis acuta
+∞
9.4
9
*
57708
ICD-8 Finland
Diseases of pancreas, Pancreatitis acuta alia
+∞
9.4
9
*
K82.8
ICD-10 Finland
Other specified diseases of gallbladder
+∞
9.4
9
*
5745B
ICD-9 Finland
Cholelithiasis, Calculus of bile duct without mention of cholecystitis[CHOLEDOCHOLITHIASIS SINE CHOLECYSTITIDE,CUM OBSTR]
+∞
9.4
9
*
5745A
ICD-9 Finland
Cholelithiasis, Calculus of bile duct without mention of cholecystitis[CHOLEDOCHOLITHIASIS SINE CHOLECYSTITIDE,SINE OBSTR]
+∞
9.4
9
*
JKB01
NOMESCO Finland
Laparoscopic incision of bile duct
+∞
9.4
9
*
I48
ICD-10 Finland
Atrial fibrillation and flutter
1.4
9.4
586
4564
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
1.4
9.3
457
3419
SPAT1216
SPAT
Assessment of functional ability
1.4
9.3
384
2785
D69.3
ICD-10 Finland
Idiopathic thrombocytopenic purpura
4.0
9.3
26
66
Q61.2
ICD-10 Finland
Polycystic kidney, autosomal dominant
4.7
9.3
21
45
TQW11
NOMESCO Finland
Vacuum treatment of wound
2.5
9.3
57
232
D12.3
ICD-10 Finland
Benign neoplasm: Transverse colon
2.3
9.3
68
300
4AB02, ,
NOMESCO Finland
9.5
9.3
18
19
JWE00
NOMESCO Finland
Reoperation for deep haemorrhage in gastroenterological surgery
13.7
9.2
15
11
ZYC01
NOMESCO Finland
Remote contact by phone
1.8
9.2
139
797
PD1AD
NOMESCO Finland
CT of abdominal aorta and branches
3.7
9.2
28
76
UJG02
NOMESCO Finland
Proctoscopy
2.5
9.1
56
228
SPAT1137
SPAT
Taking care of patient’s/customer’s hygiene
1.7
9.1
162
972
A03DA02
ATC
pitofenone and analgesics; systemic
2.8
9.1
44
159
XXA00
NOMESCO Finland
Clinical examination requiring general anaesthesia
4.6
9.1
21
46
5AB14, ,
NOMESCO Finland
15.6
9.0
14
9
K74.5
ICD-10 Finland
Biliary cirrhosis, unspecified
18.7
8.9
13
7
A46
ICD-10 Finland
Erysipelas
1.4
8.9
354
2551
I15.1
ICD-10 Finland
Hypertension secondary to other renal disorders
3.3
8.9
33
102
B25.9
ICD-10 Finland
Cytomegaloviral disease, unspecified
12.6
8.9
15
12
SPAT1229
SPAT
Assessment of need for aid
1.6
8.8
188
1185
SPAT1325
SPAT
Vaccination
1.3
8.7
796
6543
JFF13
NOMESCO Finland
Terminal enterostomy
7.6
8.6
19
25
B03XA02
ATC
darbepoetin alfa; parenteral
2.3
8.6
60
259
T81.3
ICD-10 Finland
Disruption of operation wound, not elsewhere classified
2.4
8.6
59
253
SPAT1211
SPAT
Application of soft bandage
1.6
8.5
200
1288
WX306
NOMESCO Finland
Lumbar epidural anesthesy
1.8
8.5
120
674
JK1CB
NOMESCO Finland
Cholecysto- and choledochography with X-ray
90.3
8.4
9
*
K73.8
ICD-10 Finland
Other chronic hepatitis, not elsewhere classified
90.3
8.4
9
*
N03AX12
ATC
[U] gabapentin; oral
1.4
8.4
344
2491
K29.0
ICD-10 Finland
Acute haemorrhagic gastritis
4.9
8.4
18
37
XW4AT
NOMESCO Finland
Biopsy of other inner organ with ultrasound guidance
6.7
8.4
20
30
K70.1
ICD-10 Finland
Alcoholic hepatitis
6.7
8.4
20
30
SPAT1249
SPAT
Treatment-related counselling outside office
1.3
8.3
859
7161
5750A
ICD-9 Finland
Other disorders of gallbladder, Acute cholecystitis
+∞
8.3
8
*
57402
ICD-8 Finland
Cholelithiasis, Cum cholecystitide et choledocholithiasi
+∞
8.3
8
*
JJC96
NOMESCO Finland
Other transplantation of liver or related operation
+∞
8.3
8
*
JLB42
NOMESCO Finland
Transduodenal endoscopic dilatation of pancreatic duct
+∞
8.3
8
*
JLD00
NOMESCO Finland
Pancreaticojejunostomy
+∞
8.3
8
*
A40.8
ICD-10 Finland
Other streptococcal sepsis
3.1
8.3
34
112
T81.2
ICD-10 Finland
Accidental puncture and laceration during a procedure, not elsewhere classified
3.5
8.2
27
77
C78.0
ICD-10 Finland
Secondary malignant neoplasm of lung
2.4
8.2
52
215
K57.2
ICD-10 Finland
Diverticular disease of large intestine with perforation and abscess
2.5
8.2
50
203
I10
ICD-10 Finland
Essential (primary) hypertension
1.3
8.2
1535
13746
SPAT1104
SPAT
Monitoring of emergency patient
1.7
8.2
147
884
KA2AT
NOMESCO Finland
Biopsy of transplanted kidney with ultrasound guidance
4.2
8.2
21
50
WYA20, ,
SPAT
3.7
8.2
25
68
A04AD12
ATC
aprepitant; systemic
2.5
8.2
48
192
C10AA07
ATC
rosuvastatin; oral
0.7
8.1
496
6293
A07AA02
ATC
nystatin; oral
1.7
8.1
133
780
M79.0
ICD-10 Finland
Rheumatism, unspecified
2.2
8.1
67
311
A02BX02
ATC
sucralfate; oral
2.0
8.1
90
467
L04AB02
ATC
infliximab; parenteral
4.5
8.1
19
42
K90.0
ICD-10 Finland
Coeliac disease
2.2
8.1
68
318
Z03.5
ICD-10 Finland
Observation for other suspected cardiovascular diseases
1.6
8.1
176
1113
7824A
ICD-9 Finland
Symptoms involving skin and other integumentary tissue, Jaundice, unspecified, not of newborn
33.4
8.1
10
*
E87.1
ICD-10 Finland
Hypo-osmolality and hyponatraemia
1.8
8.1
115
648
JDA55
NOMESCO Finland
Endoscopic dilatation of stomach, pylorus or anastomosis of stomach
11.7
8.1
14
12
ED1AA
NOMESCO Finland
Mandibular X-ray examination
4.0
8.1
22
55
JF1BD
NOMESCO Finland
Very extensive small bowel CT
6.8
8.1
19
28
SPAT1156
SPAT
Guidance concerning treatment of rash and skin
1.4
8.1
310
2219
JDH35
NOMESCO Finland
Endoscopic insertion of duodenal stent
22.1
8.0
11
5
GA4AT
NOMESCO Finland
Cathetrisation of pleural cavity with ultrasound guidance
2.8
8.0
38
136
F32.9
ICD-10 Finland
Depressive episode, unspecified
1.5
8.0
247
1693
NA6BG
NOMESCO Finland
Sacro-iliac joint MRI examination with high intensity magnet
3.1
8.0
32
104
WX730
NOMESCO Finland
Conventional respirator
2.8
8.0
39
142
KA9AE
NOMESCO Finland
Ultrasound examination transplanted kidney
7.2
8.0
18
25
B03XA01
ATC
erythropoietin; parenteral
3.4
7.9
27
79
Z73.3
ICD-10 Finland
Stress, not elsewhere classified
3.0
7.9
34
115
K57.9
ICD-10 Finland
Diverticular disease of intestine, part unspecified, without perforation or abscess
2.3
7.9
56
244
J05AB11
ATC
valaciclovir; oral
1.4
7.9
315
2269
K59.1
ICD-10 Finland
Functional diarrhoea
1.7
7.8
126
736
TNX10
NOMESCO Finland
Arthrocentesis, unspecified region, unspecified region
1.7
7.8
144
873
GA1AE
NOMESCO Finland
Ultrasound examination of thorax
2.2
7.8
60
271
WW200
NOMESCO Finland
Immunization
2.2
7.8
64
297
SPAT1234
SPAT
Support of social functional capacity
1.7
7.8
133
790
L29.8
ICD-10 Finland
Other pruritus
2.9
7.8
36
127
O26.6
ICD-10 Finland
Liver disorders in pregnancy, childbirth and the puerperium
3.8
7.8
23
61
K29.6
ICD-10 Finland
Other gastritis
3.0
7.8
33
111
JDA42
NOMESCO Finland
Other endoscopic haemostatic procedure in stomach or pylorus
7.0
7.8
18
26
JLC40
NOMESCO Finland
Total pancreatoduodenectomy
45.1
7.7
9
*
K73.89
ICD-10 Finland
Other long-term hepatitis, not classified differently
45.1
7.7
9
*
WD505
NOMESCO Finland
Simple enzyme inhibitor or similar therapy of methastized malignancy
3.1
7.7
31
101
CJE20
NOMESCO Finland
Phakoemulsification with implantation of artificial lens in posterior chamber
1.3
7.6
836
7007
D37.2
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Small intestine
4.5
7.6
18
40
JGB50
NOMESCO Finland
Mucosal proctectomy and ileoanal anastomosis
18.4
7.6
11
6
JX1XB
NOMESCO Finland
Other X-ray examination of alimentary tract with contrast
18.4
7.6
11
6
TJA40
NOMESCO Finland
Percutaneous local drainage of peritoneal cavity
18.4
7.6
11
6
JDA08
NOMESCO Finland
Endoscopic removal of foreign body from stomach or pylorus
18.4
7.6
11
6
M81.9
ICD-10 Finland
Osteoporosis, unspecified
1.8
7.6
116
668
QBB10
NOMESCO Finland
Major dressing of wound of skin of trunk
2.0
7.6
78
395
Z04.9
ICD-10 Finland
Examination and observation for unspecified reason
1.9
7.5
97
530
J04AB02
ATC
rifampicin; systemic
2.8
7.5
35
124
WPA10
NOMESCO Finland
Proactive palliative care treatment plan
3.2
7.5
28
87
WVA20, ,
SPAT
1.9
7.5
87
459
I20.09
ICD-10 Finland
Unstable angina
1.7
7.5
138
837
NK4XE
NOMESCO Finland
Joint ultrasound examination not elsewhere classified
1.7
7.5
139
845
C08CA05
ATC
nifedipine; systemic
1.7
7.5
143
877
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
1.3
7.5
624
5051
A29
ICPC
General symptom/complaint other
1.4
7.5
321
2345
K59.09
ICD-10 Finland
Constipation, unspecified
1.6
7.4
161
1018
K51.4
ICD-10 Finland
Inflammatory polyps
80.3
7.4
8
*
6615
FHL
Liver transplant
80.3
7.4
8
*
XW2BT
NOMESCO Finland
Other cytological test with X-ray guidance
80.3
7.4
8
*
D13.5
ICD-10 Finland
Benign neoplasm: Extrahepatic bile ducts
80.3
7.4
8
*
JDH32
NOMESCO Finland
Endoscopic dilatation of duodenum
80.3
7.4
8
*
JLA00
NOMESCO Finland
Exploration of pancreas
80.3
7.4
8
*
A08.4
ICD-10 Finland
Viral intestinal infection, unspecified
2.0
7.4
75
378
K91.8
ICD-10 Finland
Other postprocedural disorders of digestive system, not elsewhere classified
13.4
7.4
12
9
JAD11
NOMESCO Finland
Laparoscopic repair of incisional hernia
3.3
7.4
27
83
C07AG02
ATC
carvedilol; oral
1.7
7.4
144
888
R52.0
ICD-10 Finland
Acute pain
2.0
7.3
75
379
XF602
NOMESCO Finland
Bloodpressure monitoring
2.8
7.3
35
126
K03.66
ICD-10 Finland
Tooth plaque
1.6
7.3
173
1118
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
1.3
7.3
772
6437
UJK42
NOMESCO Finland
Peroral pancreaticoscopy
+∞
7.3
7
*
BE00A, ,
NOMESCO Finland
+∞
7.3
7
*
5762A
ICD-9 Finland
Other disorders of biliary tract, Obstruction of bile duct
+∞
7.3
7
*
57608
ICD-8 Finland
Other diseases of gallbladder and biliary, Dyskinesia viarum biliferarum
+∞
7.3
7
*
1282
FHL
ERCP and sphincterotomy
+∞
7.3
7
*
5770C
ICD-9 Finland
Diseases of pancreas, Acute pancreatitis[PANCREATITIS ACUTA NONALCOHOLICA RECIDIVANS]
+∞
7.3
7
*
6673
FHL
Hepatic enterostomy
+∞
7.3
7
*
6672
FHL
Cholecocenterostomy
+∞
7.3
7
*
JX1LA
NOMESCO Finland
Kinetic X-ray of alimentary tract with pictures
9.4
7.3
14
15
ZXE05
NOMESCO Finland
Procedure duration 40 to 49 minutes
1.8
7.2
106
603
PG1PT
NOMESCO Finland
Extensive endovascular embolisation for bleeding with radiological guidance not elsewhere classified
6.2
7.2
18
29
K75.2
ICD-10 Finland
Nonspecific reactive hepatitis
15.8
7.2
11
7
L97
ICD-10 Finland
Ulcer of lower limb, not elsewhere classified
1.9
7.2
93
510
JAK03
NOMESCO Finland
Laparotomy and peritoneal irrigation
30.1
7.1
9
*
QDB05
NOMESCO Finland
Revision of wound of skin of lower limb
2.1
7.1
68
335
K29.3
ICD-10 Finland
Chronic superficial gastritis
2.0
7.1
76
390
PBL10
NOMESCO Finland
Construction of arteriovenous fistula from radial artery
3.3
7.1
26
80
137
Kela drug reimbursment
Uraemia requiring dialysis
3.4
7.1
25
75
K50
ICD-10 Finland
Crohn disease [regional enteritis]
7.9
7.1
15
19
R06.0
ICD-10 Finland
Dyspnoea
1.3
7.1
633
5164
R31
ICD-10 Finland
Unspecified haematuria
1.5
7.1
253
1786
WX199
NOMESCO Finland
Other local analgesia
1.9
7.1
85
455
D12.2
ICD-10 Finland
Benign neoplasm: Ascending colon
1.9
7.0
79
413
I80.8
ICD-10 Finland
Phlebitis and thrombophlebitis of other sites
2.7
7.0
35
129
R74.9
ICD-10 Finland
Abnormal level of unspecified serum enzyme
4.2
7.0
18
43
E87.5
ICD-10 Finland
Hyperkalaemia
2.3
7.0
52
232
NG1AA
NOMESCO Finland
Knee X-ray examination without contrast
1.4
7.0
279
2010
M10.9
ICD-10 Finland
Gout, unspecified
1.6
7.0
172
1122
TPH05
NOMESCO Finland
Open cannulation of peripheral vein
3.4
7.0
24
71
XPX08
NOMESCO Finland
Intraoperative flow measurement
3.0
7.0
30
102
X57
ICD-10 Finland
Unspecified privation
2.2
7.0
53
239
E27.3
ICD-10 Finland
Drug-induced adrenocortical insufficiency
4.4
7.0
17
39
J01CA08
ATC
pivmecillinam; oral
1.3
7.0
810
6827
SPAT1231
SPAT
Assessment of adjustments needed in living environment
2.3
6.9
52
233
JFG40
NOMESCO Finland
Revision of enterostomy or colostomy without laparotomy
6.3
6.9
17
27
ZX121
NOMESCO Finland
Central venous catheter
6.3
6.9
17
27
B01AF02
ATC
apixaban; oral
1.4
6.9
334
2488
J01CA04
ATC
amoxicillin; systemic
1.3
6.9
1979
18425
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
1.7
6.9
117
695
ZXE70
NOMESCO Finland
Moren than 15 and less than 18 hours
7.5
6.9
15
20
C25.4
ICD-10 Finland
Malignant neoplasm: Endocrine pancreas
13.8
6.9
11
8
JFH20
NOMESCO Finland
Proctocolectomy and ileostomy
13.8
6.9
11
8
SPAT1217
SPAT
Assessment of need for services (elderly/care support)
1.5
6.9
192
1289
D48.5
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Skin
1.6
6.8
157
1008
SPAT1172
SPAT
Guidance concerning hydration
2.1
6.8
60
287
TKC20
NOMESCO Finland
Catheterisation of bladder
1.6
6.8
161
1042
R60.9
ICD-10 Finland
Oedema, unspecified
1.7
6.8
127
775
K25.9
ICD-10 Finland
Gastric ulcer, Unspecified as acute or chronic, without haemorrhage or perforation
2.4
6.8
43
179
C07AB02
ATC
metoprolol; systemic
1.3
6.8
490
3884
K23.8*B37.8
ICD-10 Finland
Esophagitis caused by candidiasis
5.7
6.7
18
32
R17.0
ICD-10 Finland
Hyperbilirubinaemia with mention of jaundice, not elsewhere classified
16.7
6.7
10
6
JWW96
NOMESCO Finland
Other reoperation in gastroenterological surgery
16.7
6.7
10
6
E000001, ,
ATC
1.3
6.7
418
3240
E03.9
ICD-10 Finland
Hypothyroidism, unspecified
1.4
6.7
273
1974
N18.4
ICD-10 Finland
Chronic kidney disease, stage 4
2.8
6.7
31
110
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
1.2
6.7
1028
8934
R73.9
ICD-10 Finland
Hyperglycaemia, unspecified
2.0
6.7
67
337
I50.9
ICD-10 Finland
Heart failure, unspecified
1.4
6.7
379
2898
I87.2
ICD-10 Finland
Venous insufficiency (chronic)(peripheral)
1.5
6.6
243
1723
A04.9
ICD-10 Finland
Bacterial intestinal infection, unspecified
3.7
6.6
20
54
OAB72
NOMESCO Finland
Weight control and weight loss guidance
4.0
6.6
18
45
J01DA01
ATC
[U] cefalexin
1.2
6.6
1413
12709
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
1.3
6.6
422
3284
ZXE02
NOMESCO Finland
Procedure duration 10 to 19 minutes
1.8
6.6
103
598
K21.9
ICD-10 Finland
Gastro-oesophageal reflux disease without oesophagitis
1.5
6.6
206
1416
B80
ICPC
Iron deficiency anaemia
2.1
6.6
60
291
B02.9
ICD-10 Finland
Zoster without complication
1.6
6.6
155
1002
C07AB07
ATC
bisoprolol; oral
1.2
6.6
1194
10558
ZY020
NOMESCO Finland
Telephone, letter or other consultation without direct patient contact
1.6
6.6
132
821
XX9TB
NOMESCO Finland
Complementary X-ray examination with contrast
10.0
6.5
12
12
D07AC01
ATC
betamethasone; topical
1.3
6.5
803
6802
290
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation
1.3
6.5
410
3186
M81.8
ICD-10 Finland
Other osteoporosis
2.9
6.5
29
101
WVC10
NOMESCO Finland
Subcutaneous infusion of drugs
3.9
6.4
18
46
M07.4
ICD-10 Finland
Arthropathy in Crohn disease [regional enteritis]
70.0
6.4
7
*
QBB05
NOMESCO Finland
Revision of wound of skin of trunk
2.8
6.4
30
107
S29
ICPC
Skin symptom/complaint other
1.3
6.4
449
3540
UJF34
NOMESCO Finland
Left colonoscopy
3.4
6.4
22
65
C01DA08
ATC
isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal
1.3
6.4
612
5029
B19.9
ICD-10 Finland
Unspecified viral hepatitis without hepatic coma
14.3
6.4
10
7
JWA00
NOMESCO Finland
Repair of wound dehiscence in gastroenterological surgery
3.7
6.4
19
51
K26.9
ICD-10 Finland
Duodenal ulcer, unspecified as acute or chronic, without haemorrhage or perforation
3.0
6.3
26
86
XX6XT
NOMESCO Finland
Other intravascular therapy with radiological guidance
6.0
6.3
16
27
5560A
ICD-9 Finland
Idiopathic proctocolitis, Ulcerative (chronic) enterocolitis
11.0
6.3
11
10
A03CA02
ATC
clidinium and psycholeptics; oral
1.6
6.3
126
783
3A422, ,
NOMESCO Finland
18.1
6.3
9
5
5550A
ICD-9 Finland
Regional enteritis, Small intestine
18.1
6.3
9
5
C17.0
ICD-10 Finland
Malignant neoplasm: Duodenum
18.1
6.3
9
5
K62.5
ICD-10 Finland
Haemorrhage of anus and rectum
1.6
6.3
127
792
K82.4
ICD-10 Finland
Cholesterolosis of gallbladder
+∞
6.3
6
*
Q44.1
ICD-10 Finland
Other congenital malformations of gallbladder
+∞
6.3
6
*
1260
FHL
Endoscopic retrograde cholangiography
+∞
6.3
6
*
JJC10
NOMESCO Finland
Allogenic partial transplantation of liver
+∞
6.3
6
*
JKF96
NOMESCO Finland
Other secondary operation on biliary tract
+∞
6.3
6
*
JKW98
NOMESCO Finland
Other transluminal endoscopic operation on biliary tract
+∞
6.3
6
*
JLT00
NOMESCO Finland
Extracorporeal shock wave lithotripsy of pancreatic duct
+∞
6.3
6
*
57609
ICD-8 Finland
Other diseases of gallbladder and biliary, Alii definiti sive NUD
+∞
6.3
6
*
6653
FHL
Cholecocotomy or hepaticotomy and choledocoscopy (includes stone removal)
+∞
6.3
6
*
5761B
ICD-9 Finland
Other disorders of biliary tract, Cholangitis[CHOLANGITIS CHRONICA]
+∞
6.3
6
*
5772A
ICD-9 Finland
Diseases of pancreas, Cyst and pseudocyst of pancreas[CYSTA ET PSEUDOCYSTA PANCREATIS]
+∞
6.3
6
*
K29.4
ICD-10 Finland
Chronic atrophic gastritis
2.1
6.2
54
257
XX4XT
NOMESCO Finland
Other canalization with radiological guidance
26.7
6.2
8
*
8240/3-C25.9
ICD-O-3
Neuroendocrine tumor, NOS, of pancreas, NOS
26.7
6.2
8
*
Z46.8
ICD-10 Finland
Fitting and adjustment of other specified devices
2.0
6.2
65
332
Y88.3
ICD-10 Finland
Sequelae of surgical and medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
2.0
6.2
67
346
H01CB02
ATC
octreotide; parenteral
7.0
6.2
14
20
L30.9
ICD-10 Finland
Dermatitis, unspecified
1.3
6.2
441
3484
I48.9
ICD-10 Finland
Atrial fibrillation and atrial flutter, unspecified
1.5
6.2
193
1327
E10.8
ICD-10 Finland
Type 1 diabetes mellitus, With unspecified complications
2.7
6.2
31
115
EBA15
NOMESCO Finland
Extraction of multiple teeth
1.8
6.2
91
520
M05BA04
ATC
alendronic acid; oral
1.5
6.2
207
1444
D10
ICPC
Vomiting
1.7
6.2
109
656
H25.8
ICD-10 Finland
Other senile cataract
1.4
6.2
277
2039
K29.8
ICD-10 Finland
Duodenitis
3.4
6.1
21
62
K91.4
ICD-10 Finland
Colostomy and enterostomy malfunction
7.7
6.1
13
17
H01CB03
ATC
lanreotide; parenteral
7.7
6.1
13
17
X59
ICD-10 Finland
Exposure to unspecified factor
1.3
6.1
414
3248
SPAT1097
SPAT
Recording of ECG
1.4
6.1
313
2355
L98.4
ICD-10 Finland
Chronic ulcer of skin, not elsewhere classified
2.1
6.1
53
253
WPA15
NOMESCO Finland
Palliative care consultation with the patient and loved ones
3.8
6.1
18
48
N25.8
ICD-10 Finland
Other disorders resulting from impaired renal tubular function
3.8
6.1
18
48
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
1.7
6.1
95
553
J09
ICD-10 Finland
Influenza due to identified zoonotic or pandemic influenza virus
1.9
6.0
73
392
SPAT1167
SPAT
Insertion of urinary catheter
1.8
6.0
80
443

TimeCodeWAS

↥

TODO / Current known limitations:

  • Only showing the top 300 codes, because showing all (sometimes 20k) makes the page too slow.
  • Legend / how to read the glyphs.
  • Show details (e.g. Fisher or Chi-square test, LR+, etc.) when clicking on a row.
  • Explanation on the underlying data / how the TimeCodeWAS is done (e.g. matched cases / controls, eligibility).
  • Download CSV.
  • No filters and sorters.
  • Limited amount of endpoints (~400) having TimeCodeWAS data.
  • Cross-links to Risteys lab test pages for lab test codes.
OMOP concept
ln(OR)
%cases with code / %controls with code
2×2 table
ursodeoxycholic acid; oral
A05AA02 [21600513]
3.9e+00
4.8e+00
—
—
6.5e+00
6.4e+00
6.1e+00
cases:4.88%
controls:0.10%
cases:8.12%
controls:0.07%
—
—
—
—
cases:13.65%
controls:0.02%
cases:27.34%
controls:0.06%
cases:34.19%
controls:0.12%
130
27
2536
26606
217
20
2454
26655
—
—
355
6
2246
26595
630
16
1674
25607
597
24
1149
20452
Upper gastrointestinal surgery
106 [44777669]
1.4e+00
2.4e+00
3.8e+00
7.8e+00
4.7e+00
3.1e+00
1.9e+00
cases:27.64%
controls:8.77%
cases:28.87%
controls:3.48%
cases:18.42%
controls:0.52%
cases:40.25%
controls:0.03%
cases:33.18%
controls:0.44%
cases:42.88%
controls:3.23%
cases:37.97%
controls:8.73%
737
2336
1929
24297
771
928
1900
25747
492
139
2179
26536
1075
7
1596
26668
863
118
1738
26483
988
827
1316
24796
663
1787
1083
18689
Neoplasm of uncertain or unknown behaviour: Other digestive organs
D37.7 [45552349]
2.8e+00
3.9e+00
5.0e+00
—
4.4e+00
4.1e+00
2.7e+00
cases:2.59%
controls:0.15%
cases:3.82%
controls:0.08%
cases:2.62%
controls:0.02%
—
—
cases:2.46%
controls:0.03%
cases:3.95%
controls:0.07%
cases:1.89%
controls:0.13%
69
41
2597
26592
102
21
2569
26654
70
5
2601
26670
—
64
8
2537
26593
91
18
2213
25605
33
27
1713
20449
Cancer Ag 19-9 [Units/volume] in Serum or Plasma
24108-3 [3022914]
2.2e+00
3.6e+00
5.0e+00
—
4.6e+00
3.9e+00
3.5e+00
cases:4.35%
controls:0.53%
cases:8.39%
controls:0.25%
cases:6.03%
controls:0.04%
—
—
cases:5.27%
controls:0.06%
cases:12.46%
controls:0.28%
cases:17.35%
controls:0.61%
116
140
2550
26493
224
66
2447
26609
161
12
2510
26663
—
137
15
2464
26586
287
71
2017
25552
303
125
1443
20351
Ultrasound examination of upper part of abdomen
JN1AE [2001305517]
2.5e+00
3.6e+00
5.0e+00
1.0e+50
4.4e+00
3.6e+00
3.1e+00
cases:6.86%
controls:0.61%
cases:6.29%
controls:0.19%
cases:2.73%
controls:0.02%
cases:5.99%
controls:0.00%
cases:1.81%
controls:0.02%
cases:6.73%
controls:0.19%
cases:11.28%
controls:0.58%
183
163
2483
26470
168
50
2503
26625
73
5
2598
26670
160
0
2511
26675
47
6
2554
26595
155
48
2149
25575
197
119
1549
20357
Bilirubin.total [Moles/volume] in Serum or Plasma
14631-6 [3006140]
9.2e-01
2.0e+00
3.5e+00
6.9e+00
4.1e+00
2.4e+00
1.6e+00
cases:25.88%
controls:12.21%
cases:34.29%
controls:6.54%
cases:30.85%
controls:1.27%
cases:34.26%
controls:0.05%
cases:43.64%
controls:1.32%
cases:43.06%
controls:6.33%
cases:46.05%
controls:14.89%
690
3252
1976
23381
916
1745
1755
24930
824
339
1847
26336
915
14
1756
26661
1135
351
1466
26250
992
1622
1312
24001
804
3048
942
17428
Left sided colitis
K51.5 [45533604]
2.6e+00
3.0e+00
3.7e+00
—
3.7e+00
3.6e+00
3.8e+00
cases:5.29%
controls:0.42%
cases:5.54%
controls:0.28%
cases:1.87%
controls:0.05%
—
—
cases:2.54%
controls:0.06%
cases:9.29%
controls:0.28%
cases:16.04%
controls:0.41%
141
111
2525
26522
148
74
2523
26601
50
13
2621
26662
—
66
17
2535
26584
214
72
2090
25551
280
84
1466
20392
Bacteria identified in Blood by Culture
600-7 [3023368]
8.6e-01
1.6e+00
3.4e+00
7.2e+00
3.6e+00
1.8e+00
1.1e+00
cases:12.34%
controls:5.61%
cases:12.65%
controls:2.83%
cases:10.56%
controls:0.39%
cases:22.50%
controls:0.02%
cases:12.76%
controls:0.38%
cases:15.15%
controls:2.83%
cases:20.39%
controls:8.10%
329
1493
2337
25140
338
754
2333
25921
282
105
2389
26570
601
6
2070
26669
332
102
2269
26499
349
725
1955
24898
356
1658
1390
18818
mesalazine; oral, rectal
A07EC02 [21600664]
2.4e+00
2.6e+00
2.5e+00
3.6e+00
2.6e+00
2.8e+00
3.0e+00
cases:10.35%
controls:1.09%
cases:10.48%
controls:0.90%
cases:3.71%
controls:0.31%
cases:0.67%
controls:0.02%
cases:4.81%
controls:0.38%
cases:13.80%
controls:0.92%
cases:17.64%
controls:1.11%
276
290
2390
26343
280
239
2391
26436
99
84
2572
26591
18
5
2653
26670
125
100
2476
26501
318
236
1986
25387
308
227
1438
20249
Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
83084-4 [42529201]
2.6e+00
3.5e+00
—
1.0e+50
5.4e+00
4.1e+00
3.5e+00
cases:3.00%
controls:0.22%
cases:4.94%
controls:0.15%
—
—
cases:0.26%
controls:0.00%
cases:4.15%
controls:0.02%
cases:8.03%
controls:0.14%
cases:10.08%
controls:0.32%
80
59
2586
26574
132
41
2539
26634
—
7
0
2664
26675
108
5
2493
26596
185
36
2119
25587
176
66
1570
20410
Connective tissue diseases, rheumatoid arthritis and comparable disease
202 [2001600200]
1.1e+00
2.8e+00
3.0e+00
1.0e+50
5.3e+00
4.4e+00
2.5e+00
cases:2.25%
controls:0.79%
cases:2.13%
controls:0.13%
cases:0.45%
controls:0.02%
cases:0.22%
controls:0.00%
cases:4.31%
controls:0.02%
cases:7.47%
controls:0.10%
cases:4.52%
controls:0.40%
60
211
2606
26422
57
36
2614
26639
12
6
2659
26669
6
0
2665
26675
112
6
2489
26595
172
26
2132
25597
79
82
1667
20394
Bilirubin.conjugated [Moles/volume] in Serum or Plasma
29760-6 [3005772]
1.5e+00
2.9e+00
4.0e+00
—
5.2e+00
3.1e+00
2.2e+00
cases:8.06%
controls:1.95%
cases:12.13%
controls:0.76%
cases:6.89%
controls:0.13%
—
—
cases:15.19%
controls:0.10%
cases:15.28%
controls:0.79%
cases:16.49%
controls:2.23%
215
520
2451
26113
324
204
2347
26471
184
36
2487
26639
—
395
27
2206
26574
352
203
1952
25420
288
457
1458
20019
Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
19176-7 [3015916]
2.5e+00
3.6e+00
—
1.0e+50
4.1e+00
4.2e+00
4.3e+00
cases:1.95%
controls:0.17%
cases:3.00%
controls:0.09%
—
—
cases:0.56%
controls:0.00%
cases:1.08%
controls:0.02%
cases:5.08%
controls:0.08%
cases:11.63%
controls:0.18%
52
45
2614
26588
80
23
2591
26652
—
15
0
2656
26675
28
5
2573
26596
117
20
2187
25603
203
37
1543
20439
Prealbumin [Mass/volume] in Serum or Plasma
14338-8 [3013742]
1.6e+00
2.7e+00
4.1e+00
—
4.4e+00
3.2e+00
2.4e+00
cases:8.21%
controls:1.70%
cases:10.82%
controls:0.82%
cases:5.92%
controls:0.11%
—
—
cases:8.96%
controls:0.12%
cases:13.45%
controls:0.64%
cases:18.21%
controls:1.92%
219
453
2447
26180
289
218
2382
26457
158
29
2513
26646
—
233
32
2368
26569
310
163
1994
25460
318
393
1428
20083
Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
2324-2 [3026910]
5.7e-01
1.6e+00
3.2e+00
6.8e+00
3.5e+00
1.7e+00
9.4e-01
cases:24.53%
controls:15.51%
cases:26.06%
controls:6.68%
cases:16.96%
controls:0.85%
cases:14.94%
controls:0.02%
cases:22.88%
controls:0.86%
cases:30.03%
controls:7.07%
cases:39.00%
controls:19.95%
654
4132
2012
22501
696
1781
1975
24894
453
227
2218
26448
399
5
2272
26670
595
230
2006
26371
692
1812
1612
23811
681
4085
1065
16391
Ammonium ion [Moles/volume] in Plasma
1845-7 [3023183]
1.8e+00
2.8e+00
3.9e+00
1.0e+50
4.5e+00
2.6e+00
2.1e+00
cases:1.46%
controls:0.26%
cases:1.91%
controls:0.12%
cases:0.94%
controls:0.02%
cases:0.49%
controls:0.00%
cases:2.00%
controls:0.02%
cases:1.87%
controls:0.14%
cases:2.98%
controls:0.37%
39
68
2627
26565
51
33
2620
26642
25
5
2646
26670
13
0
2658
26675
52
6
2549
26595
43
36
2261
25587
52
76
1694
20400
Other Crohn disease
K50.8 [45533599]
2.5e+00
2.8e+00
3.0e+00
—
3.0e+00
3.1e+00
3.2e+00
cases:1.95%
controls:0.17%
cases:2.06%
controls:0.13%
cases:0.86%
controls:0.04%
—
—
cases:1.00%
controls:0.05%
cases:2.82%
controls:0.13%
cases:5.04%
controls:0.21%
52
45
2614
26588
55
35
2616
26640
23
12
2648
26663
—
26
14
2575
26587
65
34
2239
25589
88
44
1658
20432
Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
1805-1 [3016417]
1.1e+00
2.4e+00
4.2e+00
—
4.6e+00
3.0e+00
2.1e+00
cases:4.58%
controls:1.59%
cases:7.75%
controls:0.78%
cases:6.21%
controls:0.10%
—
—
cases:9.80%
controls:0.11%
cases:11.20%
controls:0.64%
cases:15.29%
controls:2.07%
122
423
2544
26210
207
207
2464
26468
166
26
2505
26649
—
255
28
2346
26573
258
165
2046
25458
267
424
1479
20052
IgM [Mass/volume] in Serum or Plasma
2472-9 [3028026]
1.6e+00
2.9e+00
4.0e+00
1.0e+50
3.6e+00
2.6e+00
2.7e+00
cases:5.03%
controls:1.10%
cases:6.78%
controls:0.40%
cases:3.63%
controls:0.07%
cases:0.86%
controls:0.00%
cases:2.00%
controls:0.06%
cases:5.69%
controls:0.43%
cases:12.89%
controls:0.99%
134
294
2532
26339
181
108
2490
26567
97
18
2574
26657
23
0
2648
26675
52
15
2549
26586
131
111
2173
25512
225
203
1521
20273
Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
6768-6 [3035995]
5.8e-01
1.4e+00
3.0e+00
6.1e+00
3.4e+00
1.7e+00
1.1e+00
cases:34.73%
controls:22.90%
cases:40.21%
controls:14.05%
cases:33.62%
controls:2.56%
cases:34.86%
controls:0.12%
cases:44.83%
controls:2.54%
cases:46.79%
controls:13.91%
cases:52.86%
controls:27.91%
926
6098
1740
20535
1074
3748
1597
22927
898
684
1773
25991
931
31
1740
26644
1166
676
1435
25925
1078
3564
1226
22059
923
5714
823
14762
Abdominal CT examination
JN3AD [2001305554]
1.5e+00
2.5e+00
4.6e+00
1.0e+50
4.3e+00
2.7e+00
1.7e+00
cases:3.94%
controls:0.93%
cases:5.77%
controls:0.50%
cases:4.12%
controls:0.04%
cases:11.12%
controls:0.00%
cases:3.15%
controls:0.05%
cases:6.47%
controls:0.48%
cases:9.28%
controls:1.85%
105
248
2561
26385
154
134
2517
26541
110
11
2561
26664
297
0
2374
26675
82
12
2519
26589
149
122
2155
25501
162
379
1584
20097
Abdominal ultrasound examination
JN3AE [2001305555]
1.6e+00
2.6e+00
4.4e+00
1.0e+50
3.9e+00
2.7e+00
1.9e+00
cases:6.86%
controls:1.42%
cases:5.20%
controls:0.42%
cases:3.11%
controls:0.04%
cases:5.88%
controls:0.00%
cases:1.65%
controls:0.03%
cases:5.25%
controls:0.38%
cases:8.93%
controls:1.39%
183
378
2483
26255
139
113
2532
26562
83
11
2588
26664
157
0
2514
26675
43
9
2558
26592
121
97
2183
25526
156
285
1590
20191
Ulcerative colitis, unspecified
K51.9 [45605941]
2.7e+00
3.6e+00
3.7e+00
—
—
3.8e+00
3.3e+00
cases:4.73%
controls:0.35%
cases:3.82%
controls:0.11%
cases:1.39%
controls:0.03%
—
—
—
—
cases:5.08%
controls:0.12%
cases:8.25%
controls:0.34%
126
92
2540
26541
102
30
2569
26645
37
9
2634
26666
—
—
117
30
2187
25593
144
69
1602
20407
Emergency Room Visit
ER [9203]
6.9e-01
1.3e+00
2.8e+00
7.3e+00
2.6e+00
1.3e+00
9.3e-01
cases:51.61%
controls:34.82%
cases:34.03%
controls:11.81%
cases:19.39%
controls:1.47%
cases:41.11%
controls:0.04%
cases:16.57%
controls:1.41%
cases:31.90%
controls:11.35%
cases:50.52%
controls:28.72%
1376
9273
1290
17360
909
3149
1762
23526
518
393
2153
26282
1098
12
1573
26663
431
374
2170
26227
735
2909
1569
22714
882
5881
864
14595
Other specified diabetes mellitus, without complications
E13.9 [45537964]
3.4e+00
3.3e+00
—
1.0e+50
3.2e+00
4.0e+00
3.1e+00
cases:0.90%
controls:0.03%
cases:0.71%
controls:0.03%
—
—
cases:0.34%
controls:0.00%
cases:0.58%
controls:0.02%
cases:1.82%
controls:0.04%
cases:1.55%
controls:0.07%
24
8
2642
26625
19
7
2652
26668
—
9
0
2662
26675
15
6
2586
26595
42
9
2262
25614
27
15
1719
20461
Gastroenterology
10 [38004455]
1.5e+00
2.5e+00
3.3e+00
—
3.6e+00
3.2e+00
2.6e+00
cases:21.53%
controls:5.51%
cases:23.03%
controls:2.32%
cases:10.03%
controls:0.39%
—
—
cases:14.03%
controls:0.44%
cases:35.29%
controls:2.18%
cases:45.65%
controls:5.89%
574
1468
2092
25165
615
619
2056
26056
268
105
2403
26570
—
365
116
2236
26485
813
558
1491
25065
797
1206
949
19270
Emergency Room and Inpatient Visit
ERIP [262]
6.6e-01
1.4e+00
2.8e+00
7.0e+00
3.0e+00
1.3e+00
5.9e-01
cases:10.99%
controls:6.01%
cases:13.44%
controls:3.83%
cases:8.05%
controls:0.53%
cases:20.25%
controls:0.02%
cases:11.00%
controls:0.59%
cases:14.15%
controls:4.21%
cases:19.53%
controls:11.91%
293
1600
2373
25033
359
1021
2312
25654
215
141
2456
26534
541
6
2130
26669
286
156
2315
26445
326
1079
1978
24544
341
2438
1405
18038
Myeloperoxidase IgG Ab [Units/volume] in Serum
48404-8 [3049804]
7.9e-01
2.1e+00
4.7e+00
—
3.2e+00
3.1e+00
2.9e+00
cases:1.28%
controls:0.59%
cases:1.76%
controls:0.22%
cases:1.98%
controls:0.02%
—
—
cases:0.73%
controls:0.03%
cases:4.04%
controls:0.18%
cases:8.93%
controls:0.55%
34
156
2632
26477
47
58
2624
26617
53
5
2618
26670
—
19
8
2582
26593
93
47
2211
25576
156
112
1590
20364
Blood group antibody screen [Presence] in Serum or Plasma
890-4 [3001079]
6.0e-01
1.3e+00
2.9e+00
5.9e+00
3.6e+00
1.7e+00
8.2e-01
cases:17.10%
controls:10.21%
cases:14.49%
controls:4.49%
cases:8.76%
controls:0.55%
cases:7.19%
controls:0.02%
cases:14.11%
controls:0.47%
cases:18.45%
controls:3.84%
cases:22.51%
controls:11.35%
456
2719
2210
23914
387
1197
2284
25478
234
147
2437
26528
192
6
2479
26669
367
124
2234
26477
425
983
1879
24640
393
2324
1353
18152
Albumin [Mass/volume] in Serum or Plasma
1751-7 [3024561]
7.6e-01
1.7e+00
3.0e+00
4.8e+00
3.0e+00
1.9e+00
1.4e+00
cases:21.34%
controls:11.28%
cases:25.98%
controls:6.31%
cases:16.40%
controls:0.99%
cases:3.52%
controls:0.03%
cases:18.42%
controls:1.07%
cases:30.03%
controls:6.13%
cases:39.69%
controls:14.30%
569
3004
2097
23629
694
1682
1977
24993
438
263
2233
26412
94
8
2577
26667
479
285
2122
26316
692
1571
1612
24052
693
2928
1053
17548
Very extensive MRI examination of upper part of abdomen with high intensity magnet
JN1DG [2001305530]
2.9e+00
4.4e+00
1.0e+50
1.0e+50
—
4.5e+00
4.6e+00
cases:1.65%
controls:0.09%
cases:2.43%
controls:0.03%
cases:1.01%
controls:0.00%
cases:2.51%
controls:0.00%
—
—
cases:3.21%
controls:0.04%
cases:6.07%
controls:0.06%
44
25
2622
26608
65
8
2606
26667
27
0
2644
26675
67
0
2604
26675
—
74
9
2230
25614
106
13
1640
20463
Inpatient Hospital
21 [8717]
6.7e-01
1.3e+00
2.4e+00
6.6e+00
2.9e+00
1.5e+00
1.1e+00
cases:46.66%
controls:30.99%
cases:28.34%
controls:9.97%
cases:14.56%
controls:1.48%
cases:35.83%
controls:0.07%
cases:21.07%
controls:1.47%
cases:32.51%
controls:9.30%
cases:44.16%
controls:21.56%
1244
8253
1422
18380
757
2660
1914
24015
389
396
2282
26279
957
20
1714
26655
548
392
2053
26209
749
2382
1555
23241
771
4414
975
16062
General Surgery
2 [38004447]
7.0e-01
1.3e+00
2.7e+00
6.5e+00
2.7e+00
1.6e+00
8.9e-01
cases:27.94%
controls:16.21%
cases:16.40%
controls:4.90%
cases:9.14%
controls:0.68%
cases:18.83%
controls:0.03%
cases:8.88%
controls:0.66%
cases:19.05%
controls:4.55%
cases:25.95%
controls:12.61%
745
4316
1921
22317
438
1306
2233
25369
244
181
2427
26494
503
9
2168
26666
231
176
2370
26425
439
1166
1865
24457
453
2582
1293
17894
Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
2039-6 [3003785]
1.4e+00
2.5e+00
3.7e+00
—
3.5e+00
2.8e+00
2.4e+00
cases:7.69%
controls:2.07%
cases:12.80%
controls:1.17%
cases:8.84%
controls:0.24%
—
—
cases:8.15%
controls:0.26%
cases:17.36%
controls:1.21%
cases:22.39%
controls:2.48%
205
552
2461
26081
342
312
2329
26363
236
64
2435
26611
—
212
69
2389
26532
400
309
1904
25314
391
508
1355
19968
Outpatient Hospital
22 [8756]
6.6e-01
1.3e+00
2.4e+00
6.4e+00
2.8e+00
1.8e+00
1.1e+00
cases:38.82%
controls:24.67%
cases:21.94%
controls:6.92%
cases:8.76%
controls:0.90%
cases:20.55%
controls:0.04%
cases:12.76%
controls:0.90%
cases:26.61%
controls:5.85%
cases:34.99%
controls:15.54%
1035
6571
1631
20062
586
1846
2085
24829
234
241
2437
26434
549
12
2122
26663
332
240
2269
26361
613
1499
1691
24124
611
3181
1135
17295
Proteinase 3 Ab [Units/volume] in Serum
6968-2 [3009445]
9.4e-01
2.0e+00
4.3e+00
1.0e+50
3.4e+00
2.9e+00
2.6e+00
cases:2.18%
controls:0.86%
cases:2.28%
controls:0.31%
cases:2.25%
controls:0.03%
cases:0.71%
controls:0.00%
cases:0.92%
controls:0.03%
cases:4.30%
controls:0.24%
cases:9.56%
controls:0.79%
58
230
2608
26403
61
84
2610
26591
60
8
2611
26667
19
0
2652
26675
24
8
2577
26593
99
61
2205
25562
167
161
1579
20315
Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
9838-4 [3003265]
2.8e+00
4.8e+00
1.0e+50
1.0e+50
1.0e+50
4.4e+00
4.3e+00
cases:1.43%
controls:0.09%
cases:3.11%
controls:0.03%
cases:1.91%
controls:0.00%
cases:0.67%
controls:0.00%
cases:0.77%
controls:0.00%
cases:3.82%
controls:0.05%
cases:9.91%
controls:0.16%
38
23
2628
26610
83
7
2588
26668
51
0
2620
26675
18
0
2653
26675
20
0
2581
26601
88
13
2216
25610
173
32
1573
20444
Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
32785-8 [3043405]
2.5e+00
4.0e+00
1.0e+50
1.0e+50
1.0e+50
5.2e+00
4.5e+00
cases:1.50%
controls:0.13%
cases:4.19%
controls:0.08%
cases:1.91%
controls:0.00%
cases:2.28%
controls:0.00%
cases:2.65%
controls:0.00%
cases:5.38%
controls:0.03%
cases:10.14%
controls:0.13%
40
34
2626
26599
112
21
2559
26654
51
0
2620
26675
61
0
2610
26675
69
0
2532
26601
124
8
2180
25615
177
26
1569
20450
Biopsy of liver with ultrasound guidance
JJ2AT [2001305254]
3.5e+00
4.4e+00
—
1.0e+50
—
4.8e+00
3.4e+00
cases:2.81%
controls:0.09%
cases:3.41%
controls:0.04%
—
—
cases:0.64%
controls:0.00%
—
—
cases:3.52%
controls:0.03%
cases:3.95%
controls:0.14%
75
24
2591
26609
91
11
2580
26664
—
17
0
2654
26675
—
81
8
2223
25615
69
28
1677
20448
Liver transplant status
Z94.4 [45566478]
3.3e+00
3.9e+00
—
1.0e+50
—
4.3e+00
4.5e+00
cases:1.20%
controls:0.05%
cases:1.65%
controls:0.03%
—
—
cases:1.31%
controls:0.00%
—
—
cases:2.56%
controls:0.04%
cases:3.89%
controls:0.04%
32
12
2634
26621
44
9
2627
26666
—
35
0
2636
26675
—
59
9
2245
25614
68
9
1678
20467
Liver Pathology biopsy report
65752-8 [40768441]
3.3e+00
4.5e+00
—
1.0e+50
—
4.6e+00
3.7e+00
cases:1.91%
controls:0.08%
cases:2.51%
controls:0.03%
—
—
cases:0.22%
controls:0.00%
—
—
cases:2.39%
controls:0.02%
cases:3.15%
controls:0.08%
51
20
2615
26613
67
8
2604
26667
—
6
0
2665
26675
—
55
6
2249
25617
55
17
1691
20459
Pain localized to upper abdomen
R10.1 [45568111]
1.4e+00
2.5e+00
4.5e+00
—
3.4e+00
2.4e+00
1.8e+00
cases:6.75%
controls:1.77%
cases:6.07%
controls:0.54%
cases:4.79%
controls:0.06%
—
—
cases:2.19%
controls:0.08%
cases:5.43%
controls:0.51%
cases:10.19%
controls:1.76%
180
471
2486
26162
162
145
2509
26530
128
15
2543
26660
—
57
20
2544
26581
125
131
2179
25492
178
361
1568
20115
IgG [Mass/volume] in Serum or Plasma
2465-3 [3005719]
1.4e+00
2.6e+00
3.7e+00
—
3.3e+00
2.5e+00
2.5e+00
cases:5.36%
controls:1.45%
cases:8.12%
controls:0.66%
cases:4.46%
controls:0.12%
—
—
cases:3.19%
controls:0.12%
cases:7.42%
controls:0.68%
cases:14.83%
controls:1.39%
143
385
2523
26248
217
177
2454
26498
119
31
2552
26644
—
83
31
2518
26570
171
173
2133
25450
259
284
1487
20192
Amylase [Enzymatic activity/volume] in Serum or Plasma
1798-8 [3016771]
1.2e+00
2.3e+00
3.9e+00
1.0e+50
4.6e+00
2.5e+00
1.5e+00
cases:17.18%
controls:6.06%
cases:19.77%
controls:2.53%
cases:14.08%
controls:0.33%
cases:22.24%
controls:0.00%
cases:27.26%
controls:0.36%
cases:24.00%
controls:2.58%
cases:26.98%
controls:7.81%
458
1614
2208
25019
528
674
2143
26001
376
89
2295
26586
594
0
2077
26675
709
95
1892
26506
553
661
1751
24962
471
1600
1275
18876
Chronic active hepatitis, not elsewhere classified
K73.2 [45543340]
3.4e+00
3.8e+00
—
1.0e+50
—
4.4e+00
4.3e+00
cases:1.09%
controls:0.04%
cases:1.35%
controls:0.03%
—
—
cases:0.52%
controls:0.00%
—
—
cases:1.52%
controls:0.02%
cases:2.52%
controls:0.03%
29
10
2637
26623
36
8
2635
26667
—
14
0
2657
26675
—
35
5
2269
25618
44
7
1702
20469
Chloride [Moles/volume] in Serum or Plasma
2075-0 [3014576]
1.0e+00
1.6e+00
2.5e+00
5.0e+00
2.9e+00
1.7e+00
1.0e+00
cases:6.11%
controls:2.29%
cases:5.58%
controls:1.17%
cases:2.51%
controls:0.20%
cases:2.70%
controls:0.02%
cases:3.96%
controls:0.22%
cases:6.94%
controls:1.34%
cases:10.14%
controls:3.90%
163
610
2503
26023
149
311
2522
26364
67
54
2604
26621
72
5
2599
26670
103
58
2498
26543
160
343
2144
25280
177
799
1569
19677
Crohn disease of small intestine
K50.0 [45596324]
2.5e+00
2.7e+00
2.4e+00
1.0e+50
2.9e+00
2.7e+00
2.6e+00
cases:1.69%
controls:0.14%
cases:1.05%
controls:0.07%
cases:0.34%
controls:0.03%
cases:0.56%
controls:0.00%
cases:0.42%
controls:0.02%
cases:0.91%
controls:0.06%
cases:1.95%
controls:0.15%
45
37
2621
26596
28
19
2643
26656
9
8
2662
26667
15
0
2656
26675
11
6
2590
26595
21
16
2283
25607
34
31
1712
20445
Metastasis to liver
OMOP5000224 [36770544]
2.1e+00
2.7e+00
3.2e+00
1.0e+50
3.6e+00
2.8e+00
1.3e+00
cases:0.68%
controls:0.08%
cases:1.42%
controls:0.10%
cases:1.20%
controls:0.05%
cases:0.97%
controls:0.00%
cases:1.65%
controls:0.05%
cases:2.17%
controls:0.14%
cases:0.86%
controls:0.23%
18
22
2648
26611
38
26
2633
26649
32
13
2639
26662
26
0
2645
26675
43
12
2558
26589
50
35
2254
25588
15
47
1731
20429
Secondary malignant neoplasm of liver and intrahepatic bile duct
C78.7 [45595688]
2.1e+00
2.7e+00
3.2e+00
1.0e+50
3.6e+00
2.8e+00
1.3e+00
cases:0.68%
controls:0.08%
cases:1.42%
controls:0.10%
cases:1.20%
controls:0.05%
cases:0.97%
controls:0.00%
cases:1.65%
controls:0.05%
cases:2.17%
controls:0.14%
cases:0.86%
controls:0.23%
18
22
2648
26611
38
26
2633
26649
32
13
2639
26662
26
0
2645
26675
43
12
2558
26589
50
35
2254
25588
15
47
1731
20429
Metastasis to intrahepatic bile ducts
OMOP5031661 [35226180]
2.1e+00
2.7e+00
3.2e+00
1.0e+50
3.6e+00
2.8e+00
1.3e+00
cases:0.68%
controls:0.08%
cases:1.42%
controls:0.10%
cases:1.20%
controls:0.05%
cases:0.97%
controls:0.00%
cases:1.65%
controls:0.05%
cases:2.17%
controls:0.14%
cases:0.86%
controls:0.23%
18
22
2648
26611
38
26
2633
26649
32
13
2639
26662
26
0
2645
26675
43
12
2558
26589
50
35
2254
25588
15
47
1731
20429
Glucose [Moles/volume] in Serum or Plasma
14749-6 [3013826]
5.0e-01
1.2e+00
2.8e+00
6.1e+00
2.6e+00
1.4e+00
9.4e-01
cases:23.14%
controls:15.38%
cases:21.56%
controls:7.53%
cases:15.39%
controls:1.07%
cases:14.60%
controls:0.04%
cases:13.15%
controls:1.06%
cases:25.26%
controls:7.35%
cases:37.63%
controls:19.11%
617
4096
2049
22537
576
2008
2095
24667
411
286
2260
26389
390
10
2281
26665
342
282
2259
26319
582
1883
1722
23740
657
3912
1089
16564
Extensive MRI examination of upper part of abdomen with high intensity magnet
JN1CG [2001305527]
2.7e+00
4.1e+00
—
1.0e+50
1.0e+50
4.3e+00
4.6e+00
cases:2.14%
controls:0.15%
cases:2.73%
controls:0.04%
—
—
cases:1.57%
controls:0.00%
cases:1.00%
controls:0.00%
cases:2.17%
controls:0.03%
cases:6.93%
controls:0.08%
57
39
2609
26594
73
12
2598
26663
—
42
0
2629
26675
26
0
2575
26601
50
8
2254
25615
121
16
1625
20460
INR in Blood by Coagulation assay
34714-6 [3032080]
7.5e-01
1.5e+00
2.3e+00
5.0e+00
2.8e+00
1.8e+00
1.3e+00
cases:24.42%
controls:13.25%
cases:26.32%
controls:7.66%
cases:21.56%
controls:2.67%
cases:18.35%
controls:0.15%
cases:30.64%
controls:2.61%
cases:32.90%
controls:7.23%
cases:39.92%
controls:14.79%
651
3528
2015
23105
703
2043
1968
24632
576
713
2095
25962
490
40
2181
26635
797
695
1804
25906
758
1853
1546
23770
697
3029
1049
17447
Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
72493-0 [43055120]
1.4e+00
2.4e+00
3.2e+00
1.0e+50
3.9e+00
2.5e+00
2.2e+00
cases:1.54%
controls:0.38%
cases:2.28%
controls:0.22%
cases:1.05%
controls:0.04%
cases:0.22%
controls:0.00%
cases:1.77%
controls:0.04%
cases:2.34%
controls:0.20%
cases:3.72%
controls:0.43%
41
100
2625
26533
61
59
2610
26616
28
12
2643
26663
6
0
2665
26675
46
10
2555
26591
54
51
2250
25572
65
89
1681
20387
Ulcerative (chronic) ileocolitis
K51.1 [45755436]
3.1e+00
3.8e+00
—
1.0e+50
—
4.0e+00
4.6e+00
cases:1.46%
controls:0.07%
cases:1.31%
controls:0.03%
—
—
cases:0.56%
controls:0.00%
—
—
cases:1.43%
controls:0.03%
cases:3.26%
controls:0.03%
39
18
2627
26615
35
8
2636
26667
—
15
0
2656
26675
—
33
7
2271
25616
57
7
1689
20469
Palliative care
Z51.5 [45547323]
1.4e+00
1.6e+00
2.1e+00
4.1e+00
3.2e+00
2.0e+00
9.8e-01
cases:0.38%
controls:0.09%
cases:1.31%
controls:0.26%
cases:1.05%
controls:0.13%
cases:1.09%
controls:0.02%
cases:2.92%
controls:0.13%
cases:4.12%
controls:0.58%
cases:3.44%
controls:1.32%
10
24
2656
26609
35
69
2636
26606
28
35
2643
26640
29
5
2642
26670
76
34
2525
26567
95
149
2209
25474
60
270
1686
20206
Other ulcerative colitis
K51.8 [45586720]
2.6e+00
2.9e+00
2.8e+00
1.0e+50
—
3.4e+00
3.3e+00
cases:1.73%
controls:0.14%
cases:1.50%
controls:0.08%
cases:0.45%
controls:0.03%
cases:1.05%
controls:0.00%
—
—
cases:2.47%
controls:0.08%
cases:4.30%
controls:0.16%
46
36
2620
26597
40
22
2631
26653
12
7
2659
26668
28
0
2643
26675
—
57
21
2247
25602
75
33
1671
20443
granisetron; oral, parenteral, transdermal
A04AA02 [21600494]
1.4e+00
2.6e+00
3.0e+00
—
3.3e+00
3.0e+00
1.8e+00
cases:1.88%
controls:0.48%
cases:3.67%
controls:0.28%
cases:0.82%
controls:0.04%
—
—
cases:1.08%
controls:0.04%
cases:4.30%
controls:0.22%
cases:2.00%
controls:0.35%
50
129
2616
26504
98
74
2573
26601
22
11
2649
26664
—
28
11
2573
26590
99
57
2205
25566
35
71
1711
20405
Primary biliary cirrhosis
K74.3 [45557676]
3.3e+00
3.7e+00
—
1.0e+50
—
4.0e+00
3.9e+00
cases:1.28%
controls:0.05%
cases:1.24%
controls:0.03%
—
—
cases:0.22%
controls:0.00%
—
—
cases:1.87%
controls:0.04%
cases:2.46%
controls:0.05%
34
13
2632
26620
33
8
2638
26667
—
6
0
2665
26675
—
43
9
2261
25614
43
11
1703
20465
MRI examination of upper part of abodmen with high intensity magnet
JN1BG [2001305523]
3.3e+00
3.8e+00
1.0e+50
1.0e+50
—
4.2e+00
3.6e+00
cases:0.68%
controls:0.03%
cases:0.86%
controls:0.02%
cases:0.34%
controls:0.00%
cases:0.86%
controls:0.00%
—
—
cases:1.26%
controls:0.02%
cases:2.69%
controls:0.08%
18
7
2648
26626
23
5
2648
26670
9
0
2662
26675
23
0
2648
26675
—
29
5
2275
25618
47
16
1699
20460
IgG subclass 4 [Mass/volume] in Serum
2469-5 [3024980]
2.4e+00
3.8e+00
—
1.0e+50
—
4.5e+00
4.2e+00
cases:2.10%
controls:0.20%
cases:3.41%
controls:0.08%
—
—
cases:0.82%
controls:0.00%
—
—
cases:5.95%
controls:0.07%
cases:10.82%
controls:0.19%
56
52
2610
26581
91
22
2580
26653
—
22
0
2649
26675
—
137
18
2167
25605
189
39
1557
20437
Multidisciplinary treatment meeting
WZC20 [2001310890]
1.2e+00
2.3e+00
3.2e+00
—
3.7e+00
2.6e+00
1.9e+00
cases:1.88%
controls:0.58%
cases:2.62%
controls:0.27%
cases:0.79%
controls:0.03%
—
—
cases:1.35%
controls:0.03%
cases:2.47%
controls:0.19%
cases:2.98%
controls:0.48%
50
154
2616
26479
70
73
2601
26602
21
9
2650
26666
—
35
9
2566
26592
57
49
2247
25574
52
98
1694
20378
Demanding cystostatic therapy of methastized malignancy
WD125 [2001310680]
1.9e+00
2.7e+00
2.6e+00
—
2.5e+00
2.9e+00
2.0e+00
cases:1.69%
controls:0.24%
cases:3.67%
controls:0.24%
cases:1.35%
controls:0.10%
—
—
cases:1.15%
controls:0.10%
cases:4.08%
controls:0.23%
cases:2.18%
controls:0.31%
45
65
2621
26568
98
65
2573
26610
36
26
2635
26649
—
30
26
2571
26575
94
60
2210
25563
38
64
1708
20412
azathioprine; oral, parenteral
L04AX01 [21603927]
2.4e+00
2.3e+00
2.0e+00
—
2.5e+00
2.6e+00
2.8e+00
cases:5.18%
controls:0.51%
cases:4.12%
controls:0.42%
cases:0.97%
controls:0.14%
—
—
cases:1.38%
controls:0.11%
cases:5.51%
controls:0.43%
cases:8.13%
controls:0.52%
138
137
2528
26496
110
111
2561
26564
26
37
2645
26638
—
36
30
2565
26571
127
109
2177
25514
142
106
1604
20370
Tacrolimus [Mass/volume] in Blood
11253-2 [3026250]
1.9e+00
2.2e+00
2.5e+00
—
3.1e+00
2.2e+00
2.7e+00
cases:0.64%
controls:0.10%
cases:0.82%
controls:0.09%
cases:0.41%
controls:0.03%
—
—
cases:0.73%
controls:0.03%
cases:1.13%
controls:0.12%
cases:2.23%
controls:0.15%
17
26
2649
26607
22
24
2649
26651
11
9
2660
26666
—
19
9
2582
26592
26
32
2278
25591
39
31
1707
20445
levofloxacin; inhalant, oral, parenteral
J01MA12 [21603019]
1.1e+00
1.7e+00
3.2e+00
—
4.9e+00
2.2e+00
1.5e+00
cases:6.38%
controls:2.14%
cases:4.68%
controls:0.85%
cases:2.06%
controls:0.09%
—
—
cases:11.23%
controls:0.10%
cases:6.90%
controls:0.85%
cases:11.51%
controls:2.76%
170
571
2496
26062
125
226
2546
26449
55
23
2616
26652
—
292
26
2309
26575
159
219
2145
25404
201
566
1545
19910
tacrolimus; oral, parenteral
L04AD02 [21603925]
2.0e+00
2.2e+00
2.7e+00
—
2.3e+00
2.3e+00
2.9e+00
cases:0.79%
controls:0.11%
cases:1.05%
controls:0.12%
cases:0.64%
controls:0.04%
—
—
cases:0.35%
controls:0.03%
cases:1.56%
controls:0.15%
cases:2.58%
controls:0.15%
21
29
2645
26604
28
31
2643
26644
17
11
2654
26664
—
9
9
2592
26592
36
39
2268
25584
45
30
1701
20446
Ileoscopy through colon
UJF30 [2001305028]
1.3e+00
2.2e+00
2.7e+00
1.0e+50
2.5e+00
3.1e+00
2.7e+00
cases:4.73%
controls:1.36%
cases:3.48%
controls:0.40%
cases:0.56%
controls:0.04%
cases:0.41%
controls:0.00%
cases:0.62%
controls:0.05%
cases:6.81%
controls:0.34%
cases:13.80%
controls:1.07%
126
363
2540
26270
93
106
2578
26569
15
10
2656
26665
11
0
2660
26675
16
13
2585
26588
157
86
2147
25537
241
220
1505
20256
Fever, unspecified
R50.9 [45582716]
9.7e-01
2.2e+00
4.0e+00
1.0e+50
3.2e+00
2.4e+00
1.7e+00
cases:4.61%
controls:1.79%
cases:5.20%
controls:0.60%
cases:3.18%
controls:0.06%
cases:3.44%
controls:0.00%
cases:1.92%
controls:0.08%
cases:6.60%
controls:0.63%
cases:9.97%
controls:2.00%
123
478
2543
26155
139
159
2532
26516
85
16
2586
26659
92
0
2579
26675
50
22
2551
26579
152
161
2152
25462
174
410
1572
20066
Neoplasm of uncertain or unknown behaviour: Liver, gallbladder and bile ducts
D37.6 [45586102]
3.2e+00
4.6e+00
—
1.0e+50
—
4.1e+00
2.5e+00
cases:0.98%
controls:0.04%
cases:1.83%
controls:0.02%
—
—
cases:1.09%
controls:0.00%
—
—
cases:1.69%
controls:0.03%
cases:1.03%
controls:0.09%
26
11
2640
26622
49
5
2622
26670
—
29
0
2642
26675
—
39
7
2265
25616
18
18
1728
20458
Inpatient Visit
IP [9201]
5.6e-01
1.0e+00
2.2e+00
5.3e+00
2.9e+00
1.5e+00
7.2e-01
cases:12.90%
controls:7.78%
cases:10.03%
controls:3.81%
cases:4.46%
controls:0.50%
cases:4.87%
controls:0.03%
cases:7.69%
controls:0.45%
cases:13.59%
controls:3.48%
cases:18.27%
controls:9.82%
344
2073
2322
24560
268
1015
2403
25660
119
134
2552
26541
130
7
2541
26668
200
121
2401
26480
313
892
1991
24731
319
2010
1427
18466
Malignant tumour
130 [2001600128]
1.8e+00
2.4e+00
3.6e+00
—
3.6e+00
2.7e+00
6.7e-01
cases:3.71%
controls:0.61%
cases:4.38%
controls:0.40%
cases:1.05%
controls:0.03%
—
—
cases:1.54%
controls:0.04%
cases:3.43%
controls:0.25%
cases:1.55%
controls:0.80%
99
163
2567
26470
117
106
2554
26569
28
8
2643
26667
—
40
11
2561
26590
79
64
2225
25559
27
163
1719
20313
ciclosporin; oral, parenteral
L04AD01 [21603924]
2.0e+00
2.2e+00
2.1e+00
—
2.6e+00
2.5e+00
2.7e+00
cases:1.88%
controls:0.26%
cases:1.87%
controls:0.22%
cases:0.67%
controls:0.08%
—
—
cases:0.62%
controls:0.05%
cases:2.34%
controls:0.19%
cases:3.44%
controls:0.23%
50
70
2616
26563
50
58
2621
26617
18
22
2653
26653
—
16
12
2585
26589
54
49
2250
25574
60
48
1686
20428
Nuclear Ab [Titer] in Serum
29953-7 [3037522]
1.1e+00
2.2e+00
4.0e+00
—
2.9e+00
2.1e+00
1.9e+00
cases:6.83%
controls:2.49%
cases:6.89%
controls:0.85%
cases:3.41%
controls:0.06%
—
—
cases:1.73%
controls:0.09%
cases:5.90%
controls:0.80%
cases:13.97%
controls:2.42%
182
662
2484
25971
184
226
2487
26449
91
17
2580
26658
—
45
25
2556
26576
136
205
2168
25418
244
495
1502
19981
Smooth muscle Ab [Titer] in Serum
8095-2 [3007566]
2.4e+00
4.2e+00
—
1.0e+50
—
3.8e+00
3.6e+00
cases:4.20%
controls:0.39%
cases:6.66%
controls:0.11%
—
—
cases:0.86%
controls:0.00%
—
—
cases:5.34%
controls:0.12%
cases:11.63%
controls:0.36%
112
103
2554
26530
178
29
2493
26646
—
23
0
2648
26675
—
123
31
2181
25592
203
74
1543
20402
Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma
1825-9 [3026285]
2.4e+00
3.4e+00
—
—
3.4e+00
2.7e+00
2.2e+00
cases:2.06%
controls:0.20%
cases:2.73%
controls:0.10%
—
—
—
—
cases:0.58%
controls:0.02%
cases:0.74%
controls:0.05%
cases:1.66%
controls:0.19%
55
53
2611
26580
73
26
2598
26649
—
—
15
5
2586
26596
17
13
2287
25610
29
38
1717
20438
Office Visit
OMOP4822458 [581477]
5.6e-01
1.3e+00
2.1e+00
4.3e+00
3.3e+00
1.5e+00
8.6e-01
cases:14.55%
controls:8.86%
cases:8.16%
controls:2.32%
cases:2.55%
controls:0.31%
cases:1.57%
controls:0.02%
cases:6.07%
controls:0.23%
cases:8.72%
controls:2.01%
cases:12.94%
controls:5.90%
388
2359
2278
24274
218
618
2453
26057
68
82
2603
26593
42
6
2629
26669
158
61
2443
26540
201
516
2103
25107
226
1209
1520
19267
Emergency Medicine
93 [38004510]
4.6e-01
9.9e-01
2.5e+00
6.5e+00
2.1e+00
9.6e-01
4.8e-01
cases:23.56%
controls:16.27%
cases:21.30%
controls:9.11%
cases:14.38%
controls:1.33%
cases:24.93%
controls:0.05%
cases:8.65%
controls:1.19%
cases:21.53%
controls:9.49%
cases:34.65%
controls:24.77%
628
4332
2038
22301
569
2429
2102
24246
384
354
2287
26321
666
13
2005
26662
225
316
2376
26285
496
2431
1808
23192
605
5072
1141
15404
Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
54067-4 [3051552]
1.3e+00
2.1e+00
3.1e+00
1.0e+50
3.9e+00
2.0e+00
1.6e+00
cases:4.13%
controls:1.22%
cases:3.67%
controls:0.45%
cases:1.01%
controls:0.04%
cases:0.37%
controls:0.00%
cases:2.58%
controls:0.05%
cases:3.86%
controls:0.53%
cases:7.45%
controls:1.65%
110
324
2556
26309
98
120
2573
26555
27
12
2644
26663
10
0
2661
26675
67
14
2534
26587
89
137
2215
25486
130
338
1616
20138
Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum
32787-4 [3043453]
1.7e+00
3.9e+00
1.0e+50
—
1.0e+50
4.1e+00
4.3e+00
cases:0.94%
controls:0.17%
cases:1.80%
controls:0.04%
cases:0.94%
controls:0.00%
—
—
cases:0.27%
controls:0.00%
cases:1.82%
controls:0.03%
cases:6.24%
controls:0.09%
25
44
2641
26589
48
10
2623
26665
25
0
2646
26675
—
7
0
2594
26601
42
8
2262
25615
109
19
1637
20457
Neutrophil cytoplasmic Ab.classic [Titer] in Serum
32708-0 [3046294]
1.7e+00
3.9e+00
1.0e+50
—
1.0e+50
4.1e+00
4.3e+00
cases:0.94%
controls:0.17%
cases:1.80%
controls:0.04%
cases:0.94%
controls:0.00%
—
—
cases:0.27%
controls:0.00%
cases:1.82%
controls:0.03%
cases:6.24%
controls:0.09%
25
44
2641
26589
48
10
2623
26665
25
0
2646
26675
—
7
0
2594
26601
42
8
2262
25615
109
19
1637
20457
Internal Medicine
11 [38004456]
8.2e-01
1.3e+00
2.0e+00
5.5e+00
1.9e+00
1.4e+00
1.1e+00
cases:41.07%
controls:23.41%
cases:26.39%
controls:9.03%
cases:10.26%
controls:1.55%
cases:14.00%
controls:0.07%
cases:9.61%
controls:1.49%
cases:27.69%
controls:9.02%
cases:42.15%
controls:19.88%
1095
6235
1571
20398
705
2410
1966
24265
274
414
2397
26261
374
18
2297
26657
250
397
2351
26204
638
2310
1666
23313
736
4070
1010
16406
cycloSPORINE [Mass/volume] in Blood
3520-4 [3010375]
1.9e+00
1.9e+00
2.5e+00
—
3.0e+00
2.2e+00
2.5e+00
cases:0.86%
controls:0.14%
cases:0.90%
controls:0.13%
cases:0.64%
controls:0.05%
—
—
cases:0.81%
controls:0.04%
cases:1.17%
controls:0.13%
cases:1.78%
controls:0.15%
23
36
2643
26597
24
36
2647
26639
17
14
2654
26661
—
21
11
2580
26590
27
34
2277
25589
31
31
1715
20445
Mitochondria Ab [Titer] in Serum
20483-4 [3034770]
2.4e+00
4.1e+00
—
1.0e+50
—
3.8e+00
3.5e+00
cases:4.24%
controls:0.39%
cases:6.66%
controls:0.12%
—
—
cases:0.82%
controls:0.00%
—
—
cases:4.99%
controls:0.11%
cases:11.40%
controls:0.38%
113
105
2553
26528
178
31
2493
26644
—
22
0
2649
26675
—
115
29
2189
25594
199
77
1547
20399
Intravenous general anesthesia
WX404 [2001310807]
6.0e-01
1.6e+00
2.8e+00
1.0e+50
3.6e+00
2.8e+00
2.3e+00
cases:5.48%
controls:3.09%
cases:3.63%
controls:0.78%
cases:1.50%
controls:0.09%
cases:3.26%
controls:0.00%
cases:2.04%
controls:0.06%
cases:6.21%
controls:0.39%
cases:10.42%
controls:1.19%
146
822
2520
25811
97
207
2574
26468
40
24
2631
26651
87
0
2584
26675
53
15
2548
26586
143
99
2161
25524
182
244
1564
20232
budesonide; oral, sublingual
A07EA06 [21600658]
1.8e+00
2.4e+00
1.8e+00
—
2.6e+00
2.5e+00
2.5e+00
cases:2.74%
controls:0.47%
cases:2.28%
controls:0.22%
cases:0.45%
controls:0.07%
—
—
cases:0.69%
controls:0.05%
cases:3.04%
controls:0.25%
cases:5.73%
controls:0.47%
73
126
2593
26507
61
59
2610
26616
12
20
2659
26655
—
18
14
2583
26587
70
65
2234
25558
100
97
1646
20379
Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1920-8 [3013721]
8.2e-01
1.9e+00
3.3e+00
—
3.8e+00
2.2e+00
1.5e+00
cases:15.15%
controls:7.27%
cases:18.20%
controls:3.29%
cases:12.17%
controls:0.49%
—
—
cases:17.22%
controls:0.45%
cases:21.96%
controls:3.11%
cases:30.64%
controls:8.78%
404
1936
2262
24697
486
878
2185
25797
325
131
2346
26544
—
448
119
2153
26482
506
798
1798
24825
535
1797
1211
18679
C reactive protein [Mass/volume] in Serum or Plasma
1988-5 [3020460]
3.1e-01
9.8e-01
2.4e+00
5.2e+00
2.9e+00
1.1e+00
5.8e-01
cases:41.90%
controls:34.58%
cases:43.39%
controls:22.31%
cases:34.33%
controls:4.63%
cases:38.41%
controls:0.34%
cases:45.33%
controls:4.38%
cases:46.48%
controls:22.58%
cases:57.73%
controls:43.45%
1117
9210
1549
17423
1159
5951
1512
20724
917
1234
1754
25441
1026
92
1645
26583
1179
1165
1422
25436
1071
5786
1233
19837
1008
8896
738
11580
Oesophageal varices without bleeding
I85.9 [45581834]
3.1e+00
3.6e+00
—
1.0e+50
—
3.3e+00
3.5e+00
cases:0.79%
controls:0.04%
cases:0.79%
controls:0.02%
—
—
cases:0.19%
controls:0.00%
—
—
cases:0.82%
controls:0.03%
cases:2.06%
controls:0.06%
21
10
2645
26623
21
6
2650
26669
—
5
0
2666
26675
—
19
8
2285
25615
36
13
1710
20463
Elastase.pancreatic [Mass/mass] in Stool
25907-7 [3000570]
1.6e+00
2.9e+00
3.7e+00
—
—
3.3e+00
1.9e+00
cases:2.03%
controls:0.42%
cases:2.43%
controls:0.14%
cases:0.75%
controls:0.02%
—
—
—
—
cases:3.73%
controls:0.15%
cases:3.44%
controls:0.54%
54
112
2612
26521
65
38
2606
26637
20
5
2651
26670
—
—
86
38
2218
25585
60
110
1686
20366
Extensive abdominal CT
JN3BD [2001305556]
1.6e+00
2.7e+00
—
—
4.2e+00
2.7e+00
2.1e+00
cases:4.95%
controls:1.09%
cases:4.12%
controls:0.28%
—
—
—
—
cases:1.42%
controls:0.02%
cases:2.86%
controls:0.21%
cases:5.44%
controls:0.69%
132
291
2534
26342
110
74
2561
26601
—
—
37
6
2564
26595
66
53
2238
25570
95
142
1651
20334
Prothrombin time (PT) actual/Normal
5894-1 [3033658]
6.8e-01
1.7e+00
3.3e+00
—
3.7e+00
2.2e+00
1.5e+00
cases:11.44%
controls:6.17%
cases:14.08%
controls:2.92%
cases:10.75%
controls:0.44%
—
—
cases:15.22%
controls:0.42%
cases:19.49%
controls:2.63%
cases:25.43%
controls:6.84%
305
1643
2361
24990
376
779
2295
25896
287
117
2384
26558
—
396
112
2205
26489
449
674
1855
24949
444
1401
1302
19075
Polycystic kidney, autosomal dominant
Q61.2 [45558415]
2.6e+00
2.7e+00
2.5e+00
1.0e+50
—
2.9e+00
2.4e+00
cases:0.60%
controls:0.05%
cases:0.52%
controls:0.03%
cases:0.22%
controls:0.02%
cases:0.22%
controls:0.00%
—
—
cases:0.56%
controls:0.03%
cases:0.63%
controls:0.06%
16
12
2650
26621
14
9
2657
26666
6
5
2665
26670
6
0
2665
26675
—
13
8
2291
25615
11
12
1735
20464
Urea [Moles/volume] in Serum or Plasma
22664-7 [3020779]
9.1e-01
1.3e+00
2.0e+00
3.1e+00
2.7e+00
1.7e+00
1.3e+00
cases:4.80%
controls:1.99%
cases:4.34%
controls:1.17%
cases:1.95%
controls:0.27%
cases:0.41%
controls:0.02%
cases:3.58%
controls:0.26%
cases:7.12%
controls:1.33%
cases:8.71%
controls:2.51%
128
531
2538
26102
116
312
2555
26363
52
71
2619
26604
11
5
2660
26670
93
68
2508
26533
164
342
2140
25281
152
513
1594
19963
Troponin T.cardiac [Mass/volume] in Serum or Plasma
6598-7 [3019800]
4.9e-01
9.2e-01
2.5e+00
5.4e+00
2.4e+00
9.4e-01
4.9e-01
cases:15.04%
controls:9.78%
cases:10.75%
controls:4.59%
cases:6.89%
controls:0.63%
cases:10.52%
controls:0.05%
cases:6.04%
controls:0.61%
cases:10.98%
controls:4.61%
cases:18.84%
controls:12.49%
401
2605
2265
24028
287
1225
2384
25450
184
167
2487
26508
281
14
2390
26661
157
161
2444
26440
253
1182
2051
24441
329
2558
1417
17918
oxycodone; oral, parenteral
N02AA05 [21604260]
1.1e+00
1.8e+00
2.5e+00
2.0e+00
2.7e+00
2.0e+00
9.2e-01
cases:4.95%
controls:1.76%
cases:7.23%
controls:1.26%
cases:4.83%
controls:0.40%
cases:0.22%
controls:0.03%
cases:5.96%
controls:0.42%
cases:9.64%
controls:1.43%
cases:8.59%
controls:3.61%
132
468
2534
26165
193
336
2478
26339
129
107
2542
26568
6
8
2665
26667
155
111
2446
26490
222
367
2082
25256
150
739
1596
19737
Bacterial infection, unspecified
A49.9 [45590816]
1.1e+00
1.9e+00
3.5e+00
—
3.1e+00
2.3e+00
1.2e+00
cases:3.49%
controls:1.23%
cases:4.34%
controls:0.64%
cases:2.70%
controls:0.09%
—
—
cases:1.85%
controls:0.09%
cases:5.56%
controls:0.60%
cases:5.78%
controls:1.80%
93
328
2573
26305
116
172
2555
26503
72
23
2599
26652
—
48
23
2553
26578
128
153
2176
25470
101
368
1645
20108
Other and unspecified abdominal pain
R10.4 [45568113]
1.1e+00
2.1e+00
3.4e+00
—
3.2e+00
1.9e+00
1.3e+00
cases:13.17%
controls:4.69%
cases:11.31%
controls:1.55%
cases:6.18%
controls:0.21%
—
—
cases:3.27%
controls:0.13%
cases:8.25%
controls:1.39%
cases:15.46%
controls:4.78%
351
1250
2315
25383
302
414
2369
26261
165
57
2506
26618
—
85
35
2516
26566
190
356
2114
25267
270
978
1476
19498
Epithelial cells [#/volume] in Urine
30383-4 [3000850]
3.8e-01
9.7e-01
2.1e+00
5.7e+00
1.8e+00
1.3e+00
8.2e-01
cases:7.58%
controls:5.33%
cases:6.25%
controls:2.46%
cases:3.03%
controls:0.39%
cases:5.28%
controls:0.02%
cases:1.92%
controls:0.32%
cases:7.64%
controls:2.28%
cases:12.71%
controls:6.05%
202
1420
2464
25213
167
656
2504
26019
81
105
2590
26570
141
5
2530
26670
50
85
2551
26516
176
583
2128
25040
222
1239
1524
19237
Very extensive body CT
JN4CD [2001310902]
1.4e+00
3.1e+00
—
1.0e+50
3.1e+00
2.9e+00
2.5e+00
cases:1.69%
controls:0.41%
cases:1.72%
controls:0.08%
—
—
cases:0.60%
controls:0.00%
cases:0.50%
controls:0.02%
cases:1.39%
controls:0.08%
cases:1.26%
controls:0.11%
45
110
2621
26523
46
21
2625
26654
—
16
0
2655
26675
13
6
2588
26595
32
20
2272
25603
22
22
1724
20454
Repeated or continuing anesthesia shots throug a catheter
WX602 [2001310813]
1.3e+00
1.8e+00
2.5e+00
—
3.3e+00
2.6e+00
1.4e+00
cases:2.70%
controls:0.79%
cases:1.57%
controls:0.25%
cases:0.52%
controls:0.04%
—
—
cases:0.50%
controls:0.02%
cases:2.34%
controls:0.17%
cases:2.35%
controls:0.61%
72
210
2594
26423
42
67
2629
26608
14
11
2657
26664
—
13
5
2588
26596
54
44
2250
25579
41
124
1705
20352
capecitabine
L01BC06 [21601440]
1.4e+00
2.4e+00
2.3e+00
—
2.0e+00
2.9e+00
1.9e+00
cases:1.24%
controls:0.31%
cases:1.95%
controls:0.18%
cases:0.37%
controls:0.04%
—
—
cases:0.38%
controls:0.05%
cases:2.95%
controls:0.16%
cases:1.72%
controls:0.27%
33
82
2633
26551
52
47
2619
26628
10
10
2661
26665
—
10
14
2591
26587
68
41
2236
25582
30
55
1716
20421
Pediatric Gastroenterology
OMOP4822029 [45756810]
2.8e+00
3.3e+00
—
1.0e+50
—
3.4e+00
3.4e+00
cases:1.01%
controls:0.06%
cases:1.01%
controls:0.04%
—
—
cases:0.60%
controls:0.00%
—
—
cases:1.22%
controls:0.04%
cases:1.66%
controls:0.05%
27
17
2639
26616
27
10
2644
26665
—
16
0
2655
26675
—
28
11
2276
25612
29
11
1717
20465
Phosphatidylethanol [Mass/volume] in Blood
74661-0 [44816559]
1.4e+00
2.1e+00
3.1e+00
—
3.5e+00
1.6e+00
9.9e-01
cases:1.13%
controls:0.27%
cases:1.57%
controls:0.19%
cases:0.75%
controls:0.03%
—
—
cases:0.73%
controls:0.02%
cases:1.39%
controls:0.27%
cases:2.92%
controls:1.10%
30
72
2636
26561
42
50
2629
26625
20
9
2651
26666
—
19
6
2582
26595
32
70
2272
25553
51
226
1695
20250
Thoracal epidural anesthesia
WX302 [2001310795]
1.8e+00
2.5e+00
2.8e+00
1.0e+50
—
3.7e+00
1.8e+00
cases:2.81%
controls:0.46%
cases:2.06%
controls:0.16%
cases:0.56%
controls:0.03%
cases:0.30%
controls:0.00%
—
—
cases:3.04%
controls:0.07%
cases:2.06%
controls:0.35%
75
122
2591
26511
55
44
2616
26631
15
9
2656
26666
8
0
2663
26675
—
70
19
2234
25604
36
71
1710
20405
Calprotectin [Mass/mass] in Stool
38445-3 [3048689]
1.0e+00
1.9e+00
3.2e+00
—
2.6e+00
2.0e+00
1.9e+00
cases:6.38%
controls:2.43%
cases:6.89%
controls:1.04%
cases:3.07%
controls:0.13%
—
—
cases:1.85%
controls:0.14%
cases:7.94%
controls:1.13%
cases:17.01%
controls:3.03%
170
646
2496
25987
184
278
2487
26397
82
34
2589
26641
—
48
37
2553
26564
183
290
2121
25333
297
620
1449
19856
Hepatitis E virus IgM Ab [Presence] in Serum
14212-5 [3002222]
2.9e+00
4.1e+00
1.0e+50
—
1.0e+50
3.0e+00
2.7e+00
cases:1.13%
controls:0.06%
cases:1.76%
controls:0.03%
cases:0.52%
controls:0.00%
—
—
cases:0.69%
controls:0.00%
cases:0.52%
controls:0.03%
cases:1.20%
controls:0.08%
30
17
2636
26616
47
8
2624
26667
14
0
2657
26675
—
18
0
2583
26601
12
7
2292
25616
21
16
1725
20460
Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
49693-5 [3029023]
2.9e+00
4.1e+00
1.0e+50
—
1.0e+50
3.0e+00
2.7e+00
cases:1.13%
controls:0.06%
cases:1.76%
controls:0.03%
cases:0.52%
controls:0.00%
—
—
cases:0.69%
controls:0.00%
cases:0.52%
controls:0.03%
cases:1.20%
controls:0.08%
30
17
2636
26616
47
8
2624
26667
14
0
2657
26675
—
18
0
2583
26601
12
7
2292
25616
21
16
1725
20460
Neutrophils [#/volume] in Blood by Automated count
751-8 [3013650]
4.7e-01
1.1e+00
2.0e+00
4.6e+00
2.2e+00
1.2e+00
1.0e+00
cases:22.06%
controls:15.05%
cases:24.11%
controls:9.57%
cases:14.90%
controls:2.31%
cases:9.62%
controls:0.11%
cases:16.22%
controls:2.10%
cases:26.09%
controls:9.27%
cases:37.86%
controls:17.77%
588
4009
2078
22624
644
2552
2027
24123
398
615
2273
26060
257
29
2414
26646
422
558
2179
26043
601
2376
1703
23247
661
3638
1085
16838
General anaesthesia
WX402 [2001310806]
7.3e-01
1.6e+00
3.1e+00
—
3.4e+00
2.3e+00
1.4e+00
cases:4.80%
controls:2.36%
cases:5.95%
controls:1.22%
cases:2.28%
controls:0.11%
—
—
cases:4.15%
controls:0.14%
cases:9.85%
controls:1.06%
cases:13.17%
controls:3.47%
128
629
2538
26004
159
326
2512
26349
61
29
2610
26646
—
108
37
2493
26564
227
272
2077
25351
230
711
1516
19765
Erythrocytes [#/volume] in Urine
30391-7 [3002582]
3.3e-01
9.9e-01
2.2e+00
5.6e+00
1.8e+00
1.1e+00
5.7e-01
cases:10.73%
controls:7.96%
cases:10.97%
controls:4.37%
cases:5.47%
controls:0.65%
cases:8.54%
controls:0.03%
cases:3.73%
controls:0.64%
cases:12.15%
controls:4.31%
cases:17.93%
controls:10.99%
286
2120
2380
24513
293
1166
2378
25509
146
174
2525
26501
228
9
2443
26666
97
169
2504
26432
280
1105
2024
24518
313
2251
1433
18225
Procalcitonin [Mass/volume] in Serum or Plasma
33959-8 [3046279]
1.3e+00
1.5e+00
3.0e+00
—
3.7e+00
2.1e+00
1.1e+00
cases:2.14%
controls:0.62%
cases:1.31%
controls:0.30%
cases:0.75%
controls:0.04%
—
—
cases:2.15%
controls:0.06%
cases:2.43%
controls:0.30%
cases:3.21%
controls:1.11%
57
165
2609
26468
35
81
2636
26594
20
10
2651
26665
—
56
15
2545
26586
56
77
2248
25546
56
228
1690
20248
Casts [#/volume] in Urine by Automated count
51483-6 [3030467]
3.4e-01
1.0e+00
2.2e+00
5.5e+00
1.8e+00
1.1e+00
6.0e-01
cases:9.41%
controls:6.92%
cases:9.62%
controls:3.72%
cases:4.79%
controls:0.55%
cases:7.08%
controls:0.03%
cases:3.11%
controls:0.54%
cases:10.11%
controls:3.75%
cases:15.58%
controls:9.19%
251
1842
2415
24791
257
993
2414
25682
128
148
2543
26527
189
8
2482
26667
81
144
2520
26457
233
960
2071
24663
272
1882
1474
18594
Ulcerative colitis and Crohn's disease
208 [2001600206]
2.7e+00
3.3e+00
—
—
—
4.4e+00
2.1e+00
cases:3.49%
controls:0.24%
cases:1.65%
controls:0.06%
—
—
—
—
—
—
cases:2.13%
controls:0.03%
cases:1.15%
controls:0.14%
93
63
2573
26570
44
17
2627
26658
—
—
—
49
7
2255
25616
20
28
1726
20448
Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1742-6 [3006923]
2.2e-01
7.5e-01
2.2e+00
5.5e+00
2.7e+00
8.4e-01
3.0e-01
cases:45.20%
controls:39.91%
cases:47.47%
controls:30.02%
cases:34.89%
controls:5.41%
cases:34.56%
controls:0.22%
cases:45.10%
controls:5.34%
cases:50.56%
controls:30.58%
cases:59.56%
controls:52.10%
1205
10628
1461
16005
1268
8008
1403
18667
932
1442
1739
25233
923
59
1748
26616
1173
1420
1428
25181
1165
7835
1139
17788
1040
10668
706
9808
Esophagoscopy, gastroscopy and duodenoscopy
UJD10 [2001304788]
1.1e+00
2.0e+00
2.6e+00
—
3.2e+00
2.1e+00
1.5e+00
cases:13.28%
controls:4.64%
cases:8.42%
controls:1.26%
cases:1.76%
controls:0.14%
—
—
cases:2.81%
controls:0.12%
cases:8.38%
controls:1.16%
cases:16.09%
controls:4.05%
354
1236
2312
25397
225
335
2446
26340
47
37
2624
26638
—
73
31
2528
26570
193
297
2111
25326
281
829
1465
19647
Secondary malignant neoplasm of other specified sites
C79.8 [45547524]
1.8e+00
2.1e+00
2.5e+00
—
2.5e+00
2.2e+00
1.4e+00
cases:1.01%
controls:0.17%
cases:1.57%
controls:0.20%
cases:1.31%
controls:0.11%
—
—
cases:1.42%
controls:0.12%
cases:2.13%
controls:0.25%
cases:1.43%
controls:0.36%
27
45
2639
26588
42
53
2629
26622
35
30
2636
26645
—
37
32
2564
26569
49
64
2255
25559
25
73
1721
20403
Oxygen [Partial pressure] in Blood
11556-8 [3027315]
1.1e+00
1.5e+00
2.9e+00
1.0e+50
3.6e+00
1.8e+00
1.6e+00
cases:1.58%
controls:0.54%
cases:0.94%
controls:0.21%
cases:0.41%
controls:0.02%
cases:0.37%
controls:0.00%
cases:0.65%
controls:0.02%
cases:0.95%
controls:0.16%
cases:1.60%
controls:0.34%
42
145
2624
26488
25
57
2646
26618
11
6
2660
26669
10
0
2661
26675
17
5
2584
26596
22
42
2282
25581
28
69
1718
20407
Urinalysis microscopic panel [#/volume] - Urine by Automated count
50554-5 [3029287]
3.7e-01
9.9e-01
2.2e+00
5.2e+00
1.9e+00
1.1e+00
5.9e-01
cases:13.24%
controls:9.51%
cases:11.98%
controls:4.81%
cases:5.54%
controls:0.68%
cases:8.99%
controls:0.05%
cases:4.23%
controls:0.66%
cases:13.32%
controls:4.77%
cases:19.07%
controls:11.59%
353
2532
2313
24101
320
1283
2351
25392
148
181
2523
26494
240
14
2431
26661
110
176
2491
26425
307
1222
1997
24401
333
2373
1413
18103
Carbon dioxide [Partial pressure] in Blood
11557-6 [3013290]
1.1e+00
1.5e+00
2.9e+00
1.0e+50
3.6e+00
1.7e+00
1.6e+00
cases:1.58%
controls:0.54%
cases:0.94%
controls:0.21%
cases:0.41%
controls:0.02%
cases:0.37%
controls:0.00%
cases:0.65%
controls:0.02%
cases:0.95%
controls:0.17%
cases:1.60%
controls:0.34%
42
145
2624
26488
25
57
2646
26618
11
6
2660
26669
10
0
2661
26675
17
5
2584
26596
22
43
2282
25580
28
69
1718
20407
Base excess in Blood by calculation
11555-0 [3012501]
1.1e+00
1.5e+00
2.9e+00
1.0e+50
3.6e+00
1.7e+00
1.6e+00
cases:1.58%
controls:0.54%
cases:0.94%
controls:0.21%
cases:0.41%
controls:0.02%
cases:0.37%
controls:0.00%
cases:0.65%
controls:0.02%
cases:0.95%
controls:0.17%
cases:1.60%
controls:0.34%
42
145
2624
26488
25
57
2646
26618
11
6
2660
26669
10
0
2661
26675
17
5
2584
26596
22
43
2282
25580
28
69
1718
20407
Metastasis
OMOP4998856 [36769180]
1.8e+00
2.1e+00
2.5e+00
—
2.4e+00
2.1e+00
1.4e+00
cases:1.01%
controls:0.17%
cases:1.57%
controls:0.20%
cases:1.31%
controls:0.11%
—
—
cases:1.42%
controls:0.13%
cases:2.13%
controls:0.26%
cases:1.49%
controls:0.38%
27
45
2639
26588
42
53
2629
26622
35
30
2636
26645
—
37
34
2564
26567
49
66
2255
25557
26
77
1720
20399
Crohn disease of large intestine
K50.1 [45601173]
2.7e+00
2.9e+00
—
1.0e+50
—
3.1e+00
3.5e+00
cases:1.54%
controls:0.11%
cases:1.20%
controls:0.06%
—
—
cases:0.64%
controls:0.00%
—
—
cases:1.65%
controls:0.07%
cases:2.98%
controls:0.09%
41
28
2625
26605
32
17
2639
26658
—
17
0
2654
26675
—
38
19
2266
25604
52
19
1694
20457
Bacteria [Presence] in Urine
87829-8 [36304419]
3.4e-01
1.0e+00
2.2e+00
5.4e+00
1.7e+00
1.0e+00
5.5e-01
cases:9.11%
controls:6.67%
cases:8.99%
controls:3.50%
cases:4.53%
controls:0.54%
cases:6.40%
controls:0.03%
cases:2.73%
controls:0.50%
cases:9.38%
controls:3.51%
cases:14.26%
controls:8.72%
243
1776
2423
24857
240
934
2431
25741
121
144
2550
26531
171
8
2500
26667
71
133
2530
26468
216
899
2088
24724
249
1786
1497
18690
Crohn disease, unspecified
K50.9 [45562490]
2.6e+00
3.1e+00
—
1.0e+50
—
3.1e+00
3.3e+00
cases:1.39%
controls:0.11%
cases:1.24%
controls:0.06%
—
—
cases:0.60%
controls:0.00%
—
—
cases:1.39%
controls:0.06%
cases:2.69%
controls:0.10%
37
28
2629
26605
33
15
2638
26660
—
16
0
2655
26675
—
32
16
2272
25607
47
20
1699
20456
Lactate [Moles/volume] in Blood
32693-4 [3047181]
8.8e-01
1.8e+00
3.4e+00
1.0e+50
3.7e+00
1.4e+00
9.4e-01
cases:1.54%
controls:0.64%
cases:1.20%
controls:0.20%
cases:0.67%
controls:0.02%
cases:0.56%
controls:0.00%
cases:0.88%
controls:0.02%
cases:0.95%
controls:0.23%
cases:1.89%
controls:0.75%
41
171
2625
26462
32
54
2639
26621
18
6
2653
26669
15
0
2656
26675
23
6
2578
26595
22
58
2282
25565
33
153
1713
20323
Leukocytes [#/volume] in Urine
30405-5 [3018095]
3.3e-01
9.5e-01
2.1e+00
5.6e+00
1.7e+00
9.9e-01
4.9e-01
cases:11.74%
controls:8.74%
cases:12.21%
controls:5.08%
cases:5.88%
controls:0.78%
cases:8.91%
controls:0.04%
cases:4.15%
controls:0.76%
cases:12.80%
controls:5.17%
cases:19.59%
controls:12.97%
313
2329
2353
24304
326
1355
2345
25320
157
207
2514
26468
238
10
2433
26665
108
202
2493
26399
295
1325
2009
24298
342
2655
1404
17821
Body CT examination
JN4AD [2001310897]
1.3e+00
2.1e+00
3.0e+00
—
2.4e+00
2.1e+00
1.2e+00
cases:3.60%
controls:0.97%
cases:4.83%
controls:0.64%
cases:2.55%
controls:0.12%
—
—
cases:1.19%
controls:0.11%
cases:5.25%
controls:0.68%
cases:5.84%
controls:1.88%
96
259
2570
26374
129
171
2542
26504
68
33
2603
26642
—
31
29
2570
26572
121
175
2183
25448
102
385
1644
20091
Granulocytes/Leukocytes in Blood
30395-8 [3035933]
3.4e-01
1.9e+00
3.0e+00
—
3.2e+00
2.1e+00
1.8e+00
cases:0.75%
controls:0.54%
cases:0.97%
controls:0.14%
cases:0.37%
controls:0.02%
—
—
cases:0.54%
controls:0.02%
cases:0.87%
controls:0.11%
cases:1.72%
controls:0.28%
20
143
2646
26490
26
38
2645
26637
10
5
2661
26670
—
14
6
2587
26595
20
27
2284
25596
30
58
1716
20418
Bacteria [#/volume] in Urine by Automated count
51480-2 [3031040]
3.5e-01
8.0e-01
2.1e+00
5.6e+00
1.7e+00
9.1e-01
5.0e-01
cases:25.43%
controls:19.30%
cases:19.81%
controls:9.96%
cases:11.83%
controls:1.59%
cases:14.90%
controls:0.06%
cases:8.30%
controls:1.65%
cases:21.53%
controls:9.96%
cases:32.99%
controls:22.91%
678
5141
1988
21492
529
2656
2142
24019
316
423
2355
26252
398
17
2273
26658
216
438
2385
26163
496
2551
1808
23072
576
4691
1170
15785
Medical Oncology
90 [38004507]
6.7e-01
1.4e+00
2.2e+00
3.2e+00
2.3e+00
1.6e+00
6.5e-01
cases:8.48%
controls:4.53%
cases:11.23%
controls:3.17%
cases:8.69%
controls:1.06%
cases:3.18%
controls:0.13%
cases:9.77%
controls:1.04%
cases:13.15%
controls:3.03%
cases:8.76%
controls:4.80%
226
1206
2440
25427
300
845
2371
25830
232
283
2439
26392
85
35
2586
26640
254
277
2347
26324
303
777
2001
24846
153
982
1593
19494
Bacteria identified in Isolate by Culture
43409-2 [3042936]
7.8e-01
1.5e+00
2.4e+00
1.0e+50
3.6e+00
2.1e+00
1.6e+00
cases:5.51%
controls:2.62%
cases:4.83%
controls:1.16%
cases:1.24%
controls:0.11%
cases:1.16%
controls:0.00%
cases:3.61%
controls:0.11%
cases:8.12%
controls:1.02%
cases:14.32%
controls:3.27%
147
697
2519
25936
129
310
2542
26365
33
30
2638
26645
31
0
2640
26675
94
28
2507
26573
187
262
2117
25361
250
669
1496
19807
Hepatitis E virus Ab [Presence] in Serum
13294-4 [3006922]
2.6e+00
4.1e+00
1.0e+50
—
1.0e+50
2.9e+00
2.4e+00
cases:1.13%
controls:0.09%
cases:1.98%
controls:0.03%
cases:0.64%
controls:0.00%
—
—
cases:0.92%
controls:0.00%
cases:0.61%
controls:0.04%
cases:1.20%
controls:0.11%
30
23
2636
26610
53
9
2618
26666
17
0
2654
26675
—
24
0
2577
26601
14
9
2290
25614
21
22
1725
20454
Blood type and Crossmatch panel - Blood
34531-4 [3044640]
6.5e-01
1.4e+00
3.0e+00
—
3.8e+00
1.9e+00
1.2e+00
cases:12.72%
controls:7.04%
cases:11.27%
controls:3.01%
cases:7.26%
controls:0.40%
—
—
cases:12.15%
controls:0.30%
cases:15.23%
controls:2.61%
cases:20.39%
controls:7.37%
339
1874
2327
24759
301
804
2370
25871
194
107
2477
26568
—
316
80
2285
26521
351
668
1953
24955
356
1510
1390
18966
Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
3255-7 [3016407]
9.7e-01
2.1e+00
2.3e+00
—
3.0e+00
1.9e+00
1.7e+00
cases:1.35%
controls:0.52%
cases:1.57%
controls:0.20%
cases:0.37%
controls:0.04%
—
—
cases:0.62%
controls:0.03%
cases:1.48%
controls:0.22%
cases:2.58%
controls:0.50%
36
138
2630
26495
42
54
2629
26621
10
10
2661
26665
—
16
8
2585
26593
34
57
2270
25566
45
102
1701
20374
Cathetrisation of vein
TPH04 [2001309597]
8.4e-01
1.5e+00
3.1e+00
—
3.1e+00
2.0e+00
1.3e+00
cases:7.58%
controls:3.41%
cases:5.39%
controls:1.20%
cases:2.40%
controls:0.11%
—
—
cases:2.85%
controls:0.13%
cases:8.25%
controls:1.18%
cases:10.65%
controls:3.26%
202
908
2464
25725
144
321
2527
26354
64
29
2607
26646
—
74
35
2527
26566
190
303
2114
25320
186
667
1560
19809
Elevated level of transaminase and lactic acid dehydrogenase
274774002 [436238]
2.5e+00
4.6e+00
—
1.0e+50
—
3.0e+00
1.8e+00
cases:1.65%
controls:0.14%
cases:2.51%
controls:0.03%
—
—
cases:0.34%
controls:0.00%
—
—
cases:0.87%
controls:0.04%
cases:0.86%
controls:0.15%
44
37
2622
26596
67
7
2604
26668
—
9
0
2662
26675
—
20
11
2284
25612
15
30
1731
20446
Benign neoplasm: Pancreas
D13.6 [45605344]
2.4e+00
3.3e+00
1.0e+50
1.0e+50
1.0e+50
3.4e+00
2.8e+00
cases:0.45%
controls:0.04%
cases:0.60%
controls:0.02%
cases:0.26%
controls:0.00%
cases:0.22%
controls:0.00%
cases:0.23%
controls:0.00%
cases:0.78%
controls:0.03%
cases:0.57%
controls:0.03%
12
11
2654
26622
16
6
2655
26669
7
0
2664
26675
6
0
2665
26675
6
0
2595
26601
18
7
2286
25616
10
7
1736
20469
Hepatitis C virus Ab [Presence] in Serum
16128-1 [3017143]
1.1e+00
2.0e+00
2.9e+00
—
3.4e+00
1.4e+00
1.2e+00
cases:5.44%
controls:1.95%
cases:5.28%
controls:0.78%
cases:1.76%
controls:0.10%
—
—
cases:1.96%
controls:0.07%
cases:2.39%
controls:0.60%
cases:6.19%
controls:2.00%
145
520
2521
26113
141
208
2530
26467
47
27
2624
26648
—
51
18
2550
26583
55
153
2249
25470
108
409
1638
20067
Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
43730-1 [3043849]
1.4e+00
2.3e+00
—
1.0e+50
3.9e+00
2.3e+00
1.9e+00
cases:1.05%
controls:0.27%
cases:1.24%
controls:0.13%
—
—
cases:0.22%
controls:0.00%
cases:1.15%
controls:0.02%
cases:1.52%
controls:0.15%
cases:2.12%
controls:0.32%
28
72
2638
26561
33
34
2638
26641
—
6
0
2665
26675
30
6
2571
26595
35
39
2269
25584
37
66
1709
20410
Multiple cystostatic therapy of methastized malignancy
WD115 [2001310679]
5.8e-01
2.5e+00
2.6e+00
—
2.9e+00
3.7e+00
1.1e+00
cases:0.19%
controls:0.11%
cases:0.75%
controls:0.06%
cases:0.26%
controls:0.02%
—
—
cases:0.35%
controls:0.02%
cases:1.39%
controls:0.04%
cases:0.40%
controls:0.13%
5
28
2661
26605
20
16
2651
26659
7
5
2664
26670
—
9
5
2592
26596
32
9
2272
25614
7
27
1739
20449
Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
1778-0 [3020013]
2.0e+00
3.7e+00
—
—
—
2.5e+00
3.4e+00
cases:0.86%
controls:0.11%
cases:1.09%
controls:0.03%
—
—
—
—
—
—
cases:0.39%
controls:0.03%
cases:1.20%
controls:0.04%
23
30
2643
26603
29
7
2642
26668
—
—
—
9
8
2295
25615
21
8
1725
20468
Cathetrisation of abdominal cavity with ultrasound guidance
JA3AT [2001304536]
3.1e+00
2.7e+00
—
1.0e+50
—
3.4e+00
2.5e+00
cases:0.98%
controls:0.05%
cases:0.64%
controls:0.04%
—
—
cases:0.34%
controls:0.00%
—
—
cases:1.09%
controls:0.04%
cases:1.20%
controls:0.10%
26
12
2640
26621
17
11
2654
26664
—
9
0
2662
26675
—
25
9
2279
25614
21
21
1725
20455
Alcoholic cirrhosis of liver
K70.3 [45596343]
2.0e+00
2.1e+00
—
1.0e+50
3.4e+00
2.2e+00
2.0e+00
cases:0.71%
controls:0.10%
cases:0.71%
controls:0.09%
—
—
cases:0.30%
controls:0.00%
cases:0.58%
controls:0.02%
cases:0.78%
controls:0.09%
cases:0.97%
controls:0.14%
19
27
2647
26606
19
23
2652
26652
—
8
0
2663
26675
15
5
2586
26596
18
22
2286
25601
17
28
1729
20448
Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay
3193-0 [3005757]
2.3e+00
3.4e+00
—
—
—
3.1e+00
2.9e+00
cases:0.75%
controls:0.08%
cases:0.90%
controls:0.03%
—
—
—
—
—
—
cases:0.91%
controls:0.04%
cases:1.83%
controls:0.10%
20
21
2646
26612
24
8
2647
26667
—
—
—
21
11
2283
25612
32
20
1714
20456
Erythrocytes [Presence] in Urine by Automated
53292-9 [3041096]
3.9e-01
8.4e-01
2.0e+00
5.5e+00
1.7e+00
7.2e-01
4.1e-01
cases:9.19%
controls:6.43%
cases:7.26%
controls:3.27%
cases:3.11%
controls:0.45%
cases:4.57%
controls:0.02%
cases:2.61%
controls:0.47%
cases:6.68%
controls:3.36%
cases:13.34%
controls:9.31%
245
1713
2421
24920
194
873
2477
25802
83
119
2588
26556
122
5
2549
26670
68
125
2533
26476
154
860
2150
24763
233
1906
1513
18570
Cystostatic therapy of methastized malignancy
WD105 [2001310678]
1.4e+00
2.4e+00
1.9e+00
—
2.2e+00
2.3e+00
1.4e+00
cases:1.01%
controls:0.26%
cases:2.25%
controls:0.21%
cases:0.56%
controls:0.08%
—
—
cases:0.62%
controls:0.07%
cases:2.26%
controls:0.23%
cases:1.20%
controls:0.30%
27
70
2639
26563
60
55
2611
26620
15
22
2656
26653
—
16
19
2585
26582
52
58
2252
25565
21
61
1725
20415
Intubation
WX704 [2001310820]
6.0e-01
1.7e+00
3.1e+00
1.0e+50
3.3e+00
2.2e+00
7.2e-01
cases:1.65%
controls:0.92%
cases:1.24%
controls:0.24%
cases:0.41%
controls:0.02%
cases:0.71%
controls:0.00%
cases:0.92%
controls:0.03%
cases:2.04%
controls:0.24%
cases:2.06%
controls:1.01%
44
244
2622
26389
33
63
2638
26612
11
5
2660
26670
19
0
2652
26675
24
9
2577
26592
47
61
2257
25562
36
207
1710
20269
Hepatitis B virus core and surface Ab and surface Ag panel - Serum
77190-7 [46237023]
9.8e-01
2.4e+00
2.4e+00
—
2.9e+00
1.5e+00
1.4e+00
cases:1.28%
controls:0.48%
cases:2.02%
controls:0.19%
cases:0.34%
controls:0.03%
—
—
cases:0.46%
controls:0.03%
cases:0.61%
controls:0.13%
cases:2.12%
controls:0.53%
34
129
2632
26504
54
52
2617
26623
9
8
2662
26667
—
12
7
2589
26594
14
34
2290
25589
37
108
1709
20368
Calcium.ionized [Moles/volume] in Serum or Plasma
1995-0 [3021347]
4.9e-01
9.6e-01
1.6e+00
4.5e+00
2.2e+00
1.0e+00
8.1e-01
cases:17.89%
controls:11.73%
cases:14.83%
controls:6.26%
cases:5.02%
controls:1.02%
cases:3.14%
controls:0.04%
cases:7.80%
controls:0.95%
cases:15.71%
controls:6.27%
cases:27.61%
controls:14.45%
477
3124
2189
23509
396
1671
2275
25004
134
273
2537
26402
84
10
2587
26665
203
254
2398
26347
362
1607
1942
24016
482
2959
1264
17517
Differential panel, method unspecified - Blood
69738-3 [42870588]
5.6e-01
1.1e+00
1.7e+00
3.8e+00
2.0e+00
1.2e+00
1.1e+00
cases:13.84%
controls:8.41%
cases:13.89%
controls:4.93%
cases:6.03%
controls:1.15%
cases:1.61%
controls:0.04%
cases:6.92%
controls:0.97%
cases:15.58%
controls:5.09%
cases:24.80%
controls:9.82%
369
2241
2297
24392
371
1314
2300
25361
161
306
2510
26369
43
10
2628
26665
180
259
2421
26342
359
1304
1945
24319
433
2011
1313
18465
IgA [Mass/volume] in Serum or Plasma
2458-8 [3007164]
6.9e-01
1.9e+00
3.3e+00
1.0e+50
2.7e+00
1.6e+00
1.4e+00
cases:7.31%
controls:3.81%
cases:7.71%
controls:1.23%
cases:3.48%
controls:0.13%
cases:0.90%
controls:0.00%
cases:1.96%
controls:0.14%
cases:5.95%
controls:1.29%
cases:15.52%
controls:4.32%
195
1014
2471
25619
206
329
2465
26346
93
36
2578
26639
24
0
2647
26675
51
37
2550
26564
137
330
2167
25293
271
885
1475
19591
ABO and Rh group [Type] in Blood by Confirmatory method
77397-8 [46236098]
7.7e-01
1.4e+00
2.8e+00
—
3.6e+00
1.8e+00
1.1e+00
cases:9.86%
controls:4.81%
cases:8.76%
controls:2.26%
cases:5.09%
controls:0.33%
—
—
cases:8.46%
controls:0.24%
cases:11.11%
controls:1.97%
cases:14.43%
controls:5.56%
263
1281
2403
25352
234
603
2437
26072
136
88
2535
26587
—
220
65
2381
26536
256
504
2048
25119
252
1138
1494
19338
Liver disease, unspecified
K76.9 [45572233]
3.6e+00
4.5e+00
—
1.0e+50
—
—
3.4e+00
cases:1.65%
controls:0.05%
cases:2.25%
controls:0.03%
—
—
cases:0.22%
controls:0.00%
—
—
—
—
cases:1.26%
controls:0.04%
44
12
2622
26621
60
7
2611
26668
—
6
0
2665
26675
—
—
22
9
1724
20467
Immunoglobulin typing, IgG
1712009 [4062490]
1.6e+00
2.9e+00
1.0e+50
—
—
3.9e+00
3.0e+00
cases:0.79%
controls:0.15%
cases:1.20%
controls:0.06%
cases:0.86%
controls:0.00%
—
—
—
—
cases:1.52%
controls:0.03%
cases:2.23%
controls:0.12%
21
41
2645
26592
32
17
2639
26658
23
0
2648
26675
—
—
35
8
2269
25615
39
24
1707
20452
Epithelial cells.squamous [#/volume] in Urine by Automated count
51486-9 [3029879]
2.8e-01
9.5e-01
2.2e+00
5.4e+00
1.7e+00
9.2e-01
3.3e-01
cases:4.58%
controls:3.50%
cases:5.13%
controls:2.04%
cases:2.43%
controls:0.28%
cases:3.82%
controls:0.02%
cases:1.77%
controls:0.32%
cases:5.38%
controls:2.22%
cases:7.62%
controls:5.59%
122
933
2544
25700
137
545
2534
26130
65
75
2606
26600
102
5
2569
26670
46
86
2555
26515
124
570
2180
25053
133
1144
1613
19332
IgG subclass 1 [Mass/volume] in Serum
2466-1 [3027135]
1.6e+00
3.0e+00
1.0e+50
—
—
3.9e+00
2.9e+00
cases:0.79%
controls:0.16%
cases:1.24%
controls:0.06%
cases:0.90%
controls:0.00%
—
—
—
—
cases:1.56%
controls:0.03%
cases:2.23%
controls:0.13%
21
43
2645
26590
33
16
2638
26659
24
0
2647
26675
—
—
36
8
2268
25615
39
26
1707
20450
IgG subclass 3 [Mass/volume] in Serum
2468-7 [3024139]
1.6e+00
3.0e+00
1.0e+50
—
—
3.9e+00
2.9e+00
cases:0.79%
controls:0.16%
cases:1.24%
controls:0.06%
cases:0.90%
controls:0.00%
—
—
—
—
cases:1.56%
controls:0.03%
cases:2.23%
controls:0.13%
21
43
2645
26590
33
16
2638
26659
24
0
2647
26675
—
—
36
8
2268
25615
39
26
1707
20450
IgG subclass 2 [Mass/volume] in Serum
2467-9 [3028192]
1.6e+00
3.0e+00
1.0e+50
—
—
3.9e+00
2.9e+00
cases:0.79%
controls:0.16%
cases:1.24%
controls:0.06%
cases:0.90%
controls:0.00%
—
—
—
—
cases:1.56%
controls:0.03%
cases:2.23%
controls:0.13%
21
43
2645
26590
33
16
2638
26659
24
0
2647
26675
—
—
36
8
2268
25615
39
26
1707
20450
Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
40976-3 [3040853]
8.9e-01
1.5e+00
2.4e+00
1.0e+50
3.1e+00
2.2e+00
1.3e+00
cases:1.05%
controls:0.44%
cases:0.67%
controls:0.15%
cases:0.30%
controls:0.03%
cases:0.19%
controls:0.00%
cases:0.50%
controls:0.02%
cases:1.04%
controls:0.11%
cases:1.83%
controls:0.50%
28
116
2638
26517
18
41
2653
26634
8
7
2663
26668
5
0
2666
26675
13
6
2588
26595
24
29
2280
25594
32
103
1714
20373
Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
38917-1 [3042194]
8.2e-01
1.6e+00
2.3e+00
1.0e+50
3.1e+00
2.2e+00
1.3e+00
cases:1.05%
controls:0.47%
cases:0.79%
controls:0.16%
cases:0.26%
controls:0.03%
cases:0.19%
controls:0.00%
cases:0.50%
controls:0.02%
cases:1.13%
controls:0.12%
cases:1.83%
controls:0.48%
28
124
2638
26509
21
42
2650
26633
7
7
2664
26668
5
0
2666
26675
13
6
2588
26595
26
32
2278
25591
32
99
1714
20377
ciprofloxacin; oral, parenteral
J01MA02 [21603009]
8.0e-01
1.4e+00
2.2e+00
—
3.8e+00
1.9e+00
1.3e+00
cases:12.87%
controls:6.21%
cases:7.75%
controls:1.96%
cases:1.95%
controls:0.21%
—
—
cases:10.23%
controls:0.26%
cases:10.20%
controls:1.75%
cases:18.27%
controls:5.81%
343
1654
2323
24979
207
522
2464
26153
52
56
2619
26619
—
266
70
2335
26531
235
448
2069
25175
319
1189
1427
19287
Sedation and analgesia
WX002 [2001310758]
5.8e-01
1.5e+00
2.7e+00
1.0e+50
3.1e+00
2.0e+00
1.4e+00
cases:6.34%
controls:3.63%
cases:3.63%
controls:0.84%
cases:1.42%
controls:0.09%
cases:1.87%
controls:0.00%
cases:1.73%
controls:0.08%
cases:4.95%
controls:0.69%
cases:8.42%
controls:2.16%
169
968
2497
25665
97
224
2574
26451
38
25
2633
26650
50
0
2621
26675
45
21
2556
26580
114
178
2190
25445
147
442
1599
20034
Other and unspecified cirrhosis of liver
K74.6 [45538546]
2.6e+00
3.2e+00
—
—
—
3.2e+00
2.3e+00
cases:0.86%
controls:0.06%
cases:0.64%
controls:0.03%
—
—
—
—
—
—
cases:0.95%
controls:0.04%
cases:1.37%
controls:0.14%
23
17
2643
26616
17
7
2654
26668
—
—
—
22
10
2282
25613
24
28
1722
20448
Monocytes/Leukocytes in Blood
26485-3 [3019069]
4.4e-01
1.0e+00
1.7e+00
3.9e+00
1.9e+00
1.2e+00
1.1e+00
cases:17.29%
controls:11.91%
cases:18.01%
controls:7.27%
cases:7.79%
controls:1.53%
cases:2.10%
controls:0.04%
cases:8.65%
controls:1.35%
cases:20.27%
controls:7.24%
cases:33.51%
controls:14.35%
461
3171
2205
23462
481
1940
2190
24735
208
407
2463
26268
56
11
2615
26664
225
358
2376
26243
467
1854
1837
23769
585
2939
1161
17537
Immunohistochemistry procedure
117617002 [4035726]
7.9e-01
1.6e+00
2.3e+00
1.0e+50
3.2e+00
2.1e+00
1.3e+00
cases:3.75%
controls:1.75%
cases:3.52%
controls:0.73%
cases:1.05%
controls:0.10%
cases:0.19%
controls:0.00%
cases:1.19%
controls:0.05%
cases:3.30%
controls:0.41%
cases:4.70%
controls:1.37%
100
465
2566
26168
94
196
2577
26479
28
27
2643
26648
5
0
2666
26675
31
13
2570
26588
76
106
2228
25517
82
281
1664
20195
Eosinophils/Leukocytes in Blood
26450-7 [3006504]
4.4e-01
1.0e+00
1.7e+00
3.9e+00
1.9e+00
1.2e+00
1.1e+00
cases:17.33%
controls:11.87%
cases:17.93%
controls:7.27%
cases:7.71%
controls:1.53%
cases:2.06%
controls:0.04%
cases:8.65%
controls:1.34%
cases:20.14%
controls:7.23%
cases:33.51%
controls:14.31%
462
3162
2204
23471
479
1938
2192
24737
206
408
2465
26267
55
11
2616
26664
225
357
2376
26244
464
1853
1840
23770
585
2931
1161
17545
Basophils/Leukocytes in Blood
30180-4 [3022096]
4.4e-01
1.0e+00
1.7e+00
3.9e+00
1.9e+00
1.2e+00
1.1e+00
cases:17.18%
controls:11.81%
cases:17.90%
controls:7.27%
cases:7.75%
controls:1.52%
cases:2.06%
controls:0.04%
cases:8.61%
controls:1.35%
cases:20.14%
controls:7.22%
cases:33.33%
controls:14.33%
458
3146
2208
23487
478
1940
2193
24735
207
406
2464
26269
55
11
2616
26664
224
358
2377
26243
464
1850
1840
23773
582
2934
1164
17542
Intravenous administration of medicine
SPAT1255 [2001700356]
8.4e-01
1.3e+00
2.8e+00
1.0e+50
3.7e+00
1.5e+00
1.1e+00
cases:1.58%
controls:0.68%
cases:1.27%
controls:0.35%
cases:0.60%
controls:0.04%
cases:0.22%
controls:0.00%
cases:1.19%
controls:0.03%
cases:1.22%
controls:0.27%
cases:2.63%
controls:0.88%
42
182
2624
26451
34
93
2637
26582
16
10
2655
26665
6
0
2665
26675
31
8
2570
26593
28
70
2276
25553
46
180
1700
20296
Ulcerative colitis
K51 [45557655]
2.6e+00
2.9e+00
—
—
—
3.5e+00
2.3e+00
cases:1.61%
controls:0.13%
cases:0.94%
controls:0.05%
—
—
—
—
—
—
cases:1.17%
controls:0.04%
cases:1.49%
controls:0.16%
43
34
2623
26599
25
14
2646
26661
—
—
—
27
9
2277
25614
26
32
1720
20444
Abdominal CT examination both without and with contrast
JN3CD [2001305561]
1.9e+00
3.0e+00
1.0e+50
1.0e+50
—
3.8e+00
2.5e+00
cases:2.03%
controls:0.32%
cases:1.50%
controls:0.08%
cases:0.60%
controls:0.00%
cases:1.12%
controls:0.00%
—
—
cases:1.09%
controls:0.02%
cases:1.83%
controls:0.15%
54
84
2612
26549
40
21
2631
26654
16
0
2655
26675
30
0
2641
26675
—
25
6
2279
25617
32
31
1714
20445
Adalimumab, golimumab, infliximab and ustekinumab (intestinal diseases)
326 [2001600287]
2.0e+00
2.6e+00
—
—
—
2.6e+00
3.9e+00
cases:0.45%
controls:0.06%
cases:0.26%
controls:0.02%
—
—
—
—
—
—
cases:0.43%
controls:0.03%
cases:1.89%
controls:0.04%
12
16
2654
26617
7
5
2664
26670
—
—
—
10
8
2294
25615
33
8
1713
20468
Sodium [Moles/volume] in Serum or Plasma
2951-2 [3019550]
1.8e-01
5.9e-01
1.9e+00
5.0e+00
2.5e+00
6.6e-01
3.1e-01
cases:44.37%
controls:39.93%
cases:45.56%
controls:31.74%
cases:32.53%
controls:6.43%
cases:37.40%
controls:0.40%
cases:43.83%
controls:6.12%
cases:47.48%
controls:31.93%
cases:58.65%
controls:51.05%
1183
10635
1483
15998
1217
8466
1454
18209
869
1714
1802
24961
999
106
1672
26569
1140
1628
1461
24973
1094
8181
1210
17442
1024
10453
722
10023
Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
3216-9 [3020427]
1.1e+00
1.5e+00
2.3e+00
—
3.6e+00
1.6e+00
9.8e-01
cases:1.80%
controls:0.58%
cases:1.16%
controls:0.27%
cases:0.22%
controls:0.02%
—
—
cases:1.00%
controls:0.03%
cases:1.35%
controls:0.27%
cases:1.66%
controls:0.63%
48
155
2618
26478
31
72
2640
26603
6
6
2665
26669
—
26
7
2575
26594
31
68
2273
25555
29
129
1717
20347
Insertion of central venous catheter through external or internal jugular vein
TPH15 [2001309600]
1.4e+00
2.2e+00
2.0e+00
1.0e+50
2.8e+00
2.8e+00
1.9e+00
cases:2.81%
controls:0.68%
cases:1.80%
controls:0.20%
cases:0.19%
controls:0.03%
cases:0.37%
controls:0.00%
cases:0.42%
controls:0.03%
cases:2.78%
controls:0.18%
cases:3.15%
controls:0.48%
75
181
2591
26452
48
53
2623
26622
5
7
2666
26668
10
0
2661
26675
11
7
2590
26594
64
45
2240
25578
55
98
1691
20378
General Practice
1 [38004446]
4.6e-01
8.5e-01
1.9e+00
4.2e+00
2.5e+00
8.3e-01
4.0e-01
cases:22.96%
controls:15.81%
cases:14.45%
controls:6.75%
cases:7.04%
controls:1.14%
cases:4.23%
controls:0.06%
cases:11.42%
controls:1.07%
cases:15.97%
controls:7.69%
cases:25.26%
controls:18.46%
612
4211
2054
22422
386
1800
2285
24875
188
305
2483
26370
113
17
2558
26658
297
285
2304
26316
368
1970
1936
23653
441
3779
1305
16697
One hour or less
ZXE00 [2001311394]
5.9e-01
1.4e+00
2.6e+00
1.0e+50
3.0e+00
2.1e+00
1.5e+00
cases:11.63%
controls:6.81%
cases:5.88%
controls:1.59%
cases:1.91%
controls:0.15%
cases:3.67%
controls:0.00%
cases:3.11%
controls:0.16%
cases:8.85%
controls:1.16%
cases:14.60%
controls:3.71%
310
1814
2356
24819
157
423
2514
26252
51
40
2620
26635
98
0
2573
26675
81
42
2520
26559
204
297
2100
25326
255
760
1491
19716
Hepatitis B virus surface Ag [Presence] in Serum
5195-3 [3019284]
9.4e-01
1.8e+00
2.9e+00
—
3.1e+00
1.3e+00
9.9e-01
cases:5.96%
controls:2.41%
cases:6.18%
controls:1.04%
cases:1.95%
controls:0.11%
—
—
cases:2.35%
controls:0.11%
cases:3.08%
controls:0.84%
cases:7.39%
controls:2.87%
159
643
2507
25990
165
278
2506
26397
52
29
2619
26646
—
61
28
2540
26573
71
216
2233
25407
129
587
1617
19889
metronidazole; oral, rectal
P01AB01 [21604857]
8.2e-01
1.2e+00
2.3e+00
—
3.5e+00
1.9e+00
1.4e+00
cases:12.30%
controls:5.85%
cases:5.35%
controls:1.67%
cases:1.46%
controls:0.15%
—
—
cases:5.11%
controls:0.16%
cases:9.42%
controls:1.60%
cases:19.76%
controls:5.60%
328
1557
2338
25076
143
445
2528
26230
39
39
2632
26636
—
133
43
2468
26558
217
411
2087
25212
345
1146
1401
19330
Potassium [Moles/volume] in Serum or Plasma
2823-3 [3023103]
1.8e-01
5.8e-01
1.9e+00
5.0e+00
2.5e+00
6.4e-01
3.1e-01
cases:44.56%
controls:40.21%
cases:45.86%
controls:32.12%
cases:32.42%
controls:6.55%
cases:37.10%
controls:0.41%
cases:43.83%
controls:6.21%
cases:47.53%
controls:32.34%
cases:58.88%
controls:51.33%
1188
10709
1478
15924
1225
8568
1446
18107
866
1748
1805
24927
991
109
1680
26566
1140
1651
1461
24950
1095
8287
1209
17336
1028
10511
718
9965
Epstein Barr virus Ab [Presence] in Serum
49178-7 [3048929]
1.4e+00
2.6e+00
3.7e+00
—
—
1.8e+00
1.6e+00
cases:2.21%
controls:0.56%
cases:1.98%
controls:0.15%
cases:0.75%
controls:0.02%
—
—
—
—
cases:0.82%
controls:0.13%
cases:2.41%
controls:0.52%
59
150
2607
26483
53
41
2618
26634
20
5
2651
26670
—
—
19
34
2285
25589
42
106
1704
20370
Lymphocytes/Leukocytes in Blood
26478-8 [3002030]
3.9e-01
1.0e+00
1.7e+00
3.8e+00
1.9e+00
1.1e+00
1.1e+00
cases:17.10%
controls:12.25%
cases:18.27%
controls:7.48%
cases:7.79%
controls:1.54%
cases:2.13%
controls:0.05%
cases:8.73%
controls:1.36%
cases:20.18%
controls:7.42%
cases:33.51%
controls:14.84%
456
3262
2210
23371
488
1994
2183
24681
208
412
2463
26263
57
13
2614
26662
227
363
2374
26238
465
1902
1839
23721
585
3038
1161
17438
ondansetron; oral, parenteral, rectal
A04AA01 [21600493]
9.3e-01
1.9e+00
2.7e+00
—
2.3e+00
2.1e+00
1.1e+00
cases:1.58%
controls:0.63%
cases:2.32%
controls:0.34%
cases:0.97%
controls:0.07%
—
—
cases:0.77%
controls:0.08%
cases:2.56%
controls:0.32%
cases:2.52%
controls:0.88%
42
167
2624
26466
62
91
2609
26584
26
18
2645
26657
—
20
20
2581
26581
59
83
2245
25540
44
181
1702
20295
Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
1834-1 [3009306]
2.2e+00
2.9e+00
1.0e+50
—
1.0e+50
3.0e+00
2.9e+00
cases:0.34%
controls:0.04%
cases:0.41%
controls:0.02%
cases:0.26%
controls:0.00%
—
—
cases:0.23%
controls:0.00%
cases:0.39%
controls:0.02%
cases:1.32%
controls:0.07%
9
10
2657
26623
11
6
2660
26669
7
0
2664
26675
—
6
0
2595
26601
9
5
2295
25618
23
15
1723
20461
Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
19072-8 [3016431]
4.9e-01
9.3e-01
1.6e+00
4.2e+00
2.0e+00
1.0e+00
7.7e-01
cases:19.58%
controls:13.01%
cases:16.36%
controls:7.18%
cases:5.69%
controls:1.19%
cases:2.96%
controls:0.04%
cases:7.84%
controls:1.16%
cases:17.71%
controls:7.28%
cases:30.47%
controls:16.84%
522
3465
2144
23168
437
1915
2234
24760
152
317
2519
26358
79
12
2592
26663
204
308
2397
26293
408
1866
1896
23757
532
3449
1214
17027
Bacteria identified in Urine by Culture
630-4 [3026008]
3.8e-01
7.9e-01
1.9e+00
5.1e+00
1.5e+00
8.6e-01
4.6e-01
cases:10.50%
controls:7.43%
cases:7.82%
controls:3.70%
cases:3.67%
controls:0.57%
cases:4.31%
controls:0.03%
cases:2.46%
controls:0.57%
cases:8.77%
controls:3.90%
cases:15.18%
controls:10.19%
280
1980
2386
24653
209
988
2462
25687
98
152
2573
26523
115
7
2556
26668
64
152
2537
26449
202
999
2102
24624
265
2086
1481
18390
Epithelial cells.non-squamous [#/volume] in Urine by Automated count
51485-1 [3030306]
3.3e-01
9.4e-01
2.1e+00
5.1e+00
1.6e+00
9.2e-01
2.7e-01
cases:4.65%
controls:3.39%
cases:5.35%
controls:2.15%
cases:2.66%
controls:0.33%
cases:3.52%
controls:0.02%
cases:1.69%
controls:0.35%
cases:5.73%
controls:2.37%
cases:8.02%
controls:6.27%
124
904
2542
25729
143
574
2528
26101
71
87
2600
26588
94
6
2577
26669
44
92
2557
26509
132
607
2172
25016
140
1283
1606
19193
mycophenolic acid; oral, parenteral
L04AA06 [21603896]
1.7e+00
1.9e+00
1.6e+00
—
1.6e+00
1.9e+00
2.3e+00
cases:1.35%
controls:0.26%
cases:1.68%
controls:0.25%
cases:0.45%
controls:0.09%
—
—
cases:0.35%
controls:0.07%
cases:1.95%
controls:0.29%
cases:3.15%
controls:0.31%
36
69
2630
26564
45
67
2626
26608
12
25
2659
26650
—
9
19
2592
26582
45
74
2259
25549
55
64
1691
20412
Basophils [#/volume] in Blood
26444-0 [3006315]
4.2e-01
9.6e-01
1.7e+00
3.8e+00
2.0e+00
1.2e+00
1.1e+00
cases:18.00%
controls:12.62%
cases:18.12%
controls:7.82%
cases:7.97%
controls:1.62%
cases:2.06%
controls:0.05%
cases:8.92%
controls:1.37%
cases:21.05%
controls:7.69%
cases:34.99%
controls:15.74%
480
3362
2186
23271
484
2087
2187
24588
213
431
2458
26244
55
13
2616
26662
232
365
2369
26236
485
1971
1819
23652
611
3223
1135
17253
Monocytes [#/volume] in Blood
26484-6 [3001604]
4.2e-01
9.6e-01
1.7e+00
3.7e+00
2.0e+00
1.2e+00
1.1e+00
cases:17.93%
controls:12.57%
cases:17.97%
controls:7.77%
cases:7.90%
controls:1.61%
cases:2.02%
controls:0.05%
cases:8.92%
controls:1.36%
cases:20.92%
controls:7.66%
cases:34.94%
controls:15.65%
478
3348
2188
23285
480
2073
2191
24602
211
429
2460
26246
54
13
2617
26662
232
363
2369
26238
482
1964
1822
23659
610
3204
1136
17272
Neutrophils/Leukocytes in Blood
26511-6 [3018010]
4.3e-01
9.8e-01
1.6e+00
3.8e+00
1.9e+00
1.1e+00
1.1e+00
cases:17.10%
controls:11.85%
cases:17.33%
controls:7.29%
cases:7.30%
controls:1.49%
cases:1.98%
controls:0.04%
cases:8.00%
controls:1.32%
cases:19.57%
controls:7.26%
cases:32.76%
controls:14.55%
456
3156
2210
23477
463
1944
2208
24731
195
398
2476
26277
53
12
2618
26663
208
352
2393
26249
451
1861
1853
23762
572
2980
1174
17496
Kidney transplant status
Z94.0 [45566477]
1.6e+00
1.6e+00
2.0e+00
—
2.4e+00
1.5e+00
1.8e+00
cases:0.79%
controls:0.16%
cases:0.82%
controls:0.17%
cases:0.49%
controls:0.07%
—
—
cases:0.62%
controls:0.06%
cases:0.91%
controls:0.20%
cases:1.20%
controls:0.20%
21
43
2645
26590
22
46
2649
26629
13
18
2658
26657
—
16
15
2585
26586
21
50
2283
25573
21
40
1725
20436
mercaptopurine
L01BB02 [21601428]
2.1e+00
2.6e+00
—
—
—
3.2e+00
3.0e+00
cases:0.75%
controls:0.09%
cases:0.79%
controls:0.06%
—
—
—
—
—
—
cases:1.09%
controls:0.05%
cases:1.78%
controls:0.09%
20
25
2646
26608
21
15
2650
26660
—
—
—
25
12
2279
25611
31
18
1715
20458
Metastasis to peritoneum
OMOP5031802 [35226253]
2.7e+00
3.5e+00
—
1.0e+50
—
2.8e+00
1.9e+00
cases:0.34%
controls:0.02%
cases:0.64%
controls:0.02%
—
—
cases:0.45%
controls:0.00%
—
—
cases:0.61%
controls:0.04%
cases:0.46%
controls:0.07%
9
6
2657
26627
17
5
2654
26670
—
12
0
2659
26675
—
14
10
2290
25613
8
14
1738
20462
Albumin [Presence] in Urine by Test strip
50949-7 [3029937]
3.7e-01
8.0e-01
1.8e+00
5.2e+00
1.6e+00
6.5e-01
3.8e-01
cases:10.17%
controls:7.28%
cases:8.39%
controls:3.96%
cases:3.71%
controls:0.61%
cases:5.24%
controls:0.03%
cases:2.77%
controls:0.55%
cases:7.73%
controls:4.19%
cases:14.72%
controls:10.58%
271
1939
2395
24694
224
1056
2447
25619
99
162
2572
26513
140
8
2531
26667
72
146
2529
26455
178
1073
2126
24550
257
2166
1489
18310
CBC W Ordered Manual Differential panel - Blood
57782-5 [40760892]
5.8e-01
9.7e-01
1.7e+00
3.6e+00
2.0e+00
1.1e+00
8.4e-01
cases:7.99%
controls:4.64%
cases:6.93%
controls:2.73%
cases:2.77%
controls:0.50%
cases:1.09%
controls:0.03%
cases:3.31%
controls:0.45%
cases:7.47%
controls:2.58%
cases:12.77%
controls:5.95%
213
1235
2453
25398
185
729
2486
25946
74
133
2597
26542
29
8
2642
26667
86
119
2515
26482
172
661
2132
24962
223
1218
1523
19258
infliximab; parenteral
L04AB02 [21603909]
1.4e+00
2.0e+00
2.0e+00
—
2.2e+00
2.1e+00
3.1e+00
cases:0.49%
controls:0.12%
cases:0.49%
controls:0.07%
cases:0.19%
controls:0.03%
—
—
cases:0.27%
controls:0.03%
cases:0.69%
controls:0.08%
cases:1.72%
controls:0.08%
13
31
2653
26602
13
18
2658
26657
5
7
2666
26668
—
7
8
2594
26593
16
21
2288
25602
30
16
1716
20460
Outpatient Visit
OP [9202]
7.2e-01
9.9e-01
1.2e+00
4.0e+00
1.5e+00
1.3e+00
1.2e+00
cases:86.16%
controls:75.18%
cases:76.90%
controls:55.26%
cases:28.68%
controls:11.10%
cases:21.34%
controls:0.50%
cases:35.52%
controls:11.41%
cases:81.55%
controls:53.49%
cases:92.67%
controls:79.49%
2297
20024
369
6609
2054
14740
617
11935
766
2961
1905
23714
570
134
2101
26541
924
3036
1677
23565
1879
13707
425
11916
1618
16276
128
4200
Metastasis to retroperitoneum
OMOP5031838 [35226284]
2.7e+00
3.5e+00
—
1.0e+50
—
2.8e+00
1.9e+00
cases:0.34%
controls:0.02%
cases:0.60%
controls:0.02%
—
—
cases:0.45%
controls:0.00%
—
—
cases:0.61%
controls:0.04%
cases:0.46%
controls:0.07%
9
6
2657
26627
16
5
2655
26670
—
12
0
2659
26675
—
14
10
2290
25613
8
14
1738
20462
Secondary malignant neoplasm of retroperitoneum and peritoneum
C78.6 [45547522]
2.7e+00
3.5e+00
—
1.0e+50
—
2.8e+00
1.9e+00
cases:0.34%
controls:0.02%
cases:0.60%
controls:0.02%
—
—
cases:0.45%
controls:0.00%
—
—
cases:0.61%
controls:0.04%
cases:0.46%
controls:0.07%
9
6
2657
26627
16
5
2655
26670
—
12
0
2659
26675
—
14
10
2290
25613
8
14
1738
20462
metoclopramide; oral, parenteral, rectal
A03FA01 [21600484]
9.1e-01
1.8e+00
2.4e+00
—
2.9e+00
1.9e+00
9.7e-01
cases:7.24%
controls:3.05%
cases:7.34%
controls:1.35%
cases:1.91%
controls:0.18%
—
—
cases:2.85%
controls:0.16%
cases:7.90%
controls:1.30%
cases:8.19%
controls:3.26%
193
811
2473
25822
196
360
2475
26315
51
47
2620
26628
—
74
43
2527
26558
182
332
2122
25291
143
667
1603
19809
Short blood count panel - Blood
55429-5 [40758558]
2.8e-01
8.2e-01
1.8e+00
4.4e+00
2.0e+00
8.6e-01
7.2e-01
cases:8.33%
controls:6.41%
cases:8.05%
controls:3.72%
cases:4.42%
controls:0.78%
cases:3.44%
controls:0.04%
cases:5.50%
controls:0.79%
cases:7.99%
controls:3.53%
cases:14.83%
controls:7.83%
222
1708
2444
24925
215
993
2456
25682
118
209
2553
26466
92
12
2579
26663
143
211
2458
26390
184
905
2120
24718
259
1603
1487
18873
Eosinophils [#/volume] in Blood
26449-9 [3013115]
4.3e-01
9.6e-01
1.7e+00
3.6e+00
1.9e+00
1.1e+00
1.0e+00
cases:18.79%
controls:13.14%
cases:18.68%
controls:8.06%
cases:8.24%
controls:1.66%
cases:2.10%
controls:0.06%
cases:9.15%
controls:1.44%
cases:21.09%
controls:7.93%
cases:35.34%
controls:16.29%
501
3499
2165
23134
499
2151
2172
24524
220
444
2451
26231
56
15
2615
26660
238
383
2363
26218
486
2033
1818
23590
617
3335
1129
17141
Normoblasts [#/volume] in Blood
715-3 [3021589]
2.8e-01
7.0e-01
1.7e+00
4.6e+00
1.9e+00
9.0e-01
6.9e-01
cases:13.62%
controls:10.64%
cases:16.10%
controls:8.70%
cases:10.15%
controls:2.02%
cases:7.45%
controls:0.08%
cases:12.07%
controls:1.95%
cases:19.75%
controls:9.08%
cases:27.89%
controls:16.22%
363
2834
2303
23799
430
2320
2241
24355
271
538
2400
26137
199
22
2472
26653
314
520
2287
26081
455
2326
1849
23297
487
3321
1259
17155
Infectious Disease
44 [38004484]
7.4e-01
1.3e+00
2.8e+00
—
2.8e+00
1.8e+00
1.3e+00
cases:3.41%
controls:1.66%
cases:2.36%
controls:0.69%
cases:1.01%
controls:0.06%
—
—
cases:1.35%
controls:0.08%
cases:3.95%
controls:0.66%
cases:6.70%
controls:1.95%
91
441
2575
26192
63
183
2608
26492
27
16
2644
26659
—
35
22
2566
26579
91
169
2213
25454
117
399
1629
20077
Magnesium Ionized [Moles/volume] in Serum or Plasma
2600-5 [3021197]
2.0e+00
2.7e+00
—
—
—
2.7e+00
3.3e+00
cases:0.68%
controls:0.09%
cases:0.52%
controls:0.03%
—
—
—
—
—
—
cases:0.52%
controls:0.04%
cases:1.32%
controls:0.05%
18
25
2648
26608
14
9
2657
26666
—
—
—
12
9
2292
25614
23
10
1723
20466
Creatinine [Moles/volume] in Serum or Plasma
14682-9 [3020564]
1.5e-01
6.0e-01
1.9e+00
4.9e+00
2.3e+00
6.2e-01
2.5e-01
cases:46.40%
controls:42.67%
cases:50.28%
controls:35.61%
cases:36.47%
controls:7.79%
cases:37.66%
controls:0.46%
cases:45.33%
controls:7.62%
cases:51.22%
controls:36.17%
cases:60.88%
controls:54.71%
1237
11365
1429
15268
1343
9498
1328
17177
974
2077
1697
24598
1006
122
1665
26553
1179
2026
1422
24575
1180
9267
1124
16356
1063
11202
683
9274
Nausea and vomiting
R11 [45539317]
6.2e-01
1.5e+00
3.1e+00
1.0e+50
2.8e+00
1.6e+00
1.1e+00
cases:1.58%
controls:0.85%
cases:1.42%
controls:0.33%
cases:0.79%
controls:0.04%
cases:0.26%
controls:0.00%
cases:0.50%
controls:0.03%
cases:1.52%
controls:0.30%
cases:3.04%
controls:1.01%
42
227
2624
26406
38
88
2633
26587
21
10
2650
26665
7
0
2664
26675
13
8
2588
26593
35
77
2269
25546
53
207
1693
20269
Lymphocytes [#/volume] in Blood
26474-7 [3019198]
4.0e-01
9.6e-01
1.6e+00
3.6e+00
1.9e+00
1.1e+00
1.0e+00
cases:18.45%
controls:13.13%
cases:18.49%
controls:8.01%
cases:8.12%
controls:1.68%
cases:2.13%
controls:0.06%
cases:9.07%
controls:1.44%
cases:21.09%
controls:7.90%
cases:35.40%
controls:16.12%
492
3496
2174
23137
494
2137
2177
24538
217
447
2454
26228
57
16
2614
26659
236
382
2365
26219
486
2024
1818
23599
618
3301
1128
17175
Urinalysis macro (dipstick) panel - Urine
24357-6 [3037467]
3.2e-01
7.2e-01
1.8e+00
5.0e+00
1.6e+00
7.4e-01
4.9e-01
cases:25.99%
controls:20.27%
cases:19.28%
controls:10.43%
cases:8.65%
controls:1.53%
cases:9.40%
controls:0.07%
cases:6.96%
controls:1.52%
cases:19.75%
controls:10.47%
cases:34.08%
controls:24.01%
693
5398
1973
21235
515
2782
2156
23893
231
407
2440
26268
251
18
2420
26657
181
404
2420
26197
455
2684
1849
22939
595
4916
1151
15560
Leukocyte esterase [Presence] in Urine by Automated test strip
60026-2 [40763086]
3.0e-01
7.5e-01
1.8e+00
5.3e+00
1.6e+00
6.2e-01
3.1e-01
cases:13.35%
controls:10.23%
cases:10.75%
controls:5.37%
cases:4.46%
controls:0.78%
cases:6.25%
controls:0.03%
cases:3.65%
controls:0.73%
cases:9.64%
controls:5.42%
cases:18.79%
controls:14.48%
356
2724
2310
23909
287
1433
2384
25242
119
208
2552
26467
167
9
2504
26666
95
194
2506
26407
222
1388
2082
24235
328
2964
1418
17512
EKG study
11524-6 [3013512]
3.8e-01
5.8e-01
1.8e+00
5.2e+00
1.6e+00
6.9e-01
4.2e-01
cases:12.57%
controls:8.93%
cases:8.76%
controls:5.12%
cases:3.78%
controls:0.63%
cases:3.18%
controls:0.02%
cases:2.92%
controls:0.59%
cases:9.72%
controls:5.12%
cases:17.41%
controls:12.14%
335
2377
2331
24256
234
1367
2437
25308
101
167
2570
26508
85
5
2586
26670
76
158
2525
26443
224
1313
2080
24310
304
2485
1442
17991
Hyperbilirubinaemia, with or without jaundice, not elsewhere classified
R17 [45587498]
4.2e+00
—
1.0e+50
1.0e+50
1.0e+50
3.8e+00
2.6e+00
cases:1.76%
controls:0.03%
—
—
cases:3.26%
controls:0.00%
cases:1.72%
controls:0.00%
cases:1.11%
controls:0.00%
cases:0.87%
controls:0.02%
cases:0.74%
controls:0.05%
47
7
2619
26626
—
87
0
2584
26675
46
0
2625
26675
29
0
2572
26601
20
5
2284
25618
13
11
1733
20465
CBC panel - Blood by Automated count
58410-2 [40761511]
1.6e-01
5.9e-01
1.9e+00
4.7e+00
2.3e+00
6.8e-01
3.4e-01
cases:42.05%
controls:38.12%
cases:38.08%
controls:25.46%
cases:25.16%
controls:4.82%
cases:23.44%
controls:0.27%
cases:32.76%
controls:4.86%
cases:39.15%
controls:24.61%
cases:53.15%
controls:44.77%
1121
10152
1545
16481
1017
6791
1654
19884
672
1285
1999
25390
626
71
2045
26604
852
1292
1749
25309
902
6306
1402
19317
928
9168
818
11308
Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma
13875-0 [3036185]
2.1e+00
3.3e+00
—
—
—
2.5e+00
2.7e+00
cases:0.60%
controls:0.07%
cases:0.79%
controls:0.03%
—
—
—
—
—
—
cases:0.35%
controls:0.03%
cases:0.86%
controls:0.06%
16
19
2650
26614
21
8
2650
26667
—
—
—
8
7
2296
25616
15
12
1731
20464
Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma
13874-3 [3035062]
2.1e+00
3.3e+00
—
—
—
2.5e+00
2.7e+00
cases:0.60%
controls:0.07%
cases:0.79%
controls:0.03%
—
—
—
—
—
—
cases:0.35%
controls:0.03%
cases:0.86%
controls:0.06%
16
19
2650
26614
21
8
2650
26667
—
—
—
8
7
2296
25616
15
12
1731
20464
Demanding neoadjuvant cytostatic therapy
WB121 [2001310630]
1.8e+00
2.9e+00
3.1e+00
—
—
2.9e+00
—
cases:0.45%
controls:0.08%
cases:0.71%
controls:0.04%
cases:0.41%
controls:0.02%
—
—
—
—
cases:0.69%
controls:0.04%
—
—
12
20
2654
26613
19
11
2652
26664
11
5
2660
26670
—
—
16
10
2288
25613
—
pH of Blood
11558-4 [3010421]
1.0e+00
1.4e+00
2.6e+00
1.0e+50
2.9e+00
1.6e+00
1.1e+00
cases:1.65%
controls:0.60%
cases:1.05%
controls:0.27%
cases:0.49%
controls:0.04%
cases:0.41%
controls:0.00%
cases:0.77%
controls:0.04%
cases:1.30%
controls:0.28%
cases:2.12%
controls:0.69%
44
160
2622
26473
28
71
2643
26604
13
10
2658
26665
11
0
2660
26675
20
11
2581
26590
30
71
2274
25552
37
141
1709
20335
Phosphate [Moles/volume] in Serum or Plasma
14879-1 [3003458]
6.4e-01
1.2e+00
1.4e+00
2.6e+00
2.2e+00
1.4e+00
1.1e+00
cases:5.63%
controls:3.06%
cases:5.73%
controls:1.76%
cases:1.42%
controls:0.35%
cases:0.26%
controls:0.02%
cases:2.81%
controls:0.33%
cases:6.68%
controls:1.77%
cases:10.94%
controls:3.78%
150
814
2516
25819
153
469
2518
26206
38
93
2633
26582
7
5
2664
26670
73
89
2528
26512
154
454
2150
25169
191
774
1555
19702
Nutritional therapy
R4190 [2001310243]
1.1e+00
2.2e+00
—
—
2.8e+00
2.8e+00
1.7e+00
cases:0.94%
controls:0.30%
cases:1.39%
controls:0.16%
—
—
—
—
cases:0.42%
controls:0.03%
cases:2.39%
controls:0.15%
cases:2.41%
controls:0.45%
25
80
2641
26553
37
43
2634
26632
—
—
11
7
2590
26594
55
38
2249
25585
42
93
1704
20383
Hepatitis B virus core IgM Ab [Presence] in Serum
31204-1 [3013527]
1.3e+00
2.6e+00
2.5e+00
—
2.9e+00
1.3e+00
1.2e+00
cases:0.75%
controls:0.20%
cases:1.42%
controls:0.10%
cases:0.26%
controls:0.02%
—
—
cases:0.50%
controls:0.03%
cases:0.39%
controls:0.11%
cases:1.55%
controls:0.48%
20
53
2646
26580
38
28
2633
26647
7
6
2664
26669
—
13
7
2588
26594
9
27
2295
25596
27
99
1719
20377
Cathetrisation of artery
TPH07 [2001309747]
1.1e+00
1.3e+00
2.4e+00
—
2.6e+00
1.8e+00
1.2e+00
cases:4.13%
controls:1.44%
cases:1.87%
controls:0.51%
cases:0.37%
controls:0.03%
—
—
cases:0.88%
controls:0.06%
cases:2.99%
controls:0.48%
cases:4.64%
controls:1.40%
110
384
2556
26249
50
137
2621
26538
10
9
2661
26666
—
23
17
2578
26584
69
124
2235
25499
81
287
1665
20189
Oxygen capacity [Volume Fraction] in Arterial blood
59275-8 [40762366]
8.5e-01
1.5e+00
2.6e+00
—
2.8e+00
1.9e+00
8.6e-01
cases:2.18%
controls:0.95%
cases:1.95%
controls:0.45%
cases:0.52%
controls:0.04%
—
—
cases:1.35%
controls:0.08%
cases:2.52%
controls:0.40%
cases:3.32%
controls:1.43%
58
252
2608
26381
52
121
2619
26554
14
10
2657
26665
—
35
22
2566
26579
58
102
2246
25521
58
293
1688
20183
Respiratory and circulatory monitoring
WX700 [2001310817]
5.1e-01
1.4e+00
3.1e+00
1.0e+50
3.2e+00
1.6e+00
7.4e-01
cases:4.28%
controls:2.61%
cases:2.92%
controls:0.75%
cases:1.20%
controls:0.06%
cases:1.09%
controls:0.00%
cases:1.46%
controls:0.06%
cases:3.13%
controls:0.66%
cases:4.52%
controls:2.21%
114
696
2552
25937
78
201
2593
26474
32
15
2639
26660
29
0
2642
26675
38
16
2563
26585
72
170
2232
25453
79
452
1667
20024
Ketones [Presence] in Urine by Test strip
2514-8 [3035350]
3.1e-01
7.6e-01
1.8e+00
5.1e+00
1.6e+00
6.1e-01
2.7e-01
cases:15.64%
controls:11.97%
cases:14.04%
controls:7.13%
cases:5.99%
controls:1.07%
cases:7.45%
controls:0.05%
cases:4.77%
controls:1.00%
cases:13.24%
controls:7.64%
cases:24.74%
controls:19.98%
417
3187
2249
23446
375
1901
2296
24774
160
285
2511
26390
199
13
2472
26662
124
265
2477
26336
305
1957
1999
23666
432
4092
1314
16384
Abdominal X-ray examination without contrast
JN3AA [2001305553]
1.4e+00
1.7e+00
—
1.0e+50
3.2e+00
2.5e+00
1.6e+00
cases:1.69%
controls:0.41%
cases:0.64%
controls:0.12%
—
—
cases:0.60%
controls:0.00%
cases:0.46%
controls:0.02%
cases:1.00%
controls:0.08%
cases:1.55%
controls:0.33%
45
108
2621
26525
17
31
2654
26644
—
16
0
2655
26675
12
5
2589
26596
23
21
2281
25602
27
67
1719
20409
Nitrite [Presence] in Urine by Test strip
5802-4 [3021601]
3.1e-01
7.5e-01
1.7e+00
5.1e+00
1.6e+00
6.1e-01
2.7e-01
cases:15.38%
controls:11.74%
cases:13.82%
controls:7.01%
cases:5.73%
controls:1.06%
cases:7.49%
controls:0.05%
cases:4.73%
controls:0.98%
cases:13.02%
controls:7.54%
cases:24.28%
controls:19.68%
410
3126
2256
23507
369
1869
2302
24806
153
283
2518
26392
200
13
2471
26662
123
261
2478
26340
300
1932
2004
23691
424
4030
1322
16446
Physiotherapy
R4110 [2001310233]
4.0e-01
8.4e-01
1.5e+00
4.0e+00
1.8e+00
1.2e+00
6.4e-01
cases:8.06%
controls:5.53%
cases:4.46%
controls:1.98%
cases:0.97%
controls:0.23%
cases:1.01%
controls:0.02%
cases:1.69%
controls:0.27%
cases:5.25%
controls:1.65%
cases:8.36%
controls:4.60%
215
1473
2451
25160
119
528
2552
26147
26
61
2645
26614
27
5
2644
26670
44
72
2557
26529
121
424
2183
25199
146
941
1600
19535
Glucose [Presence] in Urine by Test strip
25428-4 [3009261]
3.0e-01
7.4e-01
1.8e+00
5.0e+00
1.6e+00
6.3e-01
2.6e-01
cases:15.87%
controls:12.21%
cases:14.08%
controls:7.26%
cases:6.03%
controls:1.07%
cases:7.53%
controls:0.05%
cases:4.73%
controls:0.99%
cases:13.37%
controls:7.62%
cases:24.51%
controls:19.97%
423
3252
2243
23381
376
1936
2295
24739
161
286
2510
26389
201
14
2470
26661
123
264
2478
26337
308
1952
1996
23671
428
4089
1318
16387
Extensive body CT
JN4BD [2001310899]
8.5e-01
1.7e+00
1.9e+00
1.0e+50
2.3e+00
2.2e+00
1.4e+00
cases:3.56%
controls:1.55%
cases:2.88%
controls:0.57%
cases:0.56%
controls:0.08%
cases:0.86%
controls:0.00%
cases:0.65%
controls:0.06%
cases:2.86%
controls:0.31%
cases:3.09%
controls:0.82%
95
414
2571
26219
77
151
2594
26524
15
22
2656
26653
23
0
2648
26675
17
17
2584
26584
66
80
2238
25543
54
168
1692
20308
Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M
62238-1 [40764999]
1.8e-01
5.4e-01
1.8e+00
4.8e+00
2.2e+00
5.8e-01
3.3e-01
cases:33.31%
controls:29.45%
cases:36.43%
controls:25.09%
cases:25.95%
controls:5.55%
cases:26.54%
controls:0.31%
cases:33.76%
controls:5.44%
cases:38.85%
controls:26.23%
cases:49.89%
controls:41.79%
888
7844
1778
18789
973
6694
1698
19981
693
1481
1978
25194
709
83
1962
26592
878
1448
1723
25153
895
6720
1409
18903
871
8557
875
11919
General anesthesia, balanced
WX408 [2001310808]
6.9e-01
1.4e+00
2.1e+00
1.0e+50
2.8e+00
2.1e+00
1.3e+00
cases:7.84%
controls:4.09%
cases:3.89%
controls:1.02%
cases:0.60%
controls:0.07%
cases:0.64%
controls:0.00%
cases:1.15%
controls:0.07%
cases:5.08%
controls:0.68%
cases:7.22%
controls:2.00%
209
1089
2457
25544
104
271
2567
26404
16
20
2655
26655
17
0
2654
26675
30
19
2571
26582
117
174
2187
25449
126
409
1620
20067
Bacteria identified in Stool by Culture
625-4 [3025941]
8.7e-01
1.5e+00
3.0e+00
1.0e+50
2.6e+00
1.1e+00
1.2e+00
cases:2.48%
controls:1.05%
cases:1.46%
controls:0.33%
cases:0.37%
controls:0.02%
cases:0.26%
controls:0.00%
cases:0.42%
controls:0.03%
cases:0.78%
controls:0.25%
cases:2.81%
controls:0.90%
66
280
2600
26353
39
87
2632
26588
10
5
2661
26670
7
0
2664
26675
11
8
2590
26593
18
65
2286
25558
49
185
1697
20291
Melaena
K92.1 [45533624]
1.2e+00
1.8e+00
2.1e+00
—
2.7e+00
1.4e+00
1.2e+00
cases:1.88%
controls:0.55%
cases:1.01%
controls:0.18%
cases:0.30%
controls:0.04%
—
—
cases:0.38%
controls:0.03%
cases:0.65%
controls:0.17%
cases:2.29%
controls:0.71%
50
147
2616
26486
27
47
2644
26628
8
10
2663
26665
—
10
7
2591
26594
15
43
2289
25580
40
145
1706
20331
filgrastim; parenteral
L03AA02 [21603851]
1.5e+00
2.3e+00
2.9e+00
—
—
2.4e+00
1.2e+00
cases:0.83%
controls:0.19%
cases:1.09%
controls:0.11%
cases:0.34%
controls:0.02%
—
—
—
—
cases:0.95%
controls:0.09%
cases:0.69%
controls:0.21%
22
50
2644
26583
29
29
2642
26646
9
5
2662
26670
—
—
22
23
2282
25600
12
42
1734
20434
Coloscopy
UJF32 [2001305029]
1.1e+00
1.6e+00
2.0e+00
—
1.9e+00
1.8e+00
1.8e+00
cases:12.64%
controls:4.42%
cases:6.74%
controls:1.38%
cases:0.82%
controls:0.11%
—
—
cases:0.77%
controls:0.12%
cases:6.94%
controls:1.18%
cases:18.79%
controls:3.79%
337
1176
2329
25457
180
369
2491
26306
22
30
2649
26645
—
20
31
2581
26570
160
302
2144
25321
328
777
1418
19699
Type 2 diabetes mellitus, without complications
E11.9 [45561952]
3.0e-01
6.8e-01
1.4e+00
4.7e+00
2.0e+00
7.9e-01
4.2e-01
cases:8.89%
controls:6.73%
cases:6.44%
controls:3.37%
cases:2.62%
controls:0.66%
cases:3.97%
controls:0.04%
cases:3.92%
controls:0.57%
cases:7.55%
controls:3.56%
cases:11.51%
controls:7.91%
237
1792
2429
24841
172
899
2499
25776
70
175
2601
26500
106
10
2565
26665
102
151
2499
26450
174
912
2130
24711
201
1619
1545
18857
Medical doctor
Z2221 [2001311556]
3.9e-01
1.3e+00
2.4e+00
—
2.4e+00
2.1e+00
1.7e+00
cases:7.16%
controls:4.98%
cases:4.57%
controls:1.27%
cases:1.72%
controls:0.16%
—
—
cases:2.15%
controls:0.21%
cases:7.81%
controls:0.98%
cases:13.06%
controls:2.75%
191
1327
2475
25306
122
339
2549
26336
46
43
2625
26632
—
56
55
2545
26546
180
252
2124
25371
228
564
1518
19912
cefalexin; oral
J01DB01 [21602870]
4.4e-01
9.0e-01
1.5e+00
2.9e+00
2.8e+00
9.7e-01
6.6e-01
cases:37.47%
controls:27.84%
cases:18.61%
controls:8.51%
cases:4.38%
controls:0.97%
cases:0.52%
controls:0.03%
cases:14.19%
controls:1.00%
cases:19.31%
controls:8.29%
cases:39.75%
controls:25.40%
999
7415
1667
19218
497
2271
2174
24404
117
259
2554
26416
14
8
2657
26667
369
265
2232
26336
445
2125
1859
23498
694
5200
1052
15276
pH of Urine
2756-5 [3015736]
2.2e-01
6.8e-01
1.7e+00
5.0e+00
1.6e+00
5.7e-01
2.8e-01
cases:11.78%
controls:9.64%
cases:9.92%
controls:5.27%
cases:4.16%
controls:0.76%
cases:4.94%
controls:0.03%
cases:3.38%
controls:0.68%
cases:9.33%
controls:5.48%
cases:19.07%
controls:15.07%
314
2567
2352
24066
265
1406
2406
25269
111
202
2560
26473
132
9
2539
26666
88
181
2513
26420
215
1405
2089
24218
333
3086
1413
17390
Platelets [#/volume] in Blood
26515-7 [3007461]
1.2e-01
5.5e-01
1.9e+00
4.8e+00
2.2e+00
5.7e-01
1.5e-01
cases:48.12%
controls:45.06%
cases:51.93%
controls:38.29%
cases:39.01%
controls:8.73%
cases:38.79%
controls:0.51%
cases:46.75%
controls:8.55%
cases:52.73%
controls:38.68%
cases:61.97%
controls:58.30%
1283
12001
1383
14632
1387
10214
1284
16461
1042
2329
1629
24346
1036
136
1635
26539
1216
2275
1385
24326
1215
9911
1089
15712
1082
11937
664
8539
MCH [Entitic mass]
28539-5 [3035941]
1.2e-01
5.5e-01
1.9e+00
4.8e+00
2.2e+00
5.7e-01
1.5e-01
cases:48.09%
controls:45.09%
cases:51.93%
controls:38.30%
cases:39.01%
controls:8.73%
cases:38.79%
controls:0.51%
cases:46.75%
controls:8.55%
cases:52.73%
controls:38.67%
cases:61.97%
controls:58.34%
1282
12008
1384
14625
1387
10217
1284
16458
1042
2330
1629
24345
1036
136
1635
26539
1216
2275
1385
24326
1215
9909
1089
15714
1082
11945
664
8531
MCV [Entitic mean volume] in Red Blood Cells
30428-7 [3024731]
1.2e-01
5.5e-01
1.9e+00
4.8e+00
2.2e+00
5.7e-01
1.5e-01
cases:48.16%
controls:45.13%
cases:51.93%
controls:38.35%
cases:39.01%
controls:8.75%
cases:38.79%
controls:0.51%
cases:46.75%
controls:8.56%
cases:52.73%
controls:38.71%
cases:61.97%
controls:58.38%
1284
12020
1382
14613
1387
10229
1284
16446
1042
2333
1629
24342
1036
136
1635
26539
1216
2278
1385
24323
1215
9919
1089
15704
1082
11954
664
8522
Hematocrit [Volume Fraction] of Blood by calculation
20570-8 [3009542]
1.2e-01
5.5e-01
1.9e+00
4.8e+00
2.2e+00
5.7e-01
1.5e-01
cases:48.16%
controls:45.14%
cases:51.93%
controls:38.35%
cases:39.05%
controls:8.76%
cases:38.79%
controls:0.51%
cases:46.75%
controls:8.57%
cases:52.73%
controls:38.70%
cases:61.97%
controls:58.39%
1284
12022
1382
14611
1387
10231
1284
16444
1043
2337
1628
24338
1036
136
1635
26539
1216
2279
1385
24322
1215
9916
1089
15707
1082
11956
664
8520
Leukocytes [#/volume] in Blood
26464-8 [3010813]
1.2e-01
5.5e-01
1.9e+00
4.8e+00
2.2e+00
5.7e-01
1.5e-01
cases:48.20%
controls:45.17%
cases:51.89%
controls:38.40%
cases:39.05%
controls:8.76%
cases:38.82%
controls:0.51%
cases:46.75%
controls:8.57%
cases:52.82%
controls:38.75%
cases:61.97%
controls:58.44%
1285
12030
1381
14603
1386
10242
1285
16433
1043
2337
1628
24338
1037
136
1634
26539
1216
2281
1385
24320
1217
9929
1087
15694
1082
11966
664
8510
Urgent procedure
ZXD05 [2001311386]
7.2e-01
1.5e+00
2.2e+00
1.0e+50
3.5e+00
1.4e+00
8.3e-01
cases:8.03%
controls:4.09%
cases:4.04%
controls:0.98%
cases:1.05%
controls:0.12%
cases:2.43%
controls:0.00%
cases:1.73%
controls:0.05%
cases:3.26%
controls:0.85%
cases:6.93%
controls:3.15%
214
1090
2452
25543
108
261
2563
26414
28
31
2643
26644
65
0
2606
26675
45
14
2556
26587
75
219
2229
25404
121
646
1625
19830
Erythrocytes [#/volume] in Blood
26453-1 [3026361]
1.2e-01
5.5e-01
1.9e+00
4.8e+00
2.2e+00
5.7e-01
1.5e-01
cases:48.12%
controls:45.14%
cases:51.93%
controls:38.37%
cases:39.01%
controls:8.75%
cases:38.79%
controls:0.51%
cases:46.75%
controls:8.56%
cases:52.73%
controls:38.73%
cases:61.97%
controls:58.39%
1283
12023
1383
14610
1387
10235
1284
16440
1042
2335
1629
24340
1036
136
1635
26539
1216
2278
1385
24323
1215
9924
1089
15699
1082
11956
664
8520
Hemoglobin [Mass/volume] in Blood
718-7 [3000963]
1.2e-01
5.5e-01
1.9e+00
4.8e+00
2.2e+00
5.7e-01
1.5e-01
cases:48.16%
controls:45.18%
cases:51.93%
controls:38.42%
cases:39.05%
controls:8.77%
cases:38.82%
controls:0.51%
cases:46.75%
controls:8.59%
cases:52.73%
controls:38.77%
cases:62.03%
controls:58.45%
1284
12032
1382
14601
1387
10248
1284
16427
1043
2339
1628
24336
1037
137
1634
26538
1216
2284
1385
24317
1215
9935
1089
15688
1083
11968
663
8508
Scheduled procedure
ZXD10 [2001311387]
4.7e-01
1.1e+00
2.3e+00
1.0e+50
2.5e+00
2.2e+00
1.5e+00
cases:10.17%
controls:6.60%
cases:4.57%
controls:1.60%
cases:1.50%
controls:0.16%
cases:2.43%
controls:0.00%
cases:1.81%
controls:0.15%
cases:8.59%
controls:1.04%
cases:13.06%
controls:3.18%
271
1759
2395
24874
122
427
2549
26248
40
42
2631
26633
65
0
2606
26675
47
39
2554
26562
198
266
2106
25357
228
651
1518
19825
Gas panel - Central venous blood
97535-9 [1616796]
1.0e+00
1.5e+00
2.1e+00
1.0e+50
2.8e+00
1.5e+00
1.1e+00
cases:1.28%
controls:0.45%
cases:0.86%
controls:0.19%
cases:0.22%
controls:0.03%
cases:0.22%
controls:0.00%
cases:0.42%
controls:0.03%
cases:0.82%
controls:0.18%
cases:1.72%
controls:0.60%
34
121
2632
26512
23
52
2648
26623
6
7
2665
26668
6
0
2665
26675
11
7
2590
26594
19
46
2285
25577
30
123
1716
20353
Clinic/Center
261Q00000X [38004207]
8.5e-01
1.7e+00
2.0e+00
—
2.1e+00
1.9e+00
1.5e+00
cases:1.91%
controls:0.83%
cases:1.46%
controls:0.26%
cases:0.45%
controls:0.06%
—
—
cases:0.65%
controls:0.08%
cases:1.74%
controls:0.27%
cases:2.41%
controls:0.56%
51
220
2615
26413
39
69
2632
26606
12
17
2659
26658
—
17
21
2584
26580
40
68
2264
25555
42
115
1704
20361
Ulcerative (chronic) pancolitis
K51.0 [45557656]
2.8e+00
—
—
—
—
3.3e+00
3.9e+00
cases:1.01%
controls:0.06%
—
—
—
—
—
—
—
—
cases:0.65%
controls:0.02%
cases:1.60%
controls:0.03%
27
17
2639
26616
—
—
—
—
15
6
2289
25617
28
7
1718
20469
loperamide; oral
A07DA03 [21600646]
1.1e+00
2.0e+00
2.0e+00
—
1.8e+00
1.8e+00
1.4e+00
cases:3.30%
controls:1.16%
cases:3.52%
controls:0.51%
cases:0.90%
controls:0.12%
—
—
cases:0.62%
controls:0.11%
cases:3.86%
controls:0.69%
cases:5.27%
controls:1.31%
88
310
2578
26323
94
137
2577
26538
24
33
2647
26642
—
16
28
2585
26573
89
177
2215
25446
92
268
1654
20208
loperamide oxide; oral
A07DA05 [21600648]
1.1e+00
2.0e+00
2.0e+00
—
1.8e+00
1.8e+00
1.4e+00
cases:3.30%
controls:1.16%
cases:3.52%
controls:0.51%
cases:0.90%
controls:0.12%
—
—
cases:0.62%
controls:0.11%
cases:3.86%
controls:0.69%
cases:5.27%
controls:1.31%
88
310
2578
26323
94
137
2577
26538
24
33
2647
26642
—
16
28
2585
26573
89
177
2215
25446
92
268
1654
20208
Bicarbonate [Moles/volume] in Serum or Plasma
1963-8 [3016293]
9.1e-01
1.2e+00
2.4e+00
—
2.8e+00
1.6e+00
1.1e+00
cases:2.78%
controls:1.13%
cases:1.98%
controls:0.61%
cases:0.75%
controls:0.07%
—
—
cases:1.58%
controls:0.10%
cases:2.95%
controls:0.59%
cases:4.35%
controls:1.50%
74
302
2592
26331
53
163
2618
26512
20
19
2651
26656
—
41
27
2560
26574
68
150
2236
25473
76
308
1670
20168
Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
34487-9 [3044938]
8.3e-01
1.4e+00
2.8e+00
—
2.4e+00
1.6e+00
8.8e-01
cases:5.89%
controls:2.66%
cases:5.54%
controls:1.41%
cases:3.18%
controls:0.20%
—
—
cases:2.50%
controls:0.23%
cases:7.25%
controls:1.56%
cases:11.86%
controls:5.26%
157
708
2509
25925
148
377
2523
26298
85
53
2586
26622
—
65
60
2536
26541
167
400
2137
25223
207
1078
1539
19398
Hepatitis B virus core Ab [Presence] in Serum
16933-4 [3021879]
9.0e-01
1.6e+00
2.2e+00
—
3.0e+00
1.2e+00
1.0e+00
cases:2.74%
controls:1.13%
cases:2.47%
controls:0.51%
cases:0.49%
controls:0.05%
—
—
cases:0.73%
controls:0.04%
cases:1.13%
controls:0.34%
cases:3.38%
controls:1.23%
73
301
2593
26332
66
135
2605
26540
13
14
2658
26661
—
19
10
2582
26591
26
88
2278
25535
59
251
1687
20225
Stomach Pathology biopsy report
66114-0 [40768797]
6.8e-01
1.7e+00
2.0e+00
1.0e+50
3.1e+00
1.5e+00
9.5e-01
cases:5.51%
controls:2.88%
cases:4.34%
controls:0.83%
cases:0.75%
controls:0.10%
cases:0.37%
controls:0.00%
cases:1.73%
controls:0.08%
cases:3.34%
controls:0.79%
cases:6.47%
controls:2.60%
147
767
2519
25866
116
222
2555
26453
20
27
2651
26648
10
0
2661
26675
45
21
2556
26580
77
202
2227
25421
113
532
1633
19944
Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
76080-1 [46235759]
6.5e-01
1.2e+00
2.6e+00
1.0e+50
2.6e+00
1.5e+00
1.3e+00
cases:1.31%
controls:0.69%
cases:1.35%
controls:0.39%
cases:0.79%
controls:0.06%
cases:1.39%
controls:0.00%
cases:0.50%
controls:0.04%
cases:1.52%
controls:0.33%
cases:3.21%
controls:0.94%
35
184
2631
26449
36
105
2635
26570
21
16
2650
26659
37
0
2634
26675
13
10
2588
26591
35
84
2269
25539
56
192
1690
20284
Crohn disease [regional enteritis]
K50 [45755435]
2.4e+00
2.4e+00
—
—
—
2.2e+00
2.8e+00
cases:0.60%
controls:0.06%
cases:0.30%
controls:0.03%
—
—
—
—
—
—
cases:0.35%
controls:0.04%
cases:0.74%
controls:0.04%
16
15
2650
26618
8
7
2663
26668
—
—
—
8
10
2296
25613
13
9
1733
20467
Noninvasive ventilation
WX725 [2001310828]
4.5e-01
1.3e+00
2.3e+00
1.0e+50
3.7e+00
1.7e+00
8.6e-01
cases:0.94%
controls:0.60%
cases:0.71%
controls:0.19%
cases:0.34%
controls:0.03%
cases:0.45%
controls:0.00%
cases:0.73%
controls:0.02%
cases:1.17%
controls:0.23%
cases:1.78%
controls:0.76%
25
159
2641
26474
19
50
2652
26625
9
9
2662
26666
12
0
2659
26675
19
5
2582
26596
27
58
2277
25565
31
155
1715
20321
hydroxyzine; oral, parenteral
N05BB01 [21604590]
7.7e-01
1.6e+00
2.6e+00
—
2.4e+00
1.5e+00
9.9e-01
cases:4.09%
controls:1.93%
cases:3.71%
controls:0.76%
cases:1.46%
controls:0.11%
—
—
cases:1.23%
controls:0.12%
cases:2.69%
controls:0.63%
cases:4.64%
controls:1.77%
109
514
2557
26119
99
203
2572
26472
39
30
2632
26645
—
32
31
2569
26570
62
162
2242
25461
81
362
1665
20114
Thorax X-ray examination outside radiological department
GD1UA [2001303652]
9.9e-01
1.3e+00
2.2e+00
1.0e+50
2.6e+00
1.7e+00
9.9e-01
cases:5.81%
controls:2.25%
cases:3.00%
controls:0.82%
cases:0.79%
controls:0.09%
cases:1.54%
controls:0.00%
cases:1.35%
controls:0.10%
cases:3.34%
controls:0.64%
cases:5.96%
controls:2.30%
155
599
2511
26034
80
219
2591
26456
21
24
2650
26651
41
0
2630
26675
35
26
2566
26575
77
165
2227
25458
104
470
1642
20006
Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
13317-3 [3019902]
7.6e-01
1.1e+00
2.4e+00
—
3.2e+00
1.4e+00
8.6e-01
cases:5.18%
controls:2.48%
cases:3.48%
controls:1.14%
cases:1.91%
controls:0.18%
—
—
cases:3.46%
controls:0.14%
cases:4.12%
controls:1.06%
cases:5.96%
controls:2.61%
138
660
2528
25973
93
304
2578
26371
51
47
2620
26628
—
90
38
2511
26563
95
272
2209
25351
104
534
1642
19942
Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
92695-6 [37019628]
7.2e-01
2.1e+00
2.5e+00
—
2.4e+00
1.4e+00
1.3e+00
cases:0.79%
controls:0.39%
cases:1.09%
controls:0.13%
cases:0.22%
controls:0.02%
—
—
cases:0.38%
controls:0.03%
cases:0.78%
controls:0.20%
cases:2.35%
controls:0.62%
21
103
2645
26530
29
36
2642
26639
6
5
2665
26670
—
10
9
2591
26592
18
50
2286
25573
41
127
1705
20349
Colonoscopy Study observation
28023-0 [3022145]
8.9e-01
1.6e+00
1.8e+00
—
1.6e+00
2.0e+00
1.7e+00
cases:5.03%
controls:2.14%
cases:3.89%
controls:0.78%
cases:0.45%
controls:0.07%
—
—
cases:0.54%
controls:0.11%
cases:5.77%
controls:0.79%
cases:13.23%
controls:2.61%
134
569
2532
26064
104
208
2567
26467
12
19
2659
26656
—
14
29
2587
26572
133
202
2171
25421
231
535
1515
19941
Sepsis due to other Gram-negative organisms
A41.5 [45556902]
1.8e+00
3.0e+00
—
1.0e+50
—
3.0e+00
1.9e+00
cases:1.88%
controls:0.31%
cases:1.83%
controls:0.09%
—
—
cases:2.43%
controls:0.00%
—
—
cases:2.43%
controls:0.12%
cases:3.15%
controls:0.47%
50
83
2616
26550
49
25
2622
26650
—
65
0
2606
26675
—
56
31
2248
25592
55
97
1691
20379
Magnesium [Moles/volume] in Serum or Plasma
2601-3 [3012095]
7.1e-01
1.5e+00
2.0e+00
—
2.8e+00
1.6e+00
1.1e+00
cases:6.41%
controls:3.27%
cases:6.25%
controls:1.42%
cases:1.80%
controls:0.25%
—
—
cases:3.42%
controls:0.21%
cases:6.73%
controls:1.41%
cases:10.77%
controls:4.00%
171
871
2495
25762
167
378
2504
26297
48
66
2623
26609
—
89
56
2512
26545
155
362
2149
25261
188
819
1558
19657
Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
40982-1 [3038288]
8.3e-01
1.4e+00
2.8e+00
—
2.4e+00
1.6e+00
6.9e-01
cases:4.09%
controls:1.82%
cases:3.67%
controls:0.92%
cases:2.02%
controls:0.12%
—
—
cases:1.77%
controls:0.17%
cases:4.90%
controls:1.07%
cases:7.45%
controls:3.87%
109
486
2557
26147
98
245
2573
26430
54
32
2617
26643
—
46
44
2555
26557
113
275
2191
25348
130
793
1616
19683
Intravenous
ZX120 [2001311495]
9.7e-01
1.4e+00
1.8e+00
—
1.6e+00
2.2e+00
1.8e+00
cases:3.19%
controls:1.24%
cases:2.10%
controls:0.54%
cases:0.64%
controls:0.10%
—
—
cases:0.38%
controls:0.08%
cases:3.26%
controls:0.37%
cases:4.98%
controls:0.89%
85
329
2581
26304
56
145
2615
26530
17
28
2654
26647
—
10
21
2591
26580
75
95
2229
25528
87
182
1659
20294
SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
94500-6 [706163]
1.7e-01
5.2e-01
2.0e+00
4.9e+00
1.4e+00
6.1e-01
2.6e-01
cases:10.92%
controls:9.39%
cases:8.61%
controls:5.30%
cases:4.72%
controls:0.69%
cases:5.35%
controls:0.04%
cases:3.15%
controls:0.79%
cases:10.37%
controls:5.89%
cases:21.88%
controls:17.69%
291
2502
2375
24131
230
1413
2441
25262
126
184
2545
26491
143
11
2528
26664
82
211
2519
26390
239
1509
2065
24114
382
3622
1364
16854
Ceruloplasmin [Mass/volume] in Serum or Plasma
2064-4 [3022756]
2.1e+00
3.6e+00
1.0e+50
—
—
2.4e+00
1.6e+00
cases:0.86%
controls:0.11%
cases:1.72%
controls:0.05%
cases:0.34%
controls:0.00%
—
—
—
—
cases:0.22%
controls:0.02%
cases:0.52%
controls:0.10%
23
29
2643
26604
46
13
2625
26662
9
0
2662
26675
—
—
5
5
2299
25618
9
21
1737
20455
Other specified sepsis
A41.8 [45595587]
1.8e+00
2.6e+00
1.0e+50
1.0e+50
—
3.4e+00
1.9e+00
cases:0.53%
controls:0.09%
cases:0.67%
controls:0.05%
cases:0.19%
controls:0.00%
cases:0.94%
controls:0.00%
—
—
cases:1.43%
controls:0.05%
cases:1.55%
controls:0.23%
14
24
2652
26609
18
13
2653
26662
5
0
2666
26675
25
0
2646
26675
—
33
13
2271
25610
27
48
1719
20428
Enteroscopy of ileoanal anastomosis
UJF14 [2001305026]
2.5e+00
—
—
—
—
3.5e+00
3.6e+00
cases:0.45%
controls:0.04%
—
—
—
—
—
—
—
—
cases:0.65%
controls:0.02%
cases:1.66%
controls:0.04%
12
10
2654
26623
—
—
—
—
15
5
2289
25618
29
9
1717
20467
Other transluminal endoscopic operation on stomach or duodenum
JDW98 [2001304774]
1.7e+00
2.4e+00
1.0e+50
1.0e+50
—
2.7e+00
2.8e+00
cases:0.71%
controls:0.13%
cases:0.49%
controls:0.04%
cases:0.19%
controls:0.00%
cases:0.34%
controls:0.00%
—
—
cases:0.78%
controls:0.05%
cases:1.55%
controls:0.10%
19
34
2647
26599
13
12
2658
26663
5
0
2666
26675
9
0
2662
26675
—
18
13
2286
25610
27
20
1719
20456
Erythrocyte [DistWidth] in Red Blood Cells
30385-9 [3002385]
5.5e-02
4.4e-01
1.8e+00
4.6e+00
2.0e+00
5.5e-01
2.4e-01
cases:29.93%
controls:28.80%
cases:32.98%
controls:24.06%
cases:25.61%
controls:5.58%
cases:23.92%
controls:0.30%
cases:29.64%
controls:5.52%
cases:35.94%
controls:24.53%
cases:45.13%
controls:39.27%
798
7670
1868
18963
881
6418
1790
20257
684
1489
1987
25186
639
80
2032
26595
771
1469
1830
25132
828
6285
1476
19338
788
8040
958
12436
Malignant neoplasm: Liver cell carcinoma
C22.0 [45552247]
—
3.3e+00
—
1.0e+50
—
3.8e+00
2.6e+00
—
—
cases:0.71%
controls:0.03%
—
—
cases:0.52%
controls:0.00%
—
—
cases:0.82%
controls:0.02%
cases:0.69%
controls:0.05%
—
19
7
2652
26668
—
14
0
2657
26675
—
19
5
2285
25618
12
11
1734
20465
Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
78445-4 [21492711]
2.2e+00
3.2e+00
1.0e+50
—
—
2.2e+00
1.9e+00
cases:0.56%
controls:0.06%
cases:0.56%
controls:0.02%
cases:0.19%
controls:0.00%
—
—
—
—
cases:0.39%
controls:0.04%
cases:1.09%
controls:0.16%
15
16
2651
26617
15
6
2656
26669
5
0
2666
26675
—
—
9
11
2295
25612
19
33
1727
20443
Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
40987-0 [3043924]
8.4e-01
1.4e+00
2.7e+00
—
2.4e+00
1.6e+00
7.7e-01
cases:3.98%
controls:1.75%
cases:3.74%
controls:0.97%
cases:2.06%
controls:0.15%
—
—
cases:1.85%
controls:0.18%
cases:5.38%
controls:1.17%
cases:8.36%
controls:4.07%
106
466
2560
26167
100
260
2571
26415
55
39
2616
26636
—
48
47
2553
26554
124
300
2180
25323
146
834
1600
19642
X-ray examination of the lungs in one projection
GD1PA [2001303645]
6.1e-01
1.5e+00
2.6e+00
—
2.5e+00
1.5e+00
8.8e-01
cases:2.33%
controls:1.28%
cases:2.06%
controls:0.48%
cases:0.86%
controls:0.06%
—
—
cases:0.62%
controls:0.05%
cases:2.30%
controls:0.51%
cases:4.35%
controls:1.86%
62
341
2604
26292
55
127
2616
26548
23
17
2648
26658
—
16
14
2585
26587
53
131
2251
25492
76
380
1670
20096
Laparoscopy
JAH01 [2001304475]
1.7e+00
2.9e+00
—
—
1.0e+50
3.7e+00
1.2e+00
cases:1.28%
controls:0.23%
cases:0.86%
controls:0.05%
—
—
—
—
cases:0.50%
controls:0.00%
cases:1.74%
controls:0.04%
cases:0.86%
controls:0.25%
34
61
2632
26572
23
13
2648
26662
—
—
13
0
2588
26601
40
11
2264
25612
15
52
1731
20424
amoxicillin and beta-lactamase inhibitor; oral, parenteral
J01CR02 [21602863]
4.8e-01
1.2e+00
2.0e+00
—
3.6e+00
1.5e+00
7.6e-01
cases:11.93%
controls:7.76%
cases:6.78%
controls:2.10%
cases:1.76%
controls:0.25%
—
—
cases:8.69%
controls:0.26%
cases:9.33%
controls:2.25%
cases:15.35%
controls:7.84%
318
2066
2348
24567
181
559
2490
26116
47
66
2624
26609
—
226
68
2375
26533
215
577
2089
25046
268
1605
1478
18871
Cystatin C [Mass/volume] in Serum or Plasma
33863-2 [3030366]
7.3e-01
1.3e+00
2.4e+00
—
2.0e+00
1.6e+00
1.5e+00
cases:1.35%
controls:0.65%
cases:1.46%
controls:0.40%
cases:0.64%
controls:0.06%
—
—
cases:0.35%
controls:0.05%
cases:1.91%
controls:0.38%
cases:3.84%
controls:0.91%
36
174
2630
26459
39
106
2632
26569
17
15
2654
26660
—
9
13
2592
26588
44
97
2260
25526
67
186
1679
20290
Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
1777-2 [3001467]
1.9e+00
3.0e+00
—
—
—
2.3e+00
2.3e+00
cases:1.20%
controls:0.18%
cases:1.46%
controls:0.07%
—
—
—
—
—
—
cases:0.56%
controls:0.06%
cases:1.78%
controls:0.18%
32
49
2634
26584
39
19
2632
26656
—
—
—
13
15
2291
25608
31
36
1715
20440
Malignant neoplasm: Head of pancreas
C25.0 [45590881]
—
5.2e+00
—
1.0e+50
—
—
4.3e+00
—
—
cases:3.93%
controls:0.02%
—
—
cases:3.59%
controls:0.00%
—
—
—
—
cases:2.12%
controls:0.03%
—
105
6
2566
26669
—
96
0
2575
26675
—
—
37
6
1709
20470
Body temperature
8310-5 [3020891]
1.1e+00
1.5e+00
2.1e+00
1.0e+50
2.8e+00
1.3e+00
7.6e-01
cases:2.33%
controls:0.77%
cases:1.61%
controls:0.38%
cases:0.60%
controls:0.07%
cases:1.39%
controls:0.00%
cases:1.11%
controls:0.07%
cases:1.56%
controls:0.44%
cases:2.86%
controls:1.36%
62
204
2604
26429
43
101
2628
26574
16
20
2655
26655
37
0
2634
26675
29
19
2572
26582
36
114
2268
25509
50
278
1696
20198
Methemoglobin/Hemoglobin.total in Blood
2614-6 [3007930]
1.1e+00
1.5e+00
2.5e+00
—
3.0e+00
1.4e+00
4.6e-01
cases:1.95%
controls:0.68%
cases:1.54%
controls:0.33%
cases:0.52%
controls:0.04%
—
—
cases:0.96%
controls:0.05%
cases:1.56%
controls:0.40%
cases:2.12%
controls:1.35%
52
182
2614
26451
41
89
2630
26586
14
12
2657
26663
—
25
13
2576
26588
36
102
2268
25521
37
276
1709
20200
Other and unspecified ventral hernia without obstruction or gangrene
K43.9 [45533594]
9.4e-01
1.5e+00
2.5e+00
1.0e+50
—
2.3e+00
2.2e+00
cases:1.05%
controls:0.41%
cases:0.56%
controls:0.13%
cases:0.22%
controls:0.02%
cases:0.19%
controls:0.00%
—
—
cases:1.17%
controls:0.12%
cases:2.29%
controls:0.26%
28
110
2638
26523
15
35
2656
26640
6
5
2665
26670
5
0
2666
26675
—
27
30
2277
25593
40
53
1706
20423
Microscopic observation [Identifier] in Isolate by Gram stain
87975-9 [36305247]
9.5e-01
1.4e+00
—
1.0e+50
3.5e+00
2.4e+00
1.1e+00
cases:1.20%
controls:0.47%
cases:1.05%
controls:0.25%
—
—
cases:0.19%
controls:0.00%
cases:0.85%
controls:0.03%
cases:1.52%
controls:0.14%
cases:1.60%
controls:0.53%
32
124
2634
26509
28
68
2643
26607
—
5
0
2666
26675
22
7
2579
26594
35
36
2269
25587
28
108
1718
20368
Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
40988-8 [3044254]
4.8e-01
1.1e+00
2.5e+00
1.0e+50
2.9e+00
1.6e+00
1.3e+00
cases:1.01%
controls:0.63%
cases:1.09%
controls:0.35%
cases:0.71%
controls:0.06%
cases:1.39%
controls:0.00%
cases:0.46%
controls:0.03%
cases:1.39%
controls:0.29%
cases:3.21%
controls:0.89%
27
167
2639
26466
29
94
2642
26581
19
16
2652
26659
37
0
2634
26675
12
7
2589
26594
32
74
2272
25549
56
182
1690
20294
dalteparin; parenteral
B01AB04 [21600975]
7.4e-01
1.7e+00
2.5e+00
—
1.9e+00
2.3e+00
9.1e-01
cases:0.86%
controls:0.41%
cases:0.75%
controls:0.13%
cases:0.41%
controls:0.03%
—
—
cases:0.27%
controls:0.04%
cases:1.30%
controls:0.13%
cases:1.09%
controls:0.44%
23
110
2643
26523
20
35
2651
26640
11
9
2660
26666
—
7
11
2594
26590
30
33
2274
25590
19
90
1727
20386
naloxegol; oral
A06AH03 [43534741]
2.5e+00
2.3e+00
—
—
—
2.5e+00
2.1e+00
cases:0.26%
controls:0.02%
cases:0.26%
controls:0.03%
—
—
—
—
—
—
cases:0.82%
controls:0.07%
cases:0.57%
controls:0.07%
7
6
2659
26627
7
7
2664
26668
—
—
—
19
17
2285
25606
10
15
1736
20461
SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
94759-8 [586526]
6.1e-01
1.4e+00
3.2e+00
—
2.8e+00
1.4e+00
5.0e-01
cases:1.54%
controls:0.84%
cases:1.65%
controls:0.43%
cases:1.31%
controls:0.06%
—
—
cases:1.00%
controls:0.06%
cases:1.87%
controls:0.47%
cases:2.75%
controls:1.68%
41
225
2625
26408
44
114
2627
26561
35
15
2636
26660
—
26
16
2575
26585
43
121
2261
25502
48
344
1698
20132
Laparotomy
JAH00 [2001304474]
2.1e+00
2.6e+00
—
—
—
3.3e+00
1.3e+00
cases:1.05%
controls:0.13%
cases:0.94%
controls:0.07%
—
—
—
—
—
—
cases:0.95%
controls:0.04%
cases:0.74%
controls:0.21%
28
35
2638
26598
25
18
2646
26657
—
—
—
22
9
2282
25614
13
42
1733
20434
Carboxyhemoglobin/Hemoglobin.total in Blood
20563-3 [3023081]
1.0e+00
1.5e+00
2.4e+00
—
3.0e+00
1.4e+00
4.8e-01
cases:1.99%
controls:0.71%
cases:1.57%
controls:0.35%
cases:0.52%
controls:0.05%
—
—
cases:0.96%
controls:0.05%
cases:1.69%
controls:0.43%
cases:2.29%
controls:1.44%
53
189
2613
26444
42
94
2629
26581
14
13
2657
26662
—
25
13
2576
26588
39
110
2265
25513
40
294
1706
20182
Bicarbonate [Moles/volume] in Venous blood
14627-4 [3027273]
9.6e-01
1.4e+00
2.4e+00
—
2.4e+00
1.3e+00
7.1e-01
cases:2.40%
controls:0.93%
cases:1.98%
controls:0.48%
cases:0.86%
controls:0.07%
—
—
cases:1.11%
controls:0.10%
cases:2.13%
controls:0.59%
cases:3.55%
controls:1.78%
64
248
2602
26385
53
127
2618
26548
23
20
2648
26655
—
29
27
2572
26574
49
152
2255
25471
62
364
1684
20112
Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
95941-1 [36031861]
6.7e-01
1.3e+00
2.6e+00
—
2.6e+00
1.3e+00
6.4e-01
cases:1.20%
controls:0.62%
cases:1.72%
controls:0.47%
cases:0.94%
controls:0.07%
—
—
cases:0.92%
controls:0.07%
cases:1.91%
controls:0.50%
cases:4.12%
controls:2.21%
32
164
2634
26469
46
126
2625
26549
25
18
2646
26657
—
24
18
2577
26583
44
129
2260
25494
72
452
1674
20024
Pure hypercholesterolaemia
E78.01 [2000501514]
2.4e-01
6.1e-01
1.3e+00
4.9e+00
1.8e+00
5.6e-01
3.2e-03
cases:5.21%
controls:4.16%
cases:3.59%
controls:1.98%
cases:1.46%
controls:0.39%
cases:2.36%
controls:0.02%
cases:2.00%
controls:0.33%
cases:3.95%
controls:2.29%
cases:6.70%
controls:6.68%
139
1107
2527
25526
96
528
2575
26147
39
104
2632
26571
63
5
2608
26670
52
89
2549
26512
91
588
2213
25035
117
1368
1629
19108
Hemoglobin [Mass/volume] in Arterial blood
30313-1 [3002173]
8.7e-01
1.5e+00
2.1e+00
—
2.6e+00
1.5e+00
7.1e-01
cases:3.86%
controls:1.66%
cases:3.18%
controls:0.76%
cases:0.79%
controls:0.10%
—
—
cases:1.81%
controls:0.14%
cases:3.21%
controls:0.76%
cases:4.98%
controls:2.51%
103
442
2563
26191
85
202
2586
26473
21
26
2650
26649
—
47
38
2554
26563
74
195
2230
25428
87
514
1659
19962
nystatin; oral
A07AA02 [21600604]
6.5e-01
1.3e+00
2.6e+00
—
2.3e+00
1.6e+00
7.5e-01
cases:1.73%
controls:0.91%
cases:0.94%
controls:0.27%
cases:0.34%
controls:0.03%
—
—
cases:0.31%
controls:0.03%
cases:1.17%
controls:0.23%
cases:1.78%
controls:0.85%
46
243
2620
26390
25
72
2646
26603
9
7
2662
26668
—
8
8
2593
26593
27
60
2277
25563
31
174
1715
20302

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
513
813
7.53
320.08
2.3
1.2
—
—
—
0
0
1468
5787
4.30
312.86
15.5
4.0
87.33
86.94
%
0.22
1445
5660
365
135
31.03
307.65
2.4
1.3
—
—
—
0
0
1296
2243
10.05
307.65
11.2
2.4
18.68
7.73
umol/l
21.92
1230
1950
2365
11741
8.33
307.65
28.1
6.0
18.72
11.88
umol/l
35.66
2330
11168
2107
10533
5.30
307.65
17.1
4.9
33.50
35.50
g/l
41.51
2049
9842
928
1984
6.56
307.65
8.7
1.8
43.34
32.43
u/l
2.69
877
1658
822
1324
8.43
307.65
2.7
1.8
1.27
1.38
g/l
0.69
787
1213
1241
2125
9.83
307.65
6.3
2.0
0.19
0.21
g/l
7.62
1205
1956
1322
2324
10.04
307.65
7.0
4.2
9.31
23.94
ug/l
1.63
1136
1897
2202
10943
6.12
307.65
24.5
16.8
1.22
1.31
inr
14.99
1954
9142
347
161
24.53
307.65
1.7
1.2
314.27
85.71
titre
5.70
110
21
965
732
19.79
307.65
7.0
3.0
558.17
2284.51
u/ml
0.66
897
623
758
535
19.19
307.65
2.3
1.2
1056.47
981.25
titre
0.06
17
16
759
539
19.08
307.65
2.4
1.2
78.25
88.46
titre
0.33
80
52
1806
7161
5.45
307.65
13.0
3.0
50.21
35.64
u/l
6.31
1752
6767
1723
6760
5.16
307.65
9.0
4.2
—
—
—
0
0
461
622
8.71
307.65
2.6
1.3
9.84
18.26
iu/ml
—
18
10
579
392
18.45
307.65
6.9
3.3
257.48
1129.94
u/ml
0.72
537
361
347
161
24.53
307.65
1.7
1.2
150.59
314.00
titre
—
17
5
596
276
27.31
307.65
2.9
1.4
0.82
0.89
g/l
0.35
509
223
906
1666
7.62
307.65
4.0
2.8
11.69
10.50
g/l
10.81
858
1535
1909
6632
7.17
307.65
8.2
2.2
62.67
56.82
u/l
1.95
1857
6093
531
965
6.58
289.25
2.5
1.5
5.48
18.21
iu/ml
0.98
76
25
1015
3240
4.38
284.85
2.9
2.0
—
—
—
0
0
300
281
11.86
282.25
1.2
1.1
1.62
1.48
g/l
4.66
284
250
220
123
19.36
276.43
1.2
1.1
—
—
—
0
0
359
458
8.87
268.67
5.5
2.7
35.20
36.01
umol/l
0.13
332
415
870
2683
4.28
251.95
5.6
2.5
187.39
138.91
ug/g
3.13
812
2145
916
2933
4.19
251.90
2.4
1.3
558.11
497.59
titre
0.42
275
646
366
541
7.65
240.89
1.6
1.3
178.43
310.80
ug/g
19.58
223
312
1559
7357
3.59
235.55
4.8
2.5
—
—
—
0
0
996
3576
3.80
229.32
3.1
2.7
21.60
22.36
%
0.84
949
3322
1014
3867
3.57
210.04
3.2
2.6
2.32
2.29
g/l
1.08
957
3565
764
2445
3.94
205.49
2.8
1.3
—
—
—
0
0
1049
4155
3.47
203.56
3.2
2.7
12.06
12.76
umol/l
2.11
1002
3865
731
2289
3.99
202.56
13.5
7.2
9.26
10.28
mmol/l
3.11
709
2190
1842
10381
3.35
194.20
5.1
2.8
—
—
estimate
—
0
0
291
431
7.43
190.09
1.5
1.3
345.69
247.23
u/ml
3.26
179
240
246
300
8.91
189.58
1.1
1.1
—
—
—
0
0
2181
13740
3.86
189.21
12.4
5.0
6.89
6.72
mmol/l
3.34
2142
13052
149
85
18.48
184.74
49.5
37.6
6.79
7.11
ug/l
0.71
133
77
141
75
19.76
180.53
4.5
2.5
0.59
0.61
mmol/l
2.20
141
75
1036
4341
3.23
179.23
2.6
1.5
2.64
2.45
g/l
2.05
864
2586
693
2300
3.69
173.78
1.7
1.6
—
—
—
0
0
280
438
7.01
173.58
1.7
1.5
—
—
—
0
0
277
444
6.83
167.68
1.6
1.4
22.57
18.06
u/ml
—
6
10
2078
13176
3.38
167.65
20.3
9.5
4.41
4.15
e9/l
4.33
1908
11323
230
306
8.11
164.62
1.1
1.0
—
—
—
0
0
2448
17326
4.82
164.13
33.6
7.6
158.19
78.73
u/l
137.58
2418
16370
138
86
16.84
163.68
37.6
32.2
125.63
126.69
ug/l
0.04
123
73
259
398
7.08
163.06
1.6
1.5
160.31
142.55
au/ml
1.01
64
124
2176
14305
3.51
162.52
14.0
3.1
171.90
45.33
u/l
106.43
2112
13338
1194
5672
2.96
162.07
4.6
2.4
—
—
—
0
0
178
175
10.81
160.77
2.0
1.2
3.44
2.97
g/l
1.68
105
135
178
175
10.81
160.77
2.0
1.2
7.67
6.83
g/l
1.47
106
135
178
175
10.81
160.77
2.0
1.2
0.44
0.41
g/l
0.24
106
136
1946
12043
3.12
160.40
13.1
7.3
1.20
1.21
mmol/l
6.76
1715
10383
175
176
10.55
155.51
1.9
1.2
—
—
—
0
0
1810
10888
2.94
154.79
13.7
6.6
8.92
9.00
%
0.55
1753
10193
766
2898
3.28
154.12
1.8
1.6
—
—
—
0
0
1801
10866
2.91
152.01
13.6
6.5
2.80
2.86
%
0.49
1741
10175
1795
10852
2.89
150.13
13.8
6.6
0.66
0.67
%
0.09
1740
10153
1792
10847
2.88
149.11
12.3
6.7
1.20
1.21
mmol/l
6.05
1719
9973
325
679
5.29
148.76
1.5
1.3
—
—
—
0
0
812
3279
3.10
145.07
9.3
6.1
1.05
1.05
mmol/l
0.03
778
3041
1813
11134
2.85
144.99
13.7
6.5
25.53
27.30
%
9.27
1771
10548
1786
10933
2.81
142.82
13.3
6.4
58.84
57.51
%
4.48
1749
10425
177
204
9.21
142.07
1.3
1.2
54.97
65.65
u/l
0.93
164
177
911
3968
2.94
141.56
6.4
3.4
0.79
0.82
mmol/l
11.62
883
3727
1868
11783
2.83
139.38
13.4
6.3
0.04
0.04
e9/l
0.14
1692
9958
1863
11760
2.82
138.35
13.4
6.3
0.61
0.60
e9/l
1.04
1688
9936
1888
12038
2.82
136.76
13.5
6.4
1.70
1.90
e9/l
9.68
1730
10459
1894
12157
2.80
134.27
13.7
6.5
0.20
0.19
e9/l
0.25
1723
10454
1235
6523
2.62
129.14
3.6
2.4
3.11
2.81
mg/l
3.30
1104
5583
110
71
16.10
127.91
1.8
4.7
—
—
—
0
0
322
770
4.60
124.76
8.1
5.0
1.60
1.50
mg/l
1.18
311
700
1291
7178
2.51
118.32
6.4
4.1
7.40
7.40
ph
0.08
988
5141
154
189
8.57
117.39
6.4
2.1
31.82
6.61
umol/l
6.19
140
131
203
344
6.29
115.64
7.6
5.9
12.46
11.78
mg/l
0.98
189
327
355
1007
3.90
108.95
2.2
1.9
2.84
2.20
ug/l
0.43
325
869
83
42
20.35
108.26
3.1
2.8
33.57
675.07
ug/l
0.46
83
42
1634
10375
2.42
108.07
4.5
2.4
75.36
77.72
nmol/l
2.88
1536
9277
530
2012
3.03
101.94
1.8
1.4
—
—
—
0
0
780
3726
2.53
95.18
3.8
2.2
30.59
29.79
s
2.41
766
3621
1306
7832
2.27
94.35
5.2
3.5
108.05
85.17
e6/l
0.15
1099
5963
112
123
9.45
92.96
1.3
1.2
148.47
76.80
u/l
3.34
102
100
2054
14995
2.47
91.18
7.0
4.8
3627.02
1875.99
e6/l
0.38
42
213
618
2687
2.68
91.14
7.2
3.9
7.37
7.38
ph
0.38
375
1572
89
72
12.74
90.92
1.0
1.1
—
—
—
0
0
89
72
12.74
90.92
1.0
1.0
—
—
—
0
0
670
3045
2.59
90.18
1.5
1.2
—
—
—
0
0
123
160
8.00
89.17
1.1
1.1
307.27
289.38
mg/l
1.11
113
140
610
2662
2.66
89.10
7.2
3.9
5.68
5.84
kpa
4.35
596
2586
987
5411
2.29
86.81
4.1
2.7
7.06
5.15
e6/l
2.32
926
4898
592
2600
2.63
84.96
7.2
4.0
1.18
1.78
mmol/l
3.33
521
2215
1584
10568
2.18
84.33
4.5
3.1
148.99
132.11
ug/l
1.45
1490
9783
1149
6786
2.19
83.34
5.1
3.4
0.54
0.46
e6/l
0.41
947
4968
876
4639
2.30
82.98
4.3
2.9
531.34
536.93
mosm/kgh2o
0.34
801
4032
1384
8853
2.14
81.02
6.2
4.1
49.99
97.63
e6/l
3.27
1111
6238
2065
15507
2.34
79.40
6.7
4.6
—
2.63
—
0
25
619
2863
2.50
79.15
1.5
1.3
—
—
—
0
0
2163
16618
2.42
78.04
8.6
4.3
17.74
12.53
mm/h
32.23
2054
15520
133
223
6.22
76.26
1.2
1.2
—
—
—
0
0
526
2295
2.60
75.73
15.1
8.9
—
—
—
0
0
194
458
4.48
75.57
1.3
1.2
—
—
—
0
0
639
3069
2.41
74.75
3.4
2.7
1.93
1.77
%
2.35
579
2711
437
1749
2.78
74.62
13.9
8.8
24.35
24.90
mmol/l
2.32
431
1741
133
232
5.97
73.24
2.4
2.5
20.29
42.39
iu/ml
0.99
19
27
1077
6481
2.09
71.67
5.1
3.3
1.16
0.00
estimate
—
5
29
400
1568
2.82
70.85
1.4
1.5
—
—
—
0
0
269
855
3.38
68.51
1.8
1.7
0.34
0.30
mg/l
0.35
73
414
1139
7136
2.02
66.58
4.0
3.3
—
—
—
0
0
512
2373
2.42
63.88
13.3
8.2
112.95
121.40
g/l
15.89
505
2313
542
2584
2.37
63.41
12.9
7.9
96.36
95.22
%
5.54
533
2485
511
2386
2.40
62.60
3.0
2.7
72.21
68.43
e9/l
1.09
384
1723
501
2324
2.41
62.25
12.6
7.8
1.39
1.37
mmol/l
0.14
489
2275
584
2898
2.29
62.11
12.5
7.6
7.41
7.42
ph
0.23
297
1570
581
2884
2.29
61.70
12.3
7.5
0.26
0.89
mmol/l
3.07
492
2381
388
1604
2.65
61.49
7.5
4.3
23.58
24.09
mmol/l
2.39
382
1586
1316
8880
1.93
60.07
3.0
2.2
—
—
—
0
0
1462
10237
1.92
59.38
28.2
11.3
0.00
0.00
e9/l
0.36
1242
8267
62
56
11.30
58.94
1.1
1.1
—
—
—
0
0
574
2908
2.23
57.62
12.6
7.5
12.76
12.12
kpa
1.93
562
2787
347
1404
2.68
57.20
14.1
10.2
15.04
15.92
%
6.32
341
1350
573
2909
2.23
57.18
12.7
7.6
4.95
5.12
kpa
4.28
560
2787
1309
8926
1.89
56.81
6.0
3.9
36.85
119.42
ng/l
1.02
1056
6535
1626
11913
1.90
56.10
5.5
3.9
0.00
0.00
estimate
0.50
408
2469
437
1996
2.41
55.76
5.8
4.3
0.65
0.71
%
0.22
209
609
450
2091
2.38
55.20
6.1
4.4
0.88
0.88
%
0.02
221
638
454
2119
2.37
55.12
2.9
2.2
357.18
377.18
nmol/l
1.09
433
1955
1646
12145
1.89
55.12
5.6
3.9
0.04
0.14
estimate
0.34
394
2374
1633
12060
1.87
54.06
5.6
3.9
20.10
3.68
estimate
1.31
419
2524
701
3945
2.04
52.99
4.2
3.2
2.47
2.06
e6/l
0.55
407
1947
1076
7041
1.87
51.74
12.6
6.3
—
—
—
0
0
303
1208
2.70
51.20
1.9
1.8
1.43
1.50
g/l
0.58
257
1042
737
4282
1.99
50.58
4.1
3.1
1.33
1.12
e6/l
0.68
447
2291
372
1650
2.45
50.33
15.9
9.7
94.66
93.78
%
2.67
372
1643
280
1088
2.75
49.69
1.4
1.2
—
—
—
0
0
423
2008
2.31
49.00
6.2
4.4
0.06
0.12
%
1.62
193
555
1346
9577
1.80
48.10
4.7
3.5
6.21
6.26
ph
0.93
753
5216
241
880
2.91
48.02
4.4
2.4
21.89
21.15
s
1.31
228
798
1192
8211
1.80
47.26
5.6
3.5
2.33
2.36
mmol/l
9.95
1108
7446
420
2017
2.28
47.22
6.4
4.6
0.05
0.28
%
0.85
176
523
805
4941
1.89
46.21
1.5
1.3
1.90
2.07
u/ml
0.12
191
1270
802
4919
1.89
46.13
8.2
4.7
—
—
—
0
0
795
4902
1.88
44.74
2.6
1.8
2.00
1.37
mg/l
2.31
661
3775
517
2750
2.08
44.70
2.1
1.7
—
—
—
0
0
447
2254
2.17
44.39
6.9
3.5
4.66
4.59
kpa
0.28
432
2186
958
6323
1.79
42.79
1.6
1.4
—
—
—
0
0
615
3535
1.95
42.55
2.0
1.9
—
—
—
0
0
502
2697
2.05
42.01
1.9
1.4
—
—
—
0
0
379
1835
2.24
41.46
5.7
3.7
1.22
1.23
mmol/l
1.36
358
1561
363
1731
2.26
41.18
7.3
4.2
4.97
5.15
kpa
4.22
347
1664
2489
21960
2.43
41.15
51.0
16.2
32.31
25.26
mg/l
23.82
2423
18059
58
78
7.57
40.77
2.3
2.4
3610.81
767.47
e6/l
0.58
42
57
266
1120
2.52
39.89
5.5
3.2
24.42
25.19
mmol/l
2.96
257
1078
353
1693
2.25
39.41
7.4
4.2
7.42
7.41
ph
0.56
312
1403
52
67
7.89
37.90
2.3
2.0
—
—
—
0
0
1081
7606
1.69
37.11
3.6
3.3
1526.48
1587.33
ng/l
0.19
960
6583
902
6070
1.72
36.32
4.2
2.8
351.80
349.06
umol/l
0.29
829
5286
1405
10644
1.66
35.88
2.5
2.2
91.76
95.68
pmol/l
2.39
840
5575
324
1557
2.23
35.85
5.9
3.3
119.64
128.83
g/l
10.55
315
1517
52
72
7.34
35.63
2.3
2.1
8586.57
28920.66
e6/l
0.37
28
41
130
393
3.42
35.54
4.1
3.7
1.50
1.61
%
0.11
122
346
492
2772
1.94
35.44
4.4
3.1
4.24
4.45
e9/l
0.46
426
2368
148
488
3.15
35.14
5.2
4.4
2.65
2.78
mmol/l
0.26
103
336
48
62
7.86
34.91
2.2
2.4
8.64
9.71
mg/l
0.43
37
53
155
528
3.05
34.81
4.8
3.8
—
—
—
0
0
50
70
7.26
33.93
4.0
4.7
8.06
8.77
mg/l
0.30
42
62
307
1477
2.21
33.79
9.4
6.1
23.80
24.55
mmol/l
2.75
297
1409
753
4922
1.73
33.10
2.0
1.7
434.99
27141178.47
pmol/l
3.74
648
4064
724
4691
1.74
32.79
4.8
3.9
109.38
655.95
ng/l
2.18
585
3831
670
4255
1.76
32.53
2.0
1.8
1224.25
1166.37
nmol/l
0.76
533
3174
95
254
3.84
31.18
1.1
1.1
—
—
—
0
0
987
7015
1.64
31.15
2.0
1.7
19.50
20.08
nmol/l
0.63
891
5910
357
1878
2.04
31.01
6.2
4.1
96.09
91.63
ng/l
0.40
320
1624
237
1067
2.34
30.47
6.7
4.6
1.57
1.60
%
0.13
230
999
938
6642
1.63
29.72
5.7
4.0
0.00
0.00
estimate
0.06
376
2231
1188
8903
1.59
29.70
5.6
3.9
1.38
0.29
estimate
0.36
367
2039
275
1338
2.17
29.29
5.2
3.0
1.14
1.16
%
0.20
275
1326
219
977
2.35
28.72
7.0
4.8
0.88
0.87
%
0.18
212
916
2487
22533
2.10
28.68
51.6
19.6
138.99
139.65
mmol/l
32.17
2473
22076
272
1330
2.16
28.59
5.3
3.0
0.69
0.61
%
3.22
272
1321
2488
22577
2.09
28.06
51.7
19.7
3.94
3.99
mmol/l
16.42
2472
22075
119
397
3.09
27.70
4.9
3.4
4.46
4.23
e9/l
0.37
119
397
290
1472
2.08
27.63
6.4
4.3
—
—
—
0
0
878
6247
1.60
26.62
5.2
3.4
0.11
0.05
estimate
0.37
347
1908
721
4896
1.64
26.45
5.0
3.0
2.48
2.45
mmol/l
6.64
657
4399
42
64
6.65
26.39
1.5
1.5
9.44
14.26
g/l
3.03
28
54
328
1783
1.95
25.73
6.4
4.0
—
—
—
0
0
135
506
2.75
25.46
4.9
3.3
57.94
58.12
%
0.05
135
506
38
55
6.99
25.03
3.2
3.7
93.62
99.32
au/ml
—
9
11
191
854
2.33
24.87
4.1
3.0
24.04
24.85
mmol/l
1.95
184
842
167
705
2.46
24.73
7.0
5.4
1.30
1.32
mmol/l
0.13
147
615
389
2274
1.83
24.31
5.7
4.5
7.38
7.35
ph
4.30
324
1602
173
750
2.39
24.16
9.6
4.2
8.95
8.38
kpa
3.44
167
735
344
1939
1.89
24.13
3.2
2.5
0.48
0.47
e6/l
0.03
333
1863
873
6354
1.55
23.30
4.0
3.0
0.14
0.05
0.41
22
172
241
1228
2.06
22.61
8.5
4.4
—
—
—
0
0
81
247
3.35
21.90
3.4
4.0
—
—
—
0
0
150
641
2.42
21.63
4.6
3.5
2.66
2.51
index
0.07
97
328
204
1001
2.12
21.13
8.8
4.6
24.21
24.65
mmol/l
1.29
193
932
2491
23044
1.88
20.15
39.0
11.7
39.58
25.58
u/l
72.50
2465
22311
1000
7690
1.47
19.70
5.0
4.1
10.39
9.07
mg/mmol
0.28
673
4843
1038
8048
1.47
19.57
4.2
3.4
7.02
7.53
mmol/l
3.46
893
6807
111
432
2.64
19.48
2.8
1.8
0.89
0.85
nmol/l
0.17
98
362
34
59
5.82
18.84
1.2
1.4
17.63
26.86
g/l
2.45
23
50
60
166
3.67
18.83
1.3
1.1
—
—
—
0
0
28
40
7.06
18.66
1.9
1.3
—
—
—
0
0
78
257
3.09
18.61
3.8
3.6
63.26
58.30
%
1.25
69
218
120
500
2.46
18.30
4.6
3.0
90.86
89.23
%
1.67
113
488
348
2132
1.72
18.25
2.3
2.6
65.72
66.22
g/l
0.52
320
1948
89
320
2.84
18.20
1.9
1.4
—
—
—
0
0
89
320
2.84
18.20
1.9
1.4
—
—
—
0
0
89
320
2.84
18.20
1.9
1.4
—
—
—
0
0
89
320
2.84
18.20
1.9
1.4
—
—
—
0
0
958
7402
1.45
18.00
2.8
2.2
274.11
230.68
u/l
0.23
919
7010
174
860
2.09
17.68
3.9
3.8
309.28
293.73
mg/l
0.06
111
389
2041
18193
1.48
16.95
55.1
20.2
14.32
13.69
%
59.05
2033
17928
754
5617
1.47
16.92
4.8
3.8
0.13
0.11
—
8
61
176
894
2.04
16.61
1.7
1.7
9.52
7.29
iu/ml
0.16
29
205
2501
23383
1.78
16.48
56.7
21.3
82.86
79.90
umol/l
2.98
2487
23070
962
7541
1.42
16.31
4.2
3.5
41.34
49.18
mg/l
0.70
665
4886
67
226
3.01
15.41
1.2
1.1
—
—
—
0
0
124
567
2.24
15.34
3.6
2.2
119.88
129.07
g/l
3.59
103
436
109
474
2.35
15.17
8.8
6.3
11.48
11.39
mmol/l
0.09
103
417
109
475
2.35
15.10
8.8
6.3
106.12
105.17
mmol/l
1.40
103
418
33
71
4.69
14.47
1.2
1.1
—
—
—
0
0
64
224
2.90
13.82
1.6
1.3
1.21
1.54
nmol/l
1.30
57
200
34
78
4.40
13.79
1.7
1.6
3591.11
2690.91
titre
—
9
11
91
386
2.40
13.42
1.1
1.3
—
20.86
—
0
7
37
94
3.98
13.16
1.1
1.1
1492.70
1527.95
miu/ml
0.07
37
94
64
233
2.79
12.88
6.0
3.3
12.84
12.31
index
0.21
58
129
124
614
2.07
12.58
1.4
1.1
—
—
—
0
0
38
104
3.69
12.21
2.6
3.0
2176.50
1025.36
u/ml
0.73
38
104
37
103
3.63
11.61
1.5
4.6
70.33
72.08
mg/l
0.06
27
79
78
334
2.37
11.31
1.1
1.1
181.36
127.20
iu/ml
—
10
64
114
572
2.04
11.19
1.8
2.0
12.52
11.97
mg/l
0.24
106
532
312
2100
1.55
11.01
3.7
2.3
4.86
7.57
ug/l
3.21
266
1835
113
570
2.02
10.94
1.2
1.3
231.25
222.16
miu/ml
0.08
32
244
159
899
1.82
10.93
2.1
2.3
719.34
738.69
ug/l
0.01
153
847
103
504
2.08
10.83
1.3
1.6
—
—
—
0
0
84
383
2.23
10.56
1.9
2.2
0.99
0.88
%
1.04
73
263
33
91
3.66
10.52
1.2
1.9
44.45
99.64
umol/l
2.42
11
59
25
56
4.50
10.48
1.2
1.1
1233.33
680.00
titre
—
6
10
185
1110
1.71
10.38
2.7
2.2
0.00
0.74
estimate
0.51
37
341
117
610
1.96
10.34
1.3
1.1
—
—
—
0
0
58
226
2.60
10.30
1.2
1.1
—
—
—
0
0
40
130
3.11
9.90
1.7
1.3
—
—
—
0
0
2506
23921
1.55
9.36
66.5
24.7
7.19
6.80
e9/l
5.58
2477
23282
2504
23908
1.54
9.23
66.5
24.7
249.28
247.09
e9/l
0.71
2482
23356
88
432
2.07
9.22
5.5
3.2
9.92
9.43
pmol/l
0.16
88
432
2504
23912
1.54
9.18
66.3
24.6
91.10
91.23
fl
0.74
2489
23601
2504
23914
1.54
9.15
66.2
24.6
30.17
30.36
pg
5.42
2488
23601
2504
23915
1.54
9.14
66.4
24.7
4.27
4.47
e12/l
58.84
2475
23287
2504
23916
1.54
9.12
68.4
25.2
38.26
40.34
%
20.75
2487
23592
2504
23921
1.53
9.06
67.1
24.9
126.82
134.68
g/l
103.26
2488
23618
52
206
2.55
8.97
1.9
2.6
986.32
1206.78
e6/l
1.14
44
179
48
184
2.64
8.85
1.2
1.1
—
—
—
0
0
293
2042
1.49
8.74
3.0
3.0
219.02
227.66
ng/l
0.13
275
1865
101
532
1.93
8.71
1.2
1.1
6.45
7.60
eliau/ml
—
10
61
39
135
2.92
8.70
2.6
2.3
8.29
7.76
mmol/l
0.45
39
135
659
5277
1.33
8.67
5.7
4.1
1.02
1.31
kg/l
0.50
476
3486
136
788
1.76
8.67
1.3
1.2
0.30
0.84
u/ml
—
7
55
36
120
3.03
8.58
3.0
2.8
—
—
—
0
0
57
244
2.36
8.36
1.0
1.1
—
—
—
0
0
255
1747
1.51
8.26
1.2
1.2
—
—
—
0
0
108
597
1.84
8.06
1.3
1.2
4.94
8.67
u/ml
—
10
83
112
629
1.81
7.95
1.3
1.2
37.17
41.10
u/ml
—
6
29
93
492
1.92
7.95
1.9
1.4
54.59
62.47
mmol/l
1.10
69
395
101
550
1.87
7.91
6.9
4.4
—
—
—
0
0
143
867
1.69
7.78
1.9
3.2
48.96
47.13
mg/l
0.19
116
724
107
597
1.82
7.76
1.3
1.2
1.40
3.61
u/ml
—
5
52
94
504
1.90
7.73
2.7
2.4
142.30
95.64
ug/min
0.34
58
312
301
2160
1.44
7.71
2.7
2.2
0.02
0.01
estimate
0.14
53
428
142
867
1.67
7.53
1.9
3.2
55.97
71.61
mg/l
0.27
113
727
43
173
2.51
7.25
1.2
1.1
—
—
—
0
0
127
775
1.67
6.78
1.9
3.1
1.41
2.73
ratio
1.52
68
440
139
2138
0.63
6.51
1.8
2.0
3.44
3.52
ratio
0.34
116
1675
31
114
2.74
6.28
2.7
2.3
500.78
500.44
min
0.01
23
82
50
231
2.19
6.23
2.4
2.4
—
—
—
0
0
17
43
3.97
6.16
2.3
1.3
—
—
—
0
0
57
280
2.06
6.08
1.2
1.4
352.42
313.51
pmol/l
0.16
50
242
26
89
2.94
6.00
2.0
1.7
—
—
—
0
0
172
1163
1.51
5.98
5.2
3.5
1.02
1.02
ratio
0.09
167
1052
98
1580
0.61
5.63
1.5
1.8
3.09
3.45
mmol/l
1.95
72
1106
154
1033
1.52
5.58
1.9
2.4
4.32
4.17
g/l
1.28
141
944
154
1033
1.52
5.58
1.9
2.4
7.64
7.39
g/l
0.99
141
944
36
153
2.37
5.48
2.1
3.0
177.80
214.07
e6/l
0.46
30
133
153
1033
1.51
5.38
1.9
2.4
3.84
3.66
g/l
0.91
141
945
148
996
1.51
5.29
1.3
1.2
—
—
—
0
0
58
304
1.93
5.22
1.3
1.4
126.17
76.99
mu/l
0.35
53
271
1823
17035
1.21
5.11
4.6
4.2
14.88
14.88
pmol/l
0.01
1681
15486
35
152
2.32
5.10
1.8
2.8
429.35
550.45
e6/l
0.62
26
123
32
134
2.40
5.05
3.2
2.6
15.43
16.22
%
0.49
32
134
30
122
2.48
5.04
1.5
1.4
1.03
1.28
nmol/l
0.75
25
93
35
153
2.30
5.03
2.7
2.5
772.75
624.04
ml
0.95
24
96
147
1000
1.50
5.01
1.2
1.1
66.00
169.46
titre
—
5
26
2139
20325
1.24
5.00
5.6
5.2
2.08
1.96
mu/l
1.30
1985
18692
13
24
5.44
4.91
1.2
1.1
—
—
—
0
0
26
100
2.62
4.89
1.6
1.7
0.89
3.92
u/field
1.05
19
74
1940
18295
1.21
4.68
55.4
21.2
330.44
332.20
g/l
14.05
1930
18173
15
43
3.50
4.61
1.5
2.2
—
—
—
0
0
16
48
3.35
4.60
1.2
1.6
—
—
—
0
0
73
429
1.72
4.58
1.2
1.2
52.08
38.76
u/l
0.30
65
371
132
896
1.50
4.57
2.0
2.5
11.64
10.30
g/l
2.23
118
799
64
363
1.78
4.54
1.6
2.0
4.63
5.08
mmol/24h
0.38
56
315
82
500
1.66
4.50
4.5
3.4
33.82
29.05
mg/l
0.63
60
353
48
255
1.90
4.21
1.2
1.1
—
—
—
0
0
168
1216
1.41
4.18
2.4
2.4
—
—
—
0
0
112
1637
0.67
4.17
1.3
1.4
—
—
—
0
0
18
62
2.92
4.17
1.4
1.5
—
—
—
0
0
2128
20321
1.21
4.15
5.1
4.3
1.31
1.27
mmol/l
2.07
1957
18537
81
508
1.61
4.02
2.3
2.2
969.29
6240.53
u/l
3.02
21
207
36
176
2.06
4.00
1.6
1.3
0.80
1.26
promille
0.98
27
139
53
296
1.81
4.00
1.8
2.3
26.61
21.80
mg/l
0.26
18
112
2230
21425
1.22
3.91
6.3
5.1
4.35
4.56
mmol/l
17.27
2083
19907
49
271
1.82
3.83
1.2
1.2
—
—
—
0
0
20
77
2.61
3.80
1.9
2.1
34.95
29.55
%
0.87
20
77
19
72
2.65
3.73
1.4
1.6
13.60
14.90
pmol/l
0.63
14
57
17
61
2.80
3.68
1.2
1.2
10.41
11.74
pmol/l
—
5
20
2191
21052
1.20
3.64
5.9
5.2
6.17
5.95
mmol/l
9.17
2039
19174
37
190
1.96
3.63
1.4
1.4
27.50
27.89
%
0.02
21
114
232
1813
1.31
3.55
3.4
2.8
6.03
6.07
ph
0.38
159
1242
8
13
6.17
3.50
1.0
2.0
—
—
—
0
0
340
2792
1.25
3.49
4.7
5.0
33.47
32.89
%
0.41
256
1816
61
972
0.62
3.45
1.1
1.1
—
—
—
0
0
57
342
1.68
3.41
2.5
2.8
—
—
—
0
0
18
70
2.58
3.38
1.4
1.1
—
—
—
0
0
50
290
1.74
3.38
1.3
1.3
—
—
—
0
0
13
42
3.11
3.37
1.2
1.2
—
—
—
0
0
31
154
2.02
3.35
1.6
2.8
7.48
6.93
mmol/l
0.55
23
100
42
232
1.82
3.34
1.1
1.2
—
—
—
0
0
2150
20668
1.19
3.33
8.5
6.4
40.94
39.46
mmol/mol
8.73
2019
19222
20
83
2.42
3.30
3.4
3.6
14.87
12.91
%
0.17
15
78
151
1121
1.37
3.29
1.2
1.1
1.02
1.46
u/ml
—
5
11
7
11
6.38
3.18
1.0
1.9
—
—
—
0
0
22
100
2.21
2.99
3.5
3.1
—
—
—
0
0
61
387
1.59
2.97
1.5
1.5
30.92
31.55
g/l
0.15
54
345
713
7949
0.86
2.97
3.9
3.2
—
—
—
0
0
41
234
1.76
2.96
1.4
1.6
66.75
63.95
%
0.15
20
147
47
280
1.69
2.93
1.3
1.4
278.03
277.42
mosm/kgh2o
0.05
35
205
26
128
2.04
2.91
1.3
1.5
—
—
—
0
0
50
304
1.66
2.89
1.5
1.4
27243.34
72943.11
e6/l
0.97
29
170
15
58
2.59
2.87
1.5
2.3
—
—
—
0
0
12
38
3.17
2.85
1.3
1.1
1.41
2.57
mmol/l
—
7
28
54
337
1.61
2.83
1.5
1.4
2626.44
1839.70
e6/l
0.21
39
230
34
186
1.84
2.83
1.1
1.1
93.15
106.03
pmol/l
0.83
34
186
33
179
1.85
2.82
2.2
2.1
1.29
1.61
u/field
0.30
17
98
39
650
0.59
2.72
1.2
1.1
0.66
0.65
ratio
—
7
91
20
92
2.18
2.67
2.9
3.3
—
—
—
0
0
57
367
1.56
2.65
1.2
1.1
—
—
—
0
0
57
368
1.56
2.62
1.2
1.1
—
—
—
0
0
51
321
1.60
2.61
1.4
1.2
4.06
4.58
u/ml
0.16
32
147
449
3911
1.18
2.53
1.3
1.3
39.65
32.44
iu/ml
0.38
146
1167
45
702
0.64
2.41
1.2
1.2
1.55
1.52
g/l
0.30
45
702
15
64
2.35
2.38
3.1
3.6
0.08
0.31
e9/l
—
6
32
45
283
1.60
2.34
1.7
1.6
—
—
—
0
0
164
1301
1.28
2.32
3.3
3.4
4.35
4.49
pmol/l
1.03
147
1158
44
276
1.60
2.31
1.4
1.5
0.36
0.32
nmol/l
0.16
37
212
17
78
2.19
2.31
1.4
1.2
845.20
131.41
ug/l
—
9
37
85
614
1.40
2.28
1.3
1.5
8.82
8.50
u/l
0.06
70
481
2242
21798
1.16
2.27
6.5
5.8
2.46
2.65
mmol/l
20.74
2082
20164
418
3655
1.17
2.25
1.3
1.3
6.47
11.30
u/ml
1.12
143
1359
9
29
3.11
2.22
1.4
1.6
1.12
1.30
umol/l
—
9
19
89
652
1.38
2.20
1.1
1.1
—
—
—
0
0
6
14
4.29
2.15
1.2
1.2
—
—
—
0
0
38
235
1.63
2.14
1.3
2.0
—
—
—
0
0
27
152
1.78
2.12
1.2
1.4
7.36
7.41
ph
0.47
18
105
31
184
1.69
2.04
4.5
2.6
31.52
32.14
mg/l
0.03
23
139
44
287
1.54
2.00
1.2
1.1
3.51
2.98
eliau/ml
0.17
17
118
20
104
1.93
2.00
1.0
1.1
—
—
—
0
0
2187
21277
1.14
1.99
6.0
5.0
1.40
1.45
mmol/l
7.30
2025
19633
36
225
1.61
1.96
1.4
1.3
—
—
—
0
0
14
66
2.13
1.82
1.3
1.3
28.21
28.77
s
0.14
14
66
23
132
1.75
1.73
2.0
2.8
37.30
38.73
%
0.12
14
69
36
542
0.66
1.72
1.3
1.2
—
—
—
0
0
43
291
1.49
1.69
1.2
1.2
—
—
—
0
0
42
283
1.49
1.69
1.9
2.2
1.03
1.42
g/24h
0.65
27
175
75
563
1.34
1.66
4.1
3.3
0.79
0.80
nmol/l
0.17
56
462
76
572
1.34
1.66
2.0
1.6
12472.61
14783.17
e6/l
0.29
51
385
30
188
1.60
1.66
2.8
2.9
18.55
22.19
mg/l
0.18
18
147
21
120
1.76
1.62
2.1
1.6
10.85
8.73
ug/l
0.29
16
104
85
660
1.30
1.52
1.8
1.6
385.45
299.24
mu/l
1.01
80
604
19
108
1.76
1.50
1.2
1.1
—
—
—
0
0
96
759
1.27
1.50
1.6
1.6
24.98
19.52
u/ml
0.24
23
158
448
4933
0.89
1.48
3.1
3.3
0.80
0.79
ug/l
0.05
292
3273
43
301
1.44
1.47
1.5
1.5
—
—
—
0
0
6
22
2.73
1.43
1.0
1.0
—
—
—
0
0
48
348
1.39
1.37
3.3
2.5
—
—
—
0
0
15
83
1.81
1.31
2.5
3.2
3.37
1.50
ug/l
0.85
15
77
33
227
1.46
1.26
1.8
2.1
—
—
—
0
0
27
178
1.52
1.26
1.1
1.2
—
67.45
—
0
11
115
956
1.21
1.20
2.5
2.7
—
—
—
0
0
17
102
1.67
1.16
1.1
1.2
1.10
1.06
ratio
—
10
82
98
806
1.22
1.14
1.3
1.5
26.55
25.56
iu/l
0.09
77
662
39
283
1.38
1.14
1.5
1.4
—
—
—
0
0
7
30
2.34
1.12
1.0
1.3
—
629.33
—
0
7
959
9125
1.08
1.12
2.3
1.9
1.37
1.34
mmol/l
0.56
828
7689
34
243
1.40
1.09
2.2
2.8
—
—
—
0
0
36
260
1.39
1.09
1.2
1.3
—
—
nmol/l
—
0
0
12
66
1.82
1.09
1.3
1.2
62.37
58.56
%
0.13
12
56
12
66
1.82
1.09
1.6
1.6
88.17
607.45
nmol/24h
0.64
12
66
12
66
1.82
1.09
1.2
1.2
36.13
39.44
g/l
—
6
35
22
144
1.53
1.08
2.3
1.5
82.55
84.10
umol/l
0.08
22
144
17
267
0.63
1.07
1.6
1.5
—
—
—
0
0
15
89
1.69
1.07
1.3
1.3
155.67
170.49
mmol/24h
0.41
15
89
126
1071
1.18
1.06
2.5
2.0
—
—
—
0
0
7
33
2.12
1.05
1.0
1.2
—
—
—
0
0
41
306
1.35
1.03
1.1
1.2
—
—
—
0
0
12
68
1.77
1.00
1.3
1.4
5.95
7.72
mmol/l
1.14
12
68
9
48
1.88
1.00
9.4
7.1
5.72
5.30
kpa
—
9
48
38
282
1.35
1.00
1.2
1.3
0.20
0.24
nmol/l
0.27
30
232
18
115
1.57
0.99
1.2
1.6
—
—
—
0
0
159
1387
1.16
0.99
1.4
1.3
182.02
222.72
u/ml
0.56
144
1289
9
49
1.84
0.98
1.1
1.1
—
—
—
0
0
46
353
1.31
0.98
1.7
1.7
—
—
—
0
0
17
259
0.65
0.96
1.5
1.4
—
—
—
0
0
13
78
1.67
0.91
1.0
1.0
—
—
—
0
0
13
78
1.67
0.91
1.0
1.0
—
—
—
0
0
13
78
1.67
0.91
1.0
1.0
—
—
—
0
0
8
43
1.86
0.87
1.1
1.3
—
145.75
—
0
8
160
1422
1.13
0.80
1.1
1.3
—
—
—
0
0
15
99
1.52
0.75
1.2
1.6
38.97
40.15
g/l
0.30
15
99
5
24
2.09
0.74
1.0
1.0
115.20
86.67
titre
—
5
24
82
698
1.18
0.74
18.3
10.8
—
—
—
0
0
5
25
2.00
0.72
1.2
4.3
—
—
—
0
0
17
117
1.46
0.71
1.8
1.6
—
—
—
0
0
152
1359
1.13
0.71
1.2
1.2
117.23
142.11
u/ml
0.27
38
482
7
40
1.75
0.71
1.1
1.1
19.37
43.29
mg/l
—
7
34
5
27
1.85
0.68
2.6
3.2
0.96
0.67
ug/l
—
5
27
5
28
1.79
0.66
2.2
2.7
—
—
—
0
0
11
70
1.57
0.65
1.0
1.0
—
—
—
0
0
221
2030
1.10
0.64
1.5
1.5
—
—
—
0
0
23
172
1.34
0.63
1.1
1.3
2.16
2.23
mmol/l
0.14
23
163
75
868
0.86
0.62
1.8
1.7
—
—
—
0
0
13
88
1.48
0.60
1.0
1.1
—
—
—
0
0
20
148
1.35
0.59
1.8
1.7
108.68
119.41
ng/l
0.30
20
148
7
112
0.62
0.58
1.3
1.2
140.14
141.60
nmol/l
—
7
112
6
35
1.72
0.57
2.7
5.9
11.32
8.52
mmol/l
—
6
35
8
54
1.48
0.57
1.6
1.4
—
—
—
0
0
9
62
1.45
0.53
1.0
1.3
—
10.56
%
—
0
9
11
75
1.47
0.50
1.5
2.0
0.00
0.04
estimate
0.49
11
75
27
221
1.22
0.42
1.0
1.1
—
—
—
0
0
0
15
0.00
0.41
0.0
1.5
—
1.56
—
0
8
31
259
1.20
0.40
1.1
1.7
—
—
—
0
0
0
18
0.00
0.40
0.0
1.0
—
0.25
—
0
6
5
35
1.43
0.39
11.4
15.3
4.90
5.85
mmol/l
—
5
35
30
251
1.20
0.39
1.2
1.2
—
—
—
0
0
155
1660
0.93
0.37
2.0
1.7
—
—
—
0
0
161
1511
1.07
0.34
2.5
2.4
21.29
20.02
au/ml
0.08
20
146
12
91
1.32
0.33
1.2
1.2
17.00
10.00
mm/h
0.45
12
91
6
46
1.31
0.33
1.0
1.0
0.19
6.92
u/ml
—
6
41
198
2087
0.94
0.31
2.1
2.4
14.18
13.12
nmol/l
1.09
170
1877
70
764
0.91
0.29
1.6
2.0
—
—
—
0
0
7
57
1.23
0.29
1.1
1.2
47.30
33.39
nmol/l
—
7
44
8
110
0.73
0.28
13.0
12.3
0.60
0.61
mmol/l
—
8
103
63
574
1.10
0.28
1.4
2.0
2.15
4.13
iu/l
4.06
19
221
32
364
0.88
0.27
1.1
1.1
1.41
1.54
u/ml
0.04
19
197
70
760
0.92
0.26
1.6
1.9
—
—
—
0
0
28
321
0.87
0.26
1.8
2.7
—
—
—
0
0
71
769
0.92
0.26
1.6
2.0
—
—
—
0
0
842
8269
1.03
0.25
5.1
5.7
2.53
3.63
ug/l
0.96
748
7442
28
319
0.88
0.25
1.1
1.1
1.63
4.20
u/ml
1.60
15
173
15
124
1.21
0.24
1.0
1.1
1.80
1.02
u/ml
—
8
52
71
765
0.93
0.23
1.6
2.0
—
—
—
0
0
24
274
0.87
0.22
1.1
1.1
0.19
0.29
u/ml
0.33
13
103
15
178
0.84
0.22
1.2
1.2
1.79
2.27
u/ml
—
9
99
0
10
0.00
0.21
0.0
1.4
—
10.83
—
0
10
0
12
0.00
0.21
0.0
1.0
—
20.00
—
0
12
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
0
13
0.00
0.21
0.0
1.3
—
39.75
—
0
8
26
291
0.89
0.19
1.1
1.1
6.12
6.46
u/ml
0.02
14
141
14
162
0.86
0.16
1.3
1.4
209.12
217.58
pmol/l
0.05
14
162
143
1378
1.04
0.16
1.3
1.3
65.22
55.57
au/ml
—
6
99
51
477
1.07
0.15
1.1
1.7
—
—
—
0
0
28
255
1.10
0.15
1.2
2.1
—
—
—
0
0
68
714
0.95
0.13
1.6
2.1
—
—
—
0
0
19
208
0.91
0.10
2.8
2.4
—
—
—
0
0
27
251
1.08
0.10
1.9
1.9
—
—
—
0
0
5
47
1.06
0.09
6.4
6.5
14.20
8.32
%
—
5
47
5
47
1.06
0.09
3.2
3.2
29.00
43.87
%
—
5
47
5
47
1.06
0.09
1.0
1.0
24.16
43.54
iu/ml
—
5
47
33
312
1.06
0.08
1.3
1.2
—
—
—
0
0
35
369
0.95
0.08
1.1
1.1
0.54
1.37
u/ml
0.87
17
179
39
372
1.05
0.07
1.1
1.1
49.02
20.99
au/ml
—
6
84
36
378
0.95
0.07
1.1
1.1
2.75
4.48
u/ml
0.58
19
214
16
147
1.09
0.07
1.0
1.2
—
—
—
0
0
7
82
0.85
0.07
2.0
2.0
—
—
—
0
0
10
89
1.12
0.06
1.5
2.9
15.52
111.61
ug/l
—
10
77
53
513
1.03
0.06
1.2
1.7
518.40
675.42
e6/l
0.12
40
403
14
150
0.93
0.04
1.0
1.1
—
—
—
0
0
52
507
1.03
0.04
1.2
1.7
15.45
37.61
e6/l
0.63
33
381
43
441
0.97
0.03
1.1
1.1
3.25
2.20
u/ml
0.18
25
245
50
501
1.00
0.00
1.4
1.3
—
—
—
0
0
58
579
1.00
0.00
1.2
1.5
465.60
556.06
mg/l
1.49
58
556
12
124
0.97
0.00
1.0
1.1
0.55
1.33
u/ml
—
6
42
17
172
0.99
0.00
6.6
5.3
46.12
51.26
u/ml
—
6
48
11
107
1.03
0.00
1.0
1.0
0.16
3.16
u/ml
—
6
31
10
103
0.97
0.00
1.0
1.2
—
73.50
%
—
0
14
0
9
0.00
0.00
0.0
1.6
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
7.25
—
0
6
0
8
0.00
-0.00
0.0
7.6
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.9
—
—
—
0
0
5
55
0.91
-0.00
2.0
1.5
0.56
0.47
e9/l
—
5
55
6
67
0.90
-0.00
1.0
1.0
12.57
8.94
mu/l
—
6
48
6
62
0.97
-0.00
1.0
1.0
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.5
—
—
—
0
0
0
6
0.00
-0.00
0.0
2.0
—
—
—
0
0

Mortality – FinRegistry

↥

Association

Association between endpoint K11_CHOLANGI and mortality.

Females

Parameter HR [95% CI] p-value
K11_CHOLANGI 2.458 [2.14, 2.83] < 0.001
Birth year 0.992 [0.98, 1.0] 0.054

During the follow-up period (1.1.1998 — 31.12.2019), 2720 out of 6016 females with K11_CHOLANGI died.

Males

Parameter HR [95% CI] p-value
K11_CHOLANGI 2.52 [2.17, 2.93] < 0.001
Birth year 0.987 [0.98, 1.0] 0.009

During the follow-up period (1.1.1998 — 31.12.2019), 2735 out of 5897 males with K11_CHOLANGI died.

Mortality risk

Mortality risk for people of age

years, who have K11_CHOLANGI.

N-year risk Females Males
1 0.165% 0.495%
5 1.088% 2.92%
10 3.025% 7.448%
15 5.777% 13.209%
20 9.879% 21.994%

Relationships between endpoints

↥

Index endpoint: K11_CHOLANGI – Cholangitis (primary sclerosing, PSC)

GWS hits: -

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data